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Tissue engineering is a recently developed field that combines material science, 
cell biology, and engineering to create or improve functional tissues/organs.  The field of 
tissue engineering has progressed from a fledgling science to an emerging technology, in 
large part due to parallel advances in the application of biomaterials and understanding 
stem cell behavior.  Current studies have evaluated certain types of natural and synthetic 
biomaterials for feasibility of replicating the physio-chemical microenvironments of stem 
cells.  Furthermore, technologies derived from micro-machining and solid free-form 
fabrication industries have utilized these biomaterials to create scaffolds that resemble 
tissue-like structures.    
 Recent scaffold fabrication methods have attempted to overcome certain 
challenges in engineering tissues and organs.  One of the fundamental limitations in 
current tissue engineering efforts has been the inability to develop multiple tissue types 
(i.e. bone, cartilage, muscles, ligaments) within a single scaffold structure in a pre-
designed manner.  The differentiation of multiple cells within a three-dimensional (3D) 
 viii
scaffold using a single stem cell population has yet to be developed due to challenges in 
integrating various biochemical factors in a spatially-patterned method.   
This dissertation discusses scaffold micro-fabrication techniques that use layer-
by-layer, ultraviolet-based (UV) stereolithography systems.  These approaches in micro-
fabricating scaffolds provide an optimal, biomimetic environment for the pre-patterned 
differentiation of mesenchymal stem cells into skeletal-type tissues.  We demonstrated 
both laser-based and digital micromirror device-based stereolithography systems for 
creating intricate scaffold architectures with multiple bio-factors encapsulated in pre-
determined regions.  We showed that micro-stereolithography has the powerful capability 
of building 3D complex scaffolds with specific pore sizes and shapes in a layer-by-layer 
fashion using photo-crosslinkable monomers.  These polymer-based scaffolds were 
functionalized with specific signaling proteins to create a biomimetic niche in which stem 
cells can respond, attach, and differentiate.  The ultimate goal of this project is to 
integrate novel concepts of micro-manufacturing along with polymer-controlled release 
kinetics and stem cell biology to attain pre-designed architectures of tissue structures. 
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CHAPTER ONE 
Introduction: Specific Aims and Overview 
1.1 INTRODUCTION 
Over the past few decades, significant advances in the field of tissue engineering 
have established a substantial groundwork for future, novel therapies in repairing and 
reconstructing tissues of the body.  Therapies and regenerative medicine in tissue 
engineering have vastly improved due to the tremendous need for organs and tissues.  
Increased interest in such studies is due to the lack of tissue and organ supplies needed 
for transplantations.  From January 2005 to December 2005, approximately 90,000 
people were on an organ transplant waiting list while only 27,527 people received them 
[1].  A current strategy to remedy this statistic has involved the development of tissue 
engineering constructs, or scaffolds, to serve as a synthetic niche for the organization of 
cells into a three-dimensional (3D) architecture and to provide the stimuli in directing cell 
proliferation and differentiation.  A unique approach to this technique is undertaken in 
this dissertation, with the hopes that it could eventually be refined to allow for arbitrarily 
complex control over the differentiation of stem cells. 
An approach for creating scaffolds capable of engineering functional tissues and 
organs must first overcome a few basic challenges.  One such fundamental limitations in 
current scaffold-derived efforts has been the inability to develop multiple tissue types (i.e. 
bone, cartilage, muscles, ligaments) in a pre-designed manner, within a single scaffold 
structure [2, 3].   Adult progenitor and embryonic stem cells have been shown to 
differentiate into a variety of cell types; however, the simultaneous development of 
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hybrid tissue structures inside a single 3D environment which mimics the complex 
architecture of organs has yet to be reported.  
Growth of multiple cells within a 3D tissue engineering scaffold using a single 
stem cell population have yet to be produced due to the difficulty in integrating multiple 
bio-factors in a spatially-patterned method.  Current methods in fabricating scaffolds only 
allow the incorporation of bio-factors in a bulk manner, (i.e., the factors are randomly 
dispersed all through-out the matrix), creating a microenvironment suitable only for the 
differentiation of a single tissue lineage.  Recent attempts in scaffolding techniques, such 
as solid free-form fabrication (SFF) [4] and constructing scaffolds with various bio-
factors [6], still do not have a prescribed manner of being compartmentalized..  Two 
crucial aspects that must be incorporated into a scaffold design in order to achieve 
patterned microenvironments for the hybrid stem cell differentiation include: (a) creating 
localized concentrations of multiple growth factors (GFs) by controlled spatial-
incorporation while preventing their diffusion to surrounding areas and (b) creating a 
temporal profile of GFs for their precise administration, similarly to the molecular 
signaling present in the physiological environment.  The development of a model 
scaffolding system that incorporates these key features is the emphasis of this 
dissertation.  One measure of success for this system will be the simultaneous 
differentiation of marrow-derived progenitor cells into bone and cartilage inside a single 
3D scaffold environment.    
Another challenge limiting the fabrication of such intricate tissue structures is our 
lack of understanding on how stem cells behave and differentiate under spatially 
distributed biochemical and physical microenvironments, similar to those encountered 
during organ development.  This dissertation is only minimally focused on this issue; 
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however, the proposed scaffolding system offers a method by which this information 
could be applied, once discovered. 
Therapies for orthopedic tissue engineering have dramatically increased within 
recent years and include the harvesting and transplanting of tissue-generating progenitor 
cells, systemic and local administration of growth factors or hormones, and biomimetic 
scaffolds that incorporate various physical and chemical properties [7].  One ultimate 
application of this project is to enable osteochondral replacements and the fabrication of 
specific craniofacial structures, (involving fibrous cartilage, alveolar bone, cementum, 
skeletal muscles, ligaments, etc.) within a single microfabricated scaffold.  However, 
such a proposed method for engineering scaffolds could be applied to a variety of tissue 
regeneration applications.  This research project will significantly advance current efforts 
in the development of complex tissues and organs.  Additionally, our novel methods of 
fabricating intricate scaffold designs would create a new platform for developmental 
biology since cells are driven by specific bioactive chemicals and physical factors.     
   Research presented here will attempt to overcome the challenges already 
iterated with two distinct areas of investigation.  One will be an analysis into the 
feasibility of ultraviolet-based (UV), layer-by-layer stereolithography (SL) processes that 
have the capability of creating precise, spatial distribution of bio-factors within 3D 
scaffolds.  Once this technique is well understood, the other focus will be to investigate 
how physical structure and material of the scaffolds directly affect the differentiation of 
mesenchymal stem cells (MSCs) into multiple cell lineages.  We hypothesize that micro-
fabricated scaffolds through our UV-based SL techniques will ultimately provide an 
optimal, biomimetic environment for the pre-patterned differentiation of MSCs into the 
skeletal tissues.  The long-term goal of this project is to integrate novel concepts of 
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micro-manufacturing along with polymer-controlled release and stem cell biology to 
attain pre-designed architectures of tissue structures. 
  
1.2 SPECIFIC AIMS 
In order to fulfill these objectives, the three specific aims for this project are as 
follows:  
 
1.2.1   Aim 1: To employ a layer-by-layer SL photo-polymerization technique that 
would microfabricate 3D polymer scaffolds with (a) variable porosities and pre-
determined architectures as well as with (b) the precise, spatial distribution of 
various bio-chemical cues and controlled-release microparticles.   
We hypothesized that a layer-by-layer photo-polymerization process would 
enable versatile designs of scaffolds at the micron-level to fabricate complex features 
found in the physiological environment.  The spatial distributions of biochemical and 
physical properties could be pre-designed within the architecture of the 3D scaffold due 
to the nature in which they are created.  Two methods were developed to create these 
temporal spatially-patterned scaffolds: UV laser-based and digital micro-mirror device-
based layer-by-layer SL systems.  With these methods, three controllable biomimetic 
factors present themselves: macro-porosities within the scaffold material, polymeric 
microparticles encapsulated in the scaffold material, and functionalizing with 
extracellular matrix components. 
 
1.2.2  Aim 2: To study whether the covalent functionalization of micro-fabricated 
scaffolds with specific extracellular matrix (ECM) components can (a) provide 
efficient stem cell seeding and (b) mesenchymal stem cell (MSC) differentiation into 
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either osteogenesis and chondrogenic pathway, and (c) create immobilized regions 
of growth factors in order to mimic the physiological environment.   
We hypothesized that the functional modification of these scaffolds with 
conjugated fibronectin and the fibronectin-derived peptide, RGD, would allow for 
optimal cell seeding.  Scaffolds were created with poly(ethylene glycol) diacrylate 
(PEGDA), a non-ionic and hydrophilic monomer characterized to limit cell and protein 
adsorption.  Surfaces were therefore modified with either fibronectin or RGD to mediate 
cellular attachment.  Additionally, the immobilization of heparin/heparan sulfate was 
completed by conjugating it to PEG-esters, thus preventing the diffusion of soluble 
growth factors and creating optimal local concentrations similar to in vivo cellular 
environments.  Specifically basic fibroblast growth factor (FGF-2) was effectively 
sequestered and protected by heparin-modified materials.  
 
1.2.3  Aim 3:  To study the osteogenic growth and differentiation of MSCs within 
microfabricated polymer scaffolds that integrate varying physical and biochemical 
properties.   
This aim was combined with the first two aims to ultimately create a micro-
patterned, polymer-based scaffold with complex architectures and functionalized ECM.  
By creating physical and biochemical microenvironments within the 3D scaffold, MSC 
differentiation would be optimally directed to the formation of osteoblasts. Using 
PEGDA as the biomaterial, patterned scaffolds were created with various architectures, 
and changes in osteoblast gene expression levels were measured.  Fibronectin was 
conjugated to the PEGDA scaffolds upon fabrication to allow MSCs to attach, proliferate, 
and then undergo osteoblast differentiation.  Furthermore, we demonstrated that PEGDA 




The following Chapter Two discusses background and significance of this 
research study and highlights the most recent advances in the fabrication of tissue 
engineering scaffolds and how these cellular microenvironments effect stem cell growth 
and behavior.  Chapter Three discusses a UV laser stereolithography system that can 
precisely pattern ligands, extracellular-matrix components, growth factors, and controlled 
release particles within a single scaffold.  Chapter Four discusses another layer-by-layer 
SL system consisting of a UV light source, a digital micro-mirror masking device, and a 
conventional computer projector.  This system allows fabrication of complex internal 
features coupled with precise spatial distribution of biological factors inside a scaffold.  
This chapter also demonstrates microfabricated scaffolds that allow for the osteogenic 
differentiation using marrow-derived progenitor cells.  Both this system and the one 
introduced in Chapter Three can produce pre-designed, complex internal architectures 
and porosities in the micro- and macro-scale.  Chapter Five discusses osteogenic 
differentiation of mesenchymal stem cells onto microfabricated polymer scaffolds.  
Analyses of extracellular matrix through histology and gene expression show successful 
differentiation of this progenitor cell population into osteoblasts.  Chapter Six discusses 
preliminary studies with the simultaneous differentiation of MSCs into bone- and 
cartilage-like cells using multi-layered scaffolds.  Finally Chapter Seven discusses the 
overall conclusions from this study and recommendations for future work.  
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Background and Significance 
2.1  CURRENT TRENDS IN TISSUE ENGINEERING 
Although organ transplantations have steadily advanced over the past several 
decades, there still exists an immense shortage of organ donors.  State of the art 
techniques in the field of tissue engineering have progressed from a fledgling science to 
an emerging technology, in large part due to parallel advances in modifying biomaterials 
and understanding stem cell behavior in the nano- and micro-scales.  Therapies in modern 
medicine have included the prevention, control, or eradication of diseases and disorders, 
and more recently, the restoration and replacement of non-functional organs through 
tissue engineering methods are becoming a possibility [1].  Complete tissue and organ 
replacement using stem cells is still a milestone in which current studies are laying the 
necessary groundwork.   
Current research studies have evaluated how certain types of materials have been 
used as substrates to mimic the physiochemical microenvironments of cells and tissues 
[2, 3].  Multiple, pre-differentiated stem cell populations combined with biomaterials 
have also been utilized to form hybrid constructs that closely mimic native tissue [4, 5].  
Presently, there exist many studies in clinically and experimentally designing 
biodegradable and bioresorbable materials to regenerate skin, bone, and cartilage for 
orthopedic, dental, and craniofacial applications.  Three general approaches have been 
used to devise systems for the regeneration of these tissues: (a) the use of scaffolding 
materials to draw specific cells into the defect site and provide a protective, regenerative 
environment, (b) the release of tissue inductive factors either directly integrated or 
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released from the matrix, and (c) the use of cell transplantation in which precursor cells 
are seeded into an appropriate environment and then moved to the defect site to form 
structurally and functionally integrated tissue.   
 
2.2  STEM CELLS IN TISSUE ENGINEERING 
Recent developments in tissue engineering have been driven by novel discoveries 
in stem cell expansion, differentiation, and methods of culture.  Stem cells are simply 
defined as a progeny of cells that have the potential to differentiate into lineages of any 
phenotype.   In literature, embryonic and adult stem cells are the two classifications and 
are distinguished by their differentiation potential.  It is well-established that the fertilized 
egg is classified as the ultimate stem cell, with the defining characteristic of giving rise to 
a plethora of undifferentiated cell lineages.  The term totipotent has been commonly used 
to classify stem cells that have the capability of differentiating into all tissues of the body.  
Embryonic stem cells are daughter cells that form from early divisions of a fertilized egg 
and retain their complete totipotent capability.   
Tissue renewal in adults, however, involves adult stem cells that are less 
totipotent and are more committed than embryonic stem cells.  Adult stem cells are 
referred to as progenitor, multipotent, or pluripotent cells since they have a more limited 
differentiation capacity and are found in several adult tissues, such as the bone marrow.  
Bone-marrow derived progenitor cells or mesenchymal stem cells (MSCs) have been 
regarded as an attractive cell population for the field of tissue engineering because of (a) 
their multipotent differentiation into end-state mesenchymal cell types and (b) their ease 
in harvest, isolation and expansion in vitro.  Before surveying the vast range of methods 
and materials currently used to understand MSCs behavior, their isolation, 
characterization, and differentiation lineages should first be examined.   
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2.3 SOURCES, CHARACTERIZATION, AND DIFFERENTIATION LINEAGES OF 
MESENCHYMAL STEM CELLS 
The primary source for isolating MSCs is in the bone marrow, but their existence 
in smaller populations have also been found in other tissues, such as in adipose tissue, 
muscle and peripheral blood [6-9].  Cells derived from the bone marrow are a 
heterogeneous population that includes both committed and progenitor cells [10].  Bone-
marrow derived MSCs have a fibroblast-like morphology in culture and are adherent to 
tissue-culture treated surfaces.  Since these progenitor cells coexist in the marrow with 
non-adherent hematopoietic cells, MSCs can be easily separated from this population by 
aspirating the floating cells 3-4 days after plating the marrow-derived cells in a treated 
plate.  Another purification method involves fractionating aspirated bone marrow based 
on a density gradient solution, such as Percoll.   
Because the marrow consists of a variety of subpopulations, an array of MSC-
specific surface markers have been determined to further purify these progenitor cells.  
As examples, the STRO-1 antibody reacts with non-hematopoietic bone marrow stromal 
cells [11-13], and the SB-10 antibody reacts with an antigen (CD166) specific to 
undifferentiated MSC populations [14, 15].  Additionally, SH-2 binds to endoglin of 
transforming growth factor-β (TGF-β) [16], and SH-3/SH-4 antibodies recognize the 
CD73 antigen on undifferentiated cells [17].  These antibodies do not react with 
osteogenic, differentiated MSCs, and with hematopoietic cells.  Hematopoietic cells can 
also be removed from MSC cultures by their negative selection using anti-CD1, anti-
CD14, anti-CD31 markers [18].                 
MSCs differentiate into a variety of end-state cell types, such as adipose tissue, 
bone, cartilage, fibroblasts, muscle, ligament, and tendon , as depicted in Figure 2.1 [19-
24].  The adipocyte phenotypic pathway for MSCs and their presence in the marrow are 
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still not yet well-established.  One theory suggests adipogenic MSCs act as space-
regulatory cells to expand or contract based on the need for hematopoiesis.  For instance, 
population of adipogenic cells within the marrow increases when hematopoiesis declines 
and vice versa.  MSCs undergoing adipogenesis in vitro have a rounded morphology and 
increased lipid content.   
Previous studies suggest that cell morphology and the amount of tension 
presented by the cytoskeleton can regulate MSC differentiation into either the adipogenic 
or osteogenic pathway based on RhoA activity, a small G-protein part of the Rho 
signaling family.  In response to extracellular signals, RhoA controls cell morphology 
and structure through actin cytoskeleton reorganization.  Various factors downstream of 
the RhoA signaling cascade act on cytoskeletal morphology to affect overall stress fiber 
formation.  Because RhoA activity within osteogenic precursor cells increases, 
osteoblasts adopt a more flattened morphology than adipocytes [25].  In addition to the 
Rho intracellular signaling pathway, osteogenesis of human MSCs can be chemically 
induced both in vitro and in vivo, using the mitogen, basic fibroblast growth factor (FGF-
2) [26].  Matrix mineralization and gene expression of bone-specific molecules, such as 
osteopontin, osteocalcin, and alkaline phosphatase, are generally used to classify in vitro 
osteogenesis for MSCs. 
Chondrogenic pathway of MSCs is initiated in vitro only in the absence of serum 
in culture media and in a three-dimensional (3D) organization or pellet-form.  Chemical 
induction into this cell lineage can be achieved using a member of the transforming 
growth factor-β (TGF-β) family [27].  TGF-β1, TGF-β2 and TGF-β3 expressions are 
continuously found during the chondrogenic differentiation of MSCs and may act 
simultaneously with other TGF-β members; however TGF-β3 and TGF-β4 may also aid 
in the process of de-differentiation, indicating capability of MSCs to also retain their 
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plasticity [28].  Biosynthesis of glycosaminoglycans and expression of cartilage-specific 
extracellular matrix (ECM) genes, such as aggrecan, collagen type-II, collagen type-X, 
and Sox9 have been used to mark MSCs differentiation into the chondrogenic pathway 
[29]. 
More recently, undifferentiated MSCs also been found to express markers for 
other cell types unrelated to connective tissues, such as neural cells, endothelial cells, and 
cardiomyocytes.  In one study, human and mouse bone-marrow derived progenitor cells 
were induced to differentiate into neural cells in the presence of epidermal growth factor 
and brain-derived neurotrophic factor [30].  Bone-marrow derived progenitor cells have 
also been induced into the neural lineage in vitro through other chemical exposures such 
as, serum withdrawal following β-mercaptoethanol treatment [31] and the addition of 
isobutylmethylxanthine and dibutyryl cyclic AMP [32].  Additionally murine MSCs have 
been shown to transform into cardiomyocytes, endothelial cells, and smooth muscle cells 
by their direct injection into the heart [33, 34].  MSC transplantations have further shown 
improved cardiac function in a rat model through the initiation of angiogenesis and 
myogenesis [35].  Since MSCs are the most, well-characterized type of adult stem cells 
both in 2D and 3D cultures, biomaterials have been exclusively modified for this 
population to further establish complex intracellular signaling and differentiation 
pathways.  Various methods of creating 3D environments have been utilized when 
studying MSCs behavior and should be discussed in further detail. 
 
2.4 MICROFABRICATION OF TISSUE ENGINEERING SCAFFOLDS 
Efforts in scaffold design must incorporate porous constructs that provide 
appropriate diffusion of biochemical cues and cellular waste as well as mechanical 
properties that mimic the target tissue that is being generated.  Soft tissues have a 
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Young’s moduli of 0.4-350 MPa, whereas hard tissues are in the range of 10-1,500 MPa 
[36].  These structures not only have to integrate the critical properties of permeability 
and strength, but also should be easily produced in complex 3D anatomical-like 
constructs.  A vast array of scaffold manufacturing techniques over the past decade has 
enabled significant leaps in creating constructs in the micro- and nano-scales.  These 
fabrications technologies are well-summarized in a review by Tsang and Bhatia, as 
shown in Table 2.1 [37].   Current, popular methods in scaffold fabrication have been 
adopted from the microelectronics manufacturing industry as well as phase separation 
chemistry. 
Advances in coupling computational topography design and solid free-form 
fabrication (SFF) have recently made it possible to generate scaffolds with controlled 
architectures.    Figure 2.2 illustrates SFF techniques that generally use 2D planar slices 
of the target tissue/organ structure based on computer-aided design (CAD) and re-build a 
synthetic 3D construct on a platform through a layer-by-layer technique, without the use 
of sacrificial materials or molds.  Each 2D planar slice or layer represents a cross-section 
of the model that is being regenerated.   Commercially available systems are commonly 
grouped into three major categories: (1) laser-based machines that photo-polymerize 
liquid macromer solutions or sintered powder compounds, (2) printer-based machines 
that can print a binder to chemically combine powdered materials or direct construct 
materials, cells, and proteins and (3) nozzle-based systems that extrude materials, 
processing them either through chemical or thermal means [36].  
Scaffold fabrication based on laser technology is considered to be the pioneer of 
rapid prototyping techniques and generally involves a laser beam directed over the top of 
a photocurable polymeric material.  The light initiates a chain reaction in polymer 
crosslinking, causing material solidification only in the exposed areas by the laser beam.  
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The liquid polymer solution is contained in a vat, and a pre-designed 3D construct can be 
developed on a stage through a layer-by-layer, raster scanning style process.  Laser 
technology can also provide heat energy to sinter particles together where the laser 
interaction increases the temperature to the transition temperature of the material.  The 
exposed regions of particles, thereby, fuse together. 
Another prevalent, scaffold fabrication method is based on inkjet printing 
technology and uses droplet formation to melt materials together.  The deposited droplet 
is a thermoplastic material that hardens when it cools.  The multiple jet heads, as found in 
a color printer, could contain various materials to create a construct with higher chemical 
complexity.  The ModelMakerIITM uses a wax-like material in a jet head as the support 
substrate and the polymeric material to build the scaffold in another jet head.  
Additionally single cells or cell aggregates can be printed onto support substrates, as 
demonstrated by Boland et. al. [38].  Approaches in laser printing technology for cellular 
guidance have also been investigated by Ringeisen et. al. [39].  
A nozzle-based system to extrude molten ceramics and polymeric substrates in a 
layer-by-layer fashion is another method of creating complex tissue engineering 
scaffolds, as demonstrated by Hutmacher et.al.[40].  This computer-guided and filament 
deposition modeling method was used to create bioresorbable poly(ε-caprolactone) with 
feature sizes ranging from 160-700µm.  Limitation to this system is that the height of a 
scaffold layer is limited to the diameter of the nozzle and that the operating temperature 
to extrude these materials is too high to use proteins during the fabrication process.  
Aside from SFF technology, other conventional means of creating scaffolds with 
micro-scale features include solvent casting and particulate leaching, gas foaming, and 
negative molding techniques [41].  Phase separation chemistries have also used to create 
bioactive polymeric constructs.  Synthetic materials are dissolved in molten phenol or 
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naphthalene, liquid-liquid phase separation occurs due to a decrease in temperature, and a 
two-phased solid is produced.  The solvent is removed through sublimation as shown by 
Lo et. al. to create a porous construct with integrating bioactive molecules [42].  Methods 
discussed in this section can use both natural and synthetic, as discussed in the following 
section.   
 
2.5 SCAFFOLD BIOMATERIALS USED FOR STUDYING MSCS  
Natural materials used for developing scaffolds can consist of components found 
in tissue, such as collagen, fibrinogen, and hyaluronan, and therefore have the advantage 
of being bioactive and biocompatible, as well as having the same mechanical properties 
of native tissue.  Additionally some natural materials can be made into components that 
can be more easily processed through chemical modifications.  For example, hyaluronan 
is present in tissue as a gel-like substance but can be chemically adjusted so that it can be 
processed as fibers, membranes, or microspheres, and is commercially known as Hyaff® 
[43].  Silk fibroin is also classified as a natural material and can be isolated from 
silkworm cocoons.  Silk has been developed into porous scaffolds using gas foaming or 
salt leaching methods [44, 45] and widely used as suture materials for surgical methods.   
Other natural materials used for studies in MSC differentiation include chitosan 
and coralline.  Chitosan is hydrophilic in nature, biodegradable, biocompatible, and has 
similar properties to glycosaminoglycans, deeming it as an attractive material for tissue 
engineering studies.  One particular study combined this chitosan with coralline, 
exoskeletons of marine species or coral, as a composite scaffold to study MSCs 
osteogenesis since coral is composed of calcium carbonate, a component found in bone 
[46].  Another material that has been used as a chitosan-composite for bone tissue 
engineering is hydroxyapatite, a natural, inorganic component of bone mineral [47].  
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Calcium phosphates, bioactive glasses, and other bioceramics are desirable materials for 
studies in MSCs osteogenesis since these materials have high mechanical properties and 
can integrate with bone to a higher degree than soft biomaterials, thereby enhancing 
mineralization and matrix formation.  Disadvantages of using natural materials over 
synthetic materials include uncontrolled degradation rates, biocompatibility of 
degradation by-products, difficulty in sterilization and pathogen/viral issues when 
isolated from different sources. 
Polyglycolides (PGA), polylactides, (PLA), polylactide-co-glycolide (PLGA) and 
their amorphous forms have been extensively used as synthetic polymers for evaluating 
cell behavior in 3D scaffolding environments [48, 49].  These materials are hydrolytically 
degradable through bulk erosion due to the presence of ester bonds, and the 
glycolic/lactic acid by-products can be physiologically removed via metabolic pathways.  
PLA/PGA molecular weight, copolymerization ratio, and their polydispersity can be 
adjusted to control the degradation rate, making them attractive synthetic materials for 
tissue engineering.  Furthermore standard methods (e.g., salt leaching, sintering, porogen 
melting, nanofiber electrospinning) have been widely established for these materials to 
incorporate interconnective porosity within 3D scaffolds [49-51].   
Non-woven fabrics developed from polyethylene terepthalate (PET) have also 
been used to study MSCs seeding, proliferation, and aggregation for tissue regeneration 
[52, 53].  Adipogenesis, chondrogenesis, and osteogenesis have all been successfully 
studied differentiation pathways on biodegradable, nanofibrous 3D scaffolds fabricated 
from poly(ε-caprolactone) (PCL) [54, 55].  Acrylated polymers that form hydrogels, such 
as poly(ethylene glycol) diacrylates (PEGDA) and poly(6-aminohexyl phosphate 
acryloyl) (PPE-HA-acryl), are widely studied for MSC cell and bio-chemical molecule 
encapsulation capabilities during photo-crosslinking [29, 54, 56, 57].  Though synthetic 
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materials provide the versatility of creating structures with tunable features (i.e., 
mechanical properties, degradation rates, and porosities), disadvantages for choosing 
such materials include poor compatibility and acidic by-products.       
 
2.6 MODIFICATIONS TO SCAFFOLD BIOMATERIALS TO MIMIC CELLULAR NICHE 
Chemical modifications to biomaterials can directly govern the intracellular 
signaling pathway in which MSCs can undergo due to the transformation of mechanical 
integrity, signals presented by the microenvironment, degradation rate, and overall 
porosity.  Because biomaterials can be designed to fine-tune their degradation kinetics 
and/or the release of biological molecules in response to their microenvironment, they 
have also been termed as intelligent or bioresponsive materials.  Furthermore, the 
intrinsic mechanical integrity of a material is a significant feature since the manner of 
forces exert by cells are dependent on their type.  For instance, chondrocytes exert 
contractile forces when integrated onto substrates and can change the overall 
microstructure of the scaffold during tissue development depending on the mechanical 
properties of the material [58, 59].  Therefore it is essential to distinguish the types of soft 
and hard materials that have been used for studying the differentiation lineages of MSCs.        
Overall mechanical integrity of scaffolding materials is a key element that needs 
to be addressed when evaluating material properties that effect differentiation pathways 
of stem cells.  Bone marrow-derived stromal cells are highly sensitive and responsive to 
mechanical stimulation in vitro [60, 61].  It can be speculated that mechanical stimuli 
activate cell surface receptors and focal adhesion sites, which in turn triggers intracellular 
signaling cascades that involve switching on genes that activate for ECM secretion.  
Differentiation of MSCs by the physical microenvironment is administered either by 
mechanical cyclical stresses applied directly to the cells [60-62] or by the compositional 
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properties inherent to the material itself (i.e. material integrity, crystallinity, crosslinking 
density, overall structural micro- and macro-porosity).          
Soft substrates or gel-like materials, such as hydrogels and collagen, closely 
resemble the consistency of soft, native tissues, making them attractive materials for use 
as scaffolds.  Additionally collagen is the most abundant protein found in the ECM of 
bone formation, and can therefore be regarded as the “gold standard” of scaffolding 
materials for tissue regeneration; however these materials are not suitable for studying 
cell lineages and tissues that undergo high cyclical stress in vivo.  When differentiating 
MSCs into the connective tissue lineages (i.e. bone, cartilage, ligaments, tendons) 
materials with high mechanical strength must be chosen to closely mimic the types of 
stresses these native tissues must physiologically undergo.   
Collagen and other gel-like materials, however, can be modified to have an 
increased modulus of elasticity, making them more suitable for applications in connective 
tissue engineering.  Collagen can be adjusted to have a higher modulus by adding 
hydroxyapatite, a brittle, yet stronger material than collagen, thereby mimicking the 
structure of bone which is mostly composed of collagen fibers and phosphate minerals.  
Adding hydroxyapatite to collagen at a 1:1 ratio alone increases the modulus from 0.392 
MPa to 0.422 MPa, which is more similar to trabecular bone (E = 0.443 MPa) [63].  
These porous collagen-hydroxyapatite composites, prepared through phase-separation 
techniques, have been used to study rat MSCs seeding and proliferation [63].   
Other composite scaffolds can be formulated using both natural and synthetic 
materials, and at the same time reinforce the mechanical integrity of the entire structure.  
Studies have also fabricated composites with collagen to contain poly-lactic-acid and 
chitin fibers, further reinforcing the mechanical integrity.  Chitin fibers were crosslinked 
within PLA  materials through dicyclohexylcarbodimide chemistries to strengthen 
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scaffolds even further, which resulted in higher human MSC attachment due to the 
neutralization of acidic by-products (due to PLA) with alkaline chitin [64].   
Silk-based materials have also been commonly used for MSC scaffolding 
materials [65-67] since they provide increased modulus of elasticity over other natural 
materials, such as collagen.  However decontamination and purification methods of silk, 
prior to their use in vivo, are extremely critical in order to avoid inflammatory and 
immunogenic reactions that are associated with this material in its natural form.  Silk-
based scaffolds seeded with hMSCs were positively evaluated for advanced bone 
formation in critical-sized, cranial defect models (larger than 4mm) using nude mice, 
indicated by the presence of bone sialoprotein, osteopontin, and osteocalcin [65].  In 
addition, positive results in gene expression and immunohistochemical staining for 
cartilage formation were seen when differentiating MSCs into the chondrogenic pathway 
[45].       
In addition to natural materials, synthetic materials can also be chemically 
modified to increase mechanical strength.  Increasing acrylate concentration in photo-
crosslinkable polymers has been shown to increase the modulus of elasticity, such as 
within PPE-HA-acryl (poly(6-aminohexyl phosphate acryloyl)) hydrogels [57].  By 
increasing the amount of acrylated-PEG that was reacted with PPE-HA by four times, the 
shear modulus was increased almost 10-fold (3 to 26 kPa).  Additionally this particular 
biodegradable phosphate-based synthetic material is highly favorable for bone tissue 
engineering due to a phosphate degradation product, which could aid in the overall 
scaffold mineralization when encapsulating MSCs and placed in osteogenic medium [57]. 
MSC differentiation induced by mechanical stimulation has also been extensively 
investigated using bioreactors [68-70], or in vitro systems that provide dynamic culturing 
conditions.  Cells in vivo consistently undergo fluid shear stress and mechanical strain, 
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thereby influencing cellular interactions and responses.  A copious amount of interest in 
mimicking these forces in vitro, specifically for connective tissue differentiation of 
MSCs, has resulted from our increased understanding of how cells behave 
physiologically.   
In a study performed by Datta and colleagues [71], titanium fiber meshes seeded 
with rat MSCs were cultured in a perfusion bioreactor to study effects on osteoblast 
differentiation.  Levels of mineralization formed by osteoblasts within the scaffolds were 
compared between plain titanium meshes and pre-generated, bone ECM-deposited 
titanium meshes.  Results concluded that synergistic effects of both mechanical 
stimulation through shear stress and the presence of ECM deposition onto scaffolding 
substrates profoundly enhanced the osteoblast differentiation as indicated by increased 
calcium content. 
Stem cell differentiation can be indirectly mediated by transforming the intrinsic 
mechanical properties of materials or directly mediated by chemically altering the bio-
chemicals present in their microenvironment.  Many studies have determined certain 
hormones and cytokines that can enhance proliferation and the differentiation potential of 
MSCs.  Several families of growth factors are marked as critical bioactive molecules that 
guide MSCs differentiation into specific cell lineages.  FGF-2 is shown to increase the 
self-renewal and the maintenance of MSCs multi-lineage differentiation potential [26, 72-
74].  Additionally bone morphogenetic proteins (BMPs) are part of the TGF- β 
superfamily that have significant roles in the regeneration and growth of skeletal tissues 
[75, 76].  At least 20 human BMPs have been identified and are known to be involved in 
skeletal formation.   
Scaffolds have directly integrated these growth factors, hormones, and chemicals 
in a variety of ways, other than exogenous delivery within culture media.  Soluble growth 
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factors can be directly encapsulated or incorporated during the scaffold fabrication 
process [77, 78], but would also require a method to sequester these bio-factors in a 
localized microenvironment to prevent their diffusion into other regions of the scaffolds 
and within the media.  Heparan sulfates, a type of glycosaminoglycans, have been known 
to bind and protect growth factors, especially FGF-2, from pH and heat denaturation 
within the body.  In our studies, we have successfully demonstrated the effective binding 
of FGF-2 within photo-polymerizable PEGDA scaffolds by covalently conjugating 
acrylated-PEG moieties to heparan sulfate [79].  Using immuno-histochemistry we 
effectively demonstrated that FGF-2 was only localized or sequestered in a region of a 
multi-layered scaffold that had heparin-PEG-acrylate.       
Physical adsorption of biomolecules onto substrate surfaces is shown to be an 
effective technique of delivery.  In situ osteogenesis was demonstrated by Carstens et al, 
using absorbable collagen sponges as delivery vehicles for recombinant human BMP-2 
(rhBMP-2) within a craniofacial mandibular defect to induce MSCs into the osteogenic 
pathway [80].  Instead of using natural materials found in bone tissues, such as 
hydroxyapatite, which would require longer times for bone reformation alone, an 
absorbable collagen sponge with rhBMP-2 adsorbed onto the surfaces was implanted into 
a mandibular defect of an adolescent Yorkshire pig.  Because of the chemotactic effects 
presented by the rhBMP-2, MSCs were found to be in the vicinity of the implanted 
collagen sponges and were characterized to be spindle-shaped and in osteoblast precursor 
form.  BMPs are osteogenic-specific proteins and are characterized to initiate bone 
formation by homing and binding to MSCs.  Another adsorption study uses titanium fiber 
mesh scaffold coated with a short, amino acid sequence, RGD (arginin-glycine-aspartic 
acid) [81], which is found in numerous cell adhesive proteins, such as fibronectin and 
laminin and takes part in cell integrin binding.  MSCs attached more strongly to RGD-
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coated titanium scaffolds, but did not however change ECM secretion of the 
differentiating cells into the osteoblast lineage.       
Although protein adsorption to scaffold surfaces can be an effective route for 
biochemical presentation [82, 83], covalently conjugating proteins to surfaces could 
provide a more dependable method since conjugation density can be controlled.  By 
incorporating methacrylic acid within PEGDA macromer solution prior to photo-
polymerizing into 3D scaffolds, we have shown that carbodiimide bioconjugation 
chemistries successfully activate free carboxyl groups (from methacrylic acid), which in 
turn forms amide bonds with fibronectin, a glycoprotein dimer found in the ECM 
mediating for cell attachment [84].  Murine MSCs were then seeded onto the 
microfabricated scaffolds created by layer-by-layer stereolithography system, and cells 
effectively adhered and transformed into osteoblasts.  These results are discussed in 
further detail in Chapter Five.   
Furthermore RGD can be covalently conjugated to PEG-acrylates using N-
hydroxysuccinimidyl-activated esters [85-88] and have also been used in PEGDA 
scaffolds for human MSCs differentiation into osteoblasts [89].  Cell integrin-matrix 
interactions were enhanced by incorporating RGD within the hydrogel scaffolds, leading 
to increased MSCs viability.  Nuttelman and colleagues show increased viability of 
encapsulated human MSCs from 15% to 75% when incorporating RGD-PEG-acrylates to 
PEGDA hydrogels [89].  RGD acts as a signaling peptide that triggers conformational 
change to cell inetgrins, thus leading to an intracellular signaling pathway that prevents 
programmed cell death or apoptosis.   
Additionally, Shin et al, shows that increasing concentrations of signaling peptide 
within oligo(PEG-fumarate) hydrogels increases alkaline phosphatase activity of 
osteoblasts when compared of hydrogels that do not contain the peptide [90].  This group 
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also compared effects between RGD and an osteopontin-derived peptide, and determined 
that hydrogels modified with osteopontin-derived peptide triggered greater osteoblast 
migration distance than RGD-modified hydrogels; however RGD was still found to be 
the dominating peptide for mediating cell-attachment [91].        
Scaffolds also operate as effective delivery vehicles using degradable components 
for signaling biomolecules that direct MSC growth and organization, in addition to 
covalently conjugating and adsorbing proteins onto scaffold surfaces and throughout the 
matrix.  The covalent conjugation and controlled-release of dexamethasone, a synthetic 
corticosteroid crucial for MSCs osteogenesis in vitro, within a scaffold polymer network 
is directly mediated by a hydrolytically-labile lactide component, a study performed by 
Nuttelman et al, [92].  Humans MSCs were encapsulated in a PEG-based hydrogel 
network with the controlled release of dexamethasone, which then lead to the osteogenic 
differentiation of entrapped progenitor cells.  The polymer network used to fabricate the 
scaffold was composed of photo-polymerizable PEGDA and a biocompatible ultra-violet 
cleavable photoinitiator that initiated polymer crosslinking.  The gene expression levels 
for two common osteogenic markers, alkaline phosphatase and core binding factor alpha 
1 (cbfα−1), were increased for MSCs cultured in scaffolds containing the released 
dexamethasone.  The concentration of the biomolecules to be delivered can be easily 
controlled by the amount loaded into the polymer network prior to photo-crosslinking.  
Furthermore the length of degradable lactide linkages attaching the biomolecules to be 
delivered can be chemically to control release kinetics.   
Delivery of growth factors and chemicals can also be mediated using degradable 
particles, which could provide temporal release kinetics for signaling biomolecules over a 
prolonged period of time [93-96].  Osteogenic studies from rat MSCs using recombinant 
human TGF-β1 was encapsulated in polymer blends of PEG-PLGA particles (sized at an 
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average of 158 µm) by Peter et al, [97].  Here they show that a loading of 6.0ng TGF-β1/ 
1mg of microparticle provided an optimal dose for growth factor delivery for enhancing 
MSC proliferation and transformation into osteoblasts, as demonstrated by increased 
alkaline phosphatase and osteocalcin secretion.          
Scaffold mineralization due to MSCs osteogenesis can be mediated through other 
chemical modifications, such as adding a degradable unit to the monomer backbone, 
making it into bio-responsive vehicle.  Adding a phosphoester to photo-polymerizable 
PEG-based hydrogels has not only been shown to act as the degradation component of 
the scaffold, but has also shown to promote the mineralization of encapsulated MCSs.  
The use of phosphoester-containing hydrogels marked increased levels of alkaline 
phosphatase and osteocalcin, as demonstrated by Wang and colleagues [98, 99].  Cell-
matrix interactions and the viability of encapsulated MSCs increase in the presence of 
phosphate molecules within hydrogel scaffolds, as shown by Nuttelman [89].  Phosphate 
moieties contribute to the adsorption of osteopontin, a sialoprotein that binds to bone 
mineralization and mediates cell adhesion. 
Components of bone mineralization have also been integrated within scaffolds for 
bone tissue engineering. A thin bone-like mineral layer, which consists of calcium 
phosphate components, influences osteogenic cell maturation when used within 
orthopedic and dental implantations.  Osteoconductivity in vivo is greatly improved by 
utilizing substrates that contain calcium phosphate mineral, which have been used to 
bond orthopedic implants to native bone tissue and is mediated by fibroblasts in the 
marrow [100, 101].  This mineral substrate also enhances proliferation and gene 
expression of osteoblasts and osteogenic precursor cells [102, 103].  Murphy et al, 
exploited these concepts by using bone-like mineral films to analyze MSCs proliferation 
and differentiation in vitro [104].  Polymer sheets fabricated from PLGA were 
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mineralized by submersing in a solution that simulated body fluid, and soaked in 
fibronectin solution prior to human MSCs seeding.  Though the mineralized PLGA sheets 
did promote MSCs proliferation, interestingly enough, osteogenic differentiation was 
inhibited.  They speculate that osteogenic inhibition could be directly due to the material 
properties, such as low crystallinity, decreased crystal size, increased surface roughness, 
and rapid mineralization layer dissolution rate [105-108].               
In addition to synthetic polymers, metals, and ceramics, natural materials can be 
chemically altered to improve specific properties for tissue engineering properties, such 
as their gelation state, degradation rate, and mechanical properties.  Proteins, such as 
fibrinogen, can be linked with PEG polymers to enhance viability of entrapped MSCs by 
mimicking the hydrophilic nature of native tissues.  Zhang and colleagues have created 
PEGylated fibrin patches to study the in vitro differentiation of MSCs into the endothelial 
cell lineage for a potential therapeutic tool in myocardial repair [109].  Chitosan is an 
example of a natural, biocompatible material that has been modified to be thermo-
responsive [110, 111].  For instance, by conjugating hydroxybutyl groups onto the amino 
and hydroxyl reactive sites of chitosan, this polymer becomes water soluble and is 
capable of turning into a gel state when exposed to 37°C [112].  In vitro culture and 
encapsulation of human MSCs were used to study this modification of chitosan as an 
injectable material for the eventual use as a therapeutic agent in degenerative disk 
diseases.  MSCs were effectively encapsulated within the chemically-modified chitosan 
gels of up to 5% wt polymer concentration, with minimal cell toxicity, and positive gene 
expression for the bone-specific markers, collagen I and aggrecan, was found [112].  
Furthermore, oligo(PEG-fumarate) has been studied as a thermo-responsive hydrogel to 
encapsulate rat MSCs by the addition of a thermally reactive radical initiator  that allows 
for the gelation of the monomer at 37°C [113].  These thermally-crosslinked hydrogels 
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show matrix calcification due transformation into osteoblasts and can be used as 
injectable cell delivery vehicles for bone regeneration studies.  
 
2.7 MECHANISM OF IN VIVO AND IN VITRO BONE FORMATION 
Bone is composed of four distinct cell types: osteoblasts, osteoclasts, bone lining 
cells, and osteocytes.  Osteoprogenitor cells produce osteoblasts, osteocytes, and bone 
lining cells, whereas osteoclasts originate from various hemopoietic tissues.  The 
morphology of osteoblasts, as described today, has not changed from when it was first 
characterized via microscopy in the late 19th-century: flat, elongated, and polygonal.  
Sources of precursor osteoblasts are not only from undifferentiated mesenchymal 
progenitor cells, but also from differentiated chondrocytes.  Osteoblasts are responsible 
for the production of bone matrix and classified to be fully differentiated cells.  
Osteocytes are mature osteoblasts found within the bone matrix and serve as 
“maintenance” cells.  Bone lining cells are inactive cells found on the surfaces of bone 
that potentially serve as precursors for osteoblasts.  Bone-resorbing cells are known as 
osteoclasts, which are characterized to be large, multi-nucleated, and are seen on bone 
surfaces when active. 
The process of osteogenesis is an intricate, multi-step process and can be divided 
into three main categories: (1) progenitor or precursor cell proliferation and active 
osteoblasts differentiation, (2) bone matrix production, such as collagenous and non-
collagenous bone proteins, and (3) bone matrix calcification, in which concentrations and 
deposition of calcium and phosphate are highly regulated at the site of calcification.  
Osteoblasts change into osteocytes as soon as the bone forming cell is surrounded by 
mineralized matrix.  Intermediate stage is osteocytic osteoblast or osteoid-osteocyte.  
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Osteocytes appear to be more elongated and 30% less in size when compared to 
osteoblasts. 
Bone matrix deposited by osteoblasts consists of multiple forms and can be 
divided into three main categories:  
(1) compact bone: a dense, well-vascularized and mineralized tissue 
encompassing the cortex of the long bones, and connected to muscles to overcome the 
mechanical forces created during motility,  
(2) trabecular bone: most commonly makes up the vertebral structure of humans 
and are characterized to be thin, flattened elements of well-mineralized bone. This forms 
during endochondral ossification along lines of stress, and continue to functions as such 
throughout adulthood, and 
(3) chondroid bone:  this tissue is characterized to have large cells, decreased 
cellular processes and function, a high collagen content, and increased amounts of 
proteoglycans than ‘mature bone’.     
Collagen I is the most abundant protein in bone matrix serving as 90% of the total 
ECM, whereas collagen V, the second class of collagen found in bone matrix, only makes 
up 3%.  This protein also acts as a scaffolding material that binds and arranges other 
proteins that nucleate hydroxyapatite deposition. Collagen is present in the ECM 
associated with numerous, other proteins, serving as a scaffold upon which nucleators are 
oriented.   
While collagen makes up most of the organic bone matrix, other non-collagenous 
glycoproteins also populate the bone ECM.  Osteonectin is another prominent bone 
matrix protein known to bind to calcium, collagen, hydroxyapatite, as well nucleating 
hydroxyapatite deposition.  Functionally this protein regulates cell progression through 
proliferation, shape, binding to growth factors and metal ions, and regulating enzymatic 
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activities.   Fibronectin is also synthesized by bone, as well as other connective tissues, 
and initially seen during the first stages of osteogenesis.  Sialoproteins found in bone 
matrix are composed of sialic acid, and the two best characterized are osteopontin and 
bone sialoprotein.  Osteopontin is usually found during the later stages of osteoblast 
maturation, binds to calcium, and mediates cellular attachment in vitro.  Bone 
sialoprotein is highly associated with mineralization, and is also a marker during the late 
stages of bone formation.  Similarly to osteopontin, this molecule has a high affinity for 
calcium and can also mediate cell attachment.  These are just some of the many 
constituents found in bone physiology, while other proteoglycans and glycoproteins are 
listed in Table 2.2.    
Alkaline phosphatase activity during bone formation is abundant along the cell 
membrane and is characterized to hydrolyze many substrates with the release of a 
monophosphate from ATPase (adenosine triphosphate).  Since alkaline phosphatases are 
concentrated within the cell surfaces, high binding affinities to positively charged 
calcium molecules occur, thus mediating calcium transport from blood vessels found in 
bone tissue. Younger osteoblasts tend to express increased alkaline phosphatase activity 
whereas mature osteocytes, found buried within the trabeculae, do not show evidence of 
cell membrane alkaline phosphatase.    
It has been widely shown that introducing organic phosphate to in vitro culture 
medium stimulates matrix calcification.  β-glycerophosphate, a non-physiological factor, 
is introduced solely for the in vitro mineralization of cell cultures. The rationale for using 
β-glycerophosphate is that this molecule acts as an organic phosphate around cells with a 
high alkaline phophatase activity, and therefore calcification of the matrix is triggered.  
Increased concentrations of β-glycerophosphate, however, have been shown to cause 
precipitation of calcium phosphate in the medium and to be inhibitory for cell growth.  
 29
Dexamethasone is another supplemented compound in osteogenic growth medium.  In in 
vitro culture, this glucocorticoid increases vitamin D receptors and cell proliferation, and 
has been shown to inhibit bone resorption by indirectly inducing apoptosis of osteoclasts, 
the bone-resorbing cells.  Lastly vitamin C, or ascorbic acid, is involved in collagen 
production, necessary to forming bone matrix, and is therefore another imperative 
supplement in osteogenic medium. 
By combining knowledge gained from scaffold fabrication methods, material 
science, and stem cell biology surveyed from literature, this dissertation discusses 
attempts in creating a an ideal microenvironment for studying hybrid MSC 
differentiation.  The ultimate goal of this research is to couple novel concepts of micro-
manufacturing along with the ECM functionalization of polymers and stem cell biology 
to attain pre-designed architectures of tissue structures. 
  
Table 2.1 Comparison of 3D Scaffolding Methods 
 
***Table by Tsang and Bhatia [37] 
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Table 2.2. Main Proteins found in Bone Matrix and their Functional Role [114] 
Protein Function 
 
collagen Type I 
Serves as scaffolding, binds to other proteins, orients other 
proteins to serve as nucleator 
 
collagen Type X 
 
Present in hypertrophic cartilage but does not regulate matrix 
mineralization 
 
collagen Type III, V  
 
Present in trace amounts, regulates collagen fibril diameter, 




Potential Ca2++ carrier, hydrolyzes inhibitors of mineral 




May mediate deposition of hydroxyapatite, binds to growth 




Cell attachment, binds to heparin, platelets, types I and V 
collagens, thrombin, fibrinogen, laminin, plasminogen, and 




Binds to cells, may regulate mineralization, may regulate 
proliferation, inhibits nitric oxide synthase, may regulate 








May regulate activity of osteoclasts and their precursors, may 





Inhibits hydroxyapatite crystal growth 
    
Figure 2.1 Differentiation Capacity of Mesenchymal Stem Cells (MSCs).  MSCs are 






Figure 2.2  Summary of Solid Free Form Fabrications Systems.  SFF systems are 
categorized by processing methods: (a) and (b) are laser 
stereolithography systems that photo-polymerize a liquid resin; (c) and 
(d) are printing-based systems; (e) and (f) are nozzle-based methods 
that extrude heated materials or printed materials that can be 






2.8  REFERENCES                                                       
1. Vacanti, J.P. and R. Langer, Tissue engineering: the design and fabrication of 
living replacement devices for surgical reconstruction and transplantation. 
Lancet, 1999. 354 Suppl 1: p. SI32-4. 
2. Yarlagadda, P.K., M. Chandrasekharan, and J.Y. Shyan, Recent advances and 
current developments in tissue scaffolding. Biomed Mater Eng, 2005. 15(3): p. 
159-77. 
3. Ahsan, T. and R.M. Nerem, Bioengineered tissues: the science, the technology, 
and the industry. Orthod Craniofac Res, 2005. 8(3): p. 134-40. 
4. Rahaman, M.N. and J.J. Mao, Stem cell-based composite tissue constructs for 
regenerative medicine. Biotechnol Bioeng, 2005. 91(3): p. 261-84. 
5. Elisseeff, J., et al., Advances in skeletal tissue engineering with hydrogels. Orthod 
Craniofac Res, 2005. 8(3): p. 150-61. 
6. Williams, J.T., et al., Cells isolated from adult human skeletal muscle capable of 
differentiating into multiple mesodermal phenotypes. Am Surg, 1999. 65(1): p. 
22-6. 
7. Romanov, Y.A., et al., Mesenchymal stem cells from human bone marrow and 
adipose tissue: isolation, characterization, and differentiation potentialities. Bull 
Exp Biol Med, 2005. 140(1): p. 138-43. 
8. Musina, R.A., E.S. Bekchanova, and G.T. Sukhikh, Comparison of mesenchymal 
stem cells obtained from different human tissues. Bull Exp Biol Med, 2005. 
139(4): p. 504-9. 
9. Kuznetsov, S.A., et al., Circulating skeletal stem cells. J Cell Biol, 2001. 153(5): 
p. 1133-40. 
 35
10. Caplan, A.I. and S.P. Bruder, Mesenchymal stem cells: building blocks for 
molecular medicine in the 21st century. Trends Mol Med, 2001. 7(6): p. 259-64. 
11. Simmons, P.J., et al., Isolation, characterization and functional activity of human 
marrow stromal progenitors in hemopoiesis. Prog Clin Biol Res, 1994. 389: p. 
271-80. 
12. Simmons, P.J. and B. Torok-Storb, Identification of stromal cell precursors in 
human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 1991. 
78(1): p. 55-62. 
13. Walsh, S., et al., Expression of the developmental markers STRO-1 and alkaline 
phosphatase in cultures of human marrow stromal cells: regulation by fibroblast 
growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. 
Bone, 2000. 27(2): p. 185-95. 
14. Bruder, S.P., et al., Monoclonal antibodies reactive with human osteogenic cell 
surface antigens. Bone, 1997. 21(3): p. 225-35. 
15. Bruder, S.P., et al., Mesenchymal stem cell surface antigen SB-10 corresponds to 
activated leukocyte cell adhesion molecule and is involved in osteogenic 
differentiation. J Bone Miner Res, 1998. 13(4): p. 655-63. 
16. Barry, F.P., et al., The monoclonal antibody SH-2, raised against human 
mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem 
Biophys Res Commun, 1999. 265(1): p. 134-9. 
17. Barry, F., et al., The SH-3 and SH-4 antibodies recognize distinct epitopes on 
CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun, 
2001. 289(2): p. 519-24. 
18. Rickard, D.J., et al., Isolation and characterization of osteoblast precursor cells 
from human bone marrow. J Bone Miner Res, 1996. 11(3): p. 312-24. 
 36
19. Jaiswal, R.K., et al., Adult human mesenchymal stem cell differentiation to the 
osteogenic or adipogenic lineage is regulated by mitogen-activated protein 
kinase. J Biol Chem, 2000. 275(13): p. 9645-52. 
20. Pittenger, M.F., et al., Multilineage potential of adult human mesenchymal stem 
cells. Science, 1999. 284(5411): p. 143-7. 
21. Pittenger, M.F., J.D. Mosca, and K.R. McIntosh, Human mesenchymal stem cells: 
progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol 
Immunol, 2000. 251: p. 3-11. 
22. Johnstone, B., et al., In vitro chondrogenesis of bone marrow-derived 
mesenchymal progenitor cells. Exp Cell Res, 1998. 238(1): p. 265-72. 
23. Wakitani, S., T. Saito, and A.I. Caplan, Myogenic cells derived from rat bone 
marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 1995. 
18(12): p. 1417-26. 
24. Noth, U., et al., Anterior cruciate ligament constructs fabricated from human 
mesenchymal stem cells in a collagen type I hydrogel. Cytotherapy, 2005. 7(5): p. 
447-55. 
25. McBeath, R., et al., Cell shape, cytoskeletal tension, and RhoA regulate stem cell 
lineage commitment. Dev Cell, 2004. 6(4): p. 483-95. 
26. Martin, I., et al., Fibroblast growth factor-2 supports ex vivo expansion and 
maintenance of osteogenic precursors from human bone marrow. Endocrinology, 
1997. 138(10): p. 4456-62. 
27. Worster, A.A., et al., Chondrocytic differentiation of mesenchymal stem cells 
sequentially exposed to transforming growth factor-beta1 in monolayer and 
insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res, 2001. 
19(4): p. 738-49. 
 37
28. Goessler, U.R., et al., In-vitro analysis of the expression of TGFbeta -superfamily-
members during chondrogenic differentiation of mesenchymal stem cells and 
chondrocytes during dedifferentiation in cell culture. Cell Mol Biol Lett, 2005. 
10(2): p. 345-62. 
29. Williams, C.G., et al., In vitro chondrogenesis of bone marrow-derived 
mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng, 2003. 9(4): 
p. 679-88. 
30. Sanchez-Ramos, J., et al., Adult bone marrow stromal cells differentiate into 
neural cells in vitro. Exp Neurol, 2000. 164(2): p. 247-56. 
31. Woodbury, D., et al., Adult rat and human bone marrow stromal cells 
differentiate into neurons. J Neurosci Res, 2000. 61(4): p. 364-70. 
32. Deng, W., et al., In vitro differentiation of human marrow stromal cells into early 
progenitors of neural cells by conditions that increase intracellular cyclic AMP. 
Biochem Biophys Res Commun, 2001. 282(1): p. 148-52. 
33. Gojo, S., et al., In vivo cardiovasculogenesis by direct injection of isolated adult 
mesenchymal stem cells. Exp Cell Res, 2003. 288(1): p. 51-9. 
34. Orlic, D., et al., Bone marrow cells regenerate infarcted myocardium. Nature, 
2001. 410(6829): p. 701-5. 
35. Nagaya, N., et al., Transplantation of mesenchymal stem cells improves cardiac 
function in a rat model of dilated cardiomyopathy. Circulation, 2005. 112(8): p. 
1128-35. 
36. Hollister, S.J., Porous scaffold design for tissue engineering. Nat Mater, 2005. 
4(7): p. 518-24. 
37. Tsang, V.L. and S.N. Bhatia, Three-dimensional tissue fabrication. Adv Drug 
Deliv Rev, 2004. 56(11): p. 1635-47. 
 38
38. Boland, T., et al., Cell and organ printing 2: fusion of cell aggregates in three-
dimensional gels. Anat Rec A Discov Mol Cell Evol Biol, 2003. 272(2): p. 497-
502. 
39. Ringeisen, B.R., et al., Jet-based methods to print living cells. Biotechnol J, 2006. 
1(9): p. 930-48. 
40. Zein, I., et al., Fused deposition modeling of novel scaffold architectures for 
tissue engineering applications. Biomaterials, 2002. 23(4): p. 1169-85. 
41. Hutmacher, D.W., M. Sittinger, and M.V. Risbud, Scaffold-based tissue 
engineering: rationale for computer-aided design and solid free-form fabrication 
systems. Trends Biotechnol, 2004. 22(7): p. 354-62. 
42. Lo, H., M.S. Ponticiello, and K.W. Leong, Fabrication of controlled release 
biodegradable foams by phase separation. Tissue Engineering, 1995. 1(1): p. 15-
28. 
43. Brun, P., et al., Chondrocyte aggregation and reorganization into three-
dimensional scaffolds. J Biomed Mater Res, 1999. 46(3): p. 337-46. 
44. Nazarov, R., H.J. Jin, and D.L. Kaplan, Porous 3-D scaffolds from regenerated 
silk fibroin. Biomacromolecules, 2004. 5(3): p. 718-26. 
45. Wang, Y., et al., In vitro cartilage tissue engineering with 3D porous aqueous-
derived silk scaffolds and mesenchymal stem cells. Biomaterials, 2005. 26(34): p. 
7082-94. 
46. Gravel, M., et al., Responses of mesenchymal stem cell to chitosan-coralline 
composites microstructured using coralline as gas forming agent. Biomaterials, 
2006. 27(9): p. 1899-906. 
 39
47. Zhao, F., et al., Effects of hydroxyapatite in 3-D chitosan-gelatin polymer network 
on human mesenchymal stem cell construct development. Biomaterials, 2006. 
27(9): p. 1859-67. 
48. Young, C.S., et al., Tissue-engineered hybrid tooth and bone. Tissue Eng, 2005. 
11(9-10): p. 1599-610. 
49. Mondrinos, M.J., et al., Engineering Three-Dimensional Pulmonary Tissue 
Constructs. Tissue Eng, 2005. 
50. Lin, A.S., et al., Microarchitectural and mechanical characterization of oriented 
porous polymer scaffolds. Biomaterials, 2003. 24(3): p. 481-9. 
51. Borden, M., M. Attawia, and C.T. Laurencin, The sintered microsphere matrix for 
bone tissue engineering: in vitro osteoconductivity studies. J Biomed Mater Res, 
2002. 61(3): p. 421-9. 
52. Grayson, W.L., T. Ma, and B. Bunnell, Human mesenchymal stem cells tissue 
development in 3D PET matrices. Biotechnol Prog, 2004. 20(3): p. 905-12. 
53. Takahashi, Y. and Y. Tabata, Homogeneous seeding of mesenchymal stem cells 
into nonwoven fabric for tissue engineering. Tissue Eng, 2003. 9(5): p. 931-8. 
54. Shin, M., H. Yoshimoto, and J.P. Vacanti, In vivo bone tissue engineering using 
mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng, 
2004. 10(1-2): p. 33-41. 
55. Li, W.J., et al., Multilineage differentiation of human mesenchymal stem cells in a 
three-dimensional nanofibrous scaffold. Biomaterials, 2005. 26(25): p. 5158-66. 
56. Nuttelman, C.R., M.C. Tripodi, and K.S. Anseth, In vitro osteogenic 
differentiation of human mesenchymal stem cells photoencapsulated in PEG 
hydrogels. J Biomed Mater Res, 2004. 68A(4): p. 773-82. 
 40
57. Li, Q., et al., Biodegradable and photocrosslinkable polyphosphoester hydrogel. 
Biomaterials, 2006. 27(7): p. 1027-34. 
58. Subramanian, A. and H.Y. Lin, Crosslinked chitosan: its physical properties and 
the effects of matrix stiffness on chondrocyte cell morphology and proliferation. J 
Biomed Mater Res A, 2005. 75(3): p. 742-53. 
59. Zaleskas, J.M., et al., Contractile forces generated by articular chondrocytes in 
collagen-glycosaminoglycan matrices. Biomaterials, 2004. 25(7-8): p. 1299-308. 
60. Wang, F.S., et al., Superoxide mediates shock wave induction of ERK-dependent 
osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation 
toward osteoprogenitors. J Biol Chem, 2002. 277(13): p. 10931-7. 
61. Altman, G.H., et al., Cell differentiation by mechanical stress. Faseb J, 2002. 
16(2): p. 270-2. 
62. Simmons, C.A., et al., Cyclic strain enhances matrix mineralization by adult 
human mesenchymal stem cells via the extracellular signal-regulated kinase 
(ERK1/2) signaling pathway. J Biomech, 2003. 36(8): p. 1087-96. 
63. Liu, L., et al., Preparation and characterization of collagen-hydroxyapatite 
composite used for bone tissue engineering scaffold. Artif Cells Blood Substit 
Immobil Biotechnol, 2003. 31(4): p. 435-48. 
64. Li, X., et al., Chemical characteristics and cytocompatibility of collagen-based 
scaffold reinforced by chitin fibers for bone tissue engineering. J Biomed Mater 
Res B Appl Biomater, 2005. 
65. Meinel, L., et al., Silk implants for the healing of critical size bone defects. Bone, 
2005. 37(5): p. 688-98. 
66. Meinel, L., et al., Engineering cartilage-like tissue using human mesenchymal 
stem cells and silk protein scaffolds. Biotechnol Bioeng, 2004. 88(3): p. 379-91. 
 41
67. Meinel, L., et al., Engineering bone-like tissue in vitro using human bone marrow 
stem cells and silk scaffolds. J Biomed Mater Res A, 2004. 71(1): p. 25-34. 
68. Gomes, M.E., et al., In Vitro Localization of Bone Growth Factors in Constructs 
of Biodegradable Scaffolds Seeded with Marrow Stromal Cells and Cultured in a 
Flow Perfusion Bioreactor. Tissue Eng, 2006. 12(1): p. 177-188. 
69. Holtorf, H.L., et al., Scaffold mesh size affects the osteoblastic differentiation of 
seeded marrow stromal cells cultured in a flow perfusion bioreactor. J Biomed 
Mater Res A, 2005. 74(2): p. 171-80. 
70. Holtorf, H.L., J.A. Jansen, and A.G. Mikos, Flow perfusion culture induces the 
osteoblastic differentiation of marrow stroma cell-scaffold constructs in the 
absence of dexamethasone. J Biomed Mater Res A, 2005. 72(3): p. 326-34. 
71. Datta, N., et al., In vitro generated extracellular matrix and fluid shear stress 
synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S 
A, 2006. 
72. Tsutsumi, S., et al., Retention of multilineage differentiation potential of 
mesenchymal cells during proliferation in response to FGF. Biochem Biophys 
Res Commun, 2001. 288(2): p. 413-9. 
73. Solchaga, L.A., et al., FGF-2 enhances the mitotic and chondrogenic potentials of 
human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol, 2005. 
203(2): p. 398-409. 
74. Bianchi, G., et al., Ex vivo enrichment of mesenchymal cell progenitors by 
fibroblast growth factor 2. Exp Cell Res, 2003. 287(1): p. 98-105. 
75. Reddi, A.H. and N.S. Cunningham, Initiation and promotion of bone 
differentiation by bone morphogenetic proteins. J Bone Miner Res, 1993. 8 Suppl 
2: p. S499-502. 
 42
76. Wozney, J.M., The bone morphogenetic protein family and osteogenesis. 
Molecular Reproduction and Development, 1992. 32(1): p. 160-7. 
77. Richardson, T.P., et al., Polymeric system for dual growth factor delivery. Nat 
Biotechnol, 2001. 19(11): p. 1029-34. 
78. Jansen, J.A., et al., Growth factor-loaded scaffolds for bone engineering. J 
Control Release, 2005. 101(1-3): p. 127-36. 
79. Mapili, G., et al., Laser-layered microfabrication of spatially patterned 
functionalized tissue-engineering scaffolds. J Biomed Mater Res B Appl 
Biomater, 2005. 75(2): p. 414-24. 
80. Carstens, M.H., M. Chin, and X.J. Li, In situ osteogenesis: regeneration of 10-cm 
mandibular defect in porcine model using recombinant human bone 
morphogenetic protein-2 (rhBMP-2) and Helistat absorbable collagen sponge. J 
Craniofac Surg, 2005. 16(6): p. 1033-42. 
81. Holtorf, H.L., J.A. Jansen, and A.G. Mikos, Ectopic bone formation in rat 
marrow stromal cell/titanium fiber mesh scaffold constructs: effect of initial cell 
phenotype. Biomaterials, 2005. 26(31): p. 6208-16. 
82. Takahashi, Y., M. Yamamoto, and Y. Tabata, Enhanced osteoinduction by 
controlled release of bone morphogenetic protein-2 from biodegradable sponge 
composed of gelatin and beta-tricalcium phosphate. Biomaterials, 2005. 26(23): 
p. 4856-65. 
83. Yang, X.B., et al., Human osteoprogenitor growth and differentiation on synthetic 
biodegradable structures after surface modification. Bone, 2001. 29(6): p. 523-
31. 
 43
84. Lu, Y., et al., A digital micro-mirror device-based system for the microfabrication 
of complex, spatially patterned tissue engineering scaffolds. J Biomed Mater Res 
A, 2006. 
85. Hern, D.L. and J.A. Hubbell, Incorporation of adhesion peptides into nonadhesive 
hydrogels useful for tissue resurfacing. J Biomed Mater Res, 1998. 39(2): p. 266-
76. 
86. Hersel, U., C. Dahmen, and H. Kessler, RGD modified polymers: biomaterials for 
stimulated cell adhesion and beyond. Biomaterials, 2003. 24(24): p. 4385-415. 
87. Schnaar, R.L., B.G. Langer, and B.K. Brandley, Reversible covalent 
immobilization of ligands and proteins on polyacrylamide gels. Anal Biochem, 
1985. 151(2): p. 268-81. 
88. Brandley, B.K. and R.L. Schnaar, Covalent attachment of an Arg-Gly-Asp 
sequence peptide to derivatizable polyacrylamide surfaces: support of fibroblast 
adhesion and long-term growth. Anal Biochem, 1988. 172(1): p. 270-8. 
89. Nuttelman, C.R., M.C. Tripodi, and K.S. Anseth, Synthetic hydrogel niches that 
promote hMSC viability. Matrix Biol, 2005. 24(3): p. 208-18. 
90. Shin, H., et al., Osteogenic differentiation of rat bone marrow stromal cells 
cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-
glycerol phosphate. Biomaterials, 2005. 26(17): p. 3645-54. 
91. Shin, H., et al., Attachment, proliferation, and migration of marrow stromal 
osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-
derived peptide. Biomaterials, 2004. 25(5): p. 895-906. 
92. Nuttelman, C.R., M.C. Tripodi, and K.S. Anseth, Dexamethasone-functionalized 
gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater 
Res A, 2006. 76(1): p. 183-95. 
 44
93. Lalani, Z., et al., Spatial and temporal localization of transforming growth factor-
beta1, bone morphogenetic protein-2, and platelet-derived growth factor-A in 
healing tooth extraction sockets in a rabbit model. J Oral Maxillofac Surg, 2003. 
61(9): p. 1061-72. 
94. Wake, M.C., et al., Effects of biodegradable polymer particles on rat marrow-
derived stromal osteoblasts in vitro. Biomaterials, 1998. 19(14): p. 1255-68. 
95. Park, H., et al., Delivery of TGF-beta1 and chondrocytes via injectable, 
biodegradable hydrogels for cartilage tissue engineering applications. 
Biomaterials, 2005. 26(34): p. 7095-103. 
96. Holland, T.A., Y. Tabata, and A.G. Mikos, Dual growth factor delivery from 
degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage 
tissue engineering. J Control Release, 2005. 101(1-3): p. 111-25. 
97. Peter, S.J., et al., Effects of transforming growth factor beta1 released from 
biodegradable polymer microparticles on marrow stromal osteoblasts cultured on 
poly(propylene fumarate) substrates. J Biomed Mater Res, 2000. 50(3): p. 452-
62. 
98. Wang, D.A., et al., Bioresponsive phosphoester hydrogels for bone tissue 
engineering. Tissue Eng, 2005. 11(1-2): p. 201-13. 
99. Wang, J., H.Q. Mao, and K.W. Leong, A novel biodegradable gene carrier based 
on polyphosphoester. J Am Chem Soc, 2001. 123(38): p. 9480-1. 
100. Nishimura, N., et al., A new bioactive bone cement: its histological and 
mechanical characterization. J Appl Biomater, 1991. 2(4): p. 219-29. 
101. Kokubo, T., Bioactive glass ceramics: properties and applications. Biomaterials, 
1991. 12(2): p. 155-63. 
 45
102. Ehara, A., et al., Effects of alpha-TCP and TetCP on MC3T3-E1 proliferation, 
differentiation and mineralization. Biomaterials, 2003. 24(5): p. 831-6. 
103. Sun, J.S., et al., The effects of calcium phosphate particles on the growth of 
osteoblasts. Journal of Biomedical Materials Research, 1997. 37(3): p. 324-34. 
104. Murphy, W.L., et al., Effects of a bone-like mineral film on phenotype of adult 
human mesenchymal stem cells in vitro. Biomaterials, 2005. 26(3): p. 303-10. 
105. Ong, J.L., et al., Osteoblast precursor cell activity on HA surfaces of different 
treatments. J Biomed Mater Res, 1998. 39(2): p. 176-83. 
106. Chang, Y.L., C.M. Stanford, and J.C. Keller, Calcium and phosphate 
supplementation promotes bone cell mineralization: implications for 
hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res, 2000. 52(2): 
p. 270-8. 
107. Chou, L., B. Marek, and W.R. Wagner, Effects of hydroxylapatite coating 
crystallinity on biosolubility, cell attachment efficiency and proliferation in vitro. 
Biomaterials, 1999. 20(10): p. 977-85. 
108. Deligianni, D.D., et al., Effect of surface roughness of hydroxyapatite on human 
bone marrow cell adhesion, proliferation, differentiation and detachment 
strength. Biomaterials, 2001. 22(1): p. 87-96. 
109. Zhang, G., et al., A PEGylated Fibrin Patch for Mesenchymal Stem Cell Delivery. 
Tissue Eng, 2006. 12(1-2): p. 9-19. 
110. Cho, J.H., et al., Chondrogenic differentiation of human mesenchymal stem cells 
using a thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan 
copolymer. Biomaterials, 2004. 25(26): p. 5743-51. 
111. Ruel-Gariepy, E., et al., A thermosensitive chitosan-based hydrogel for the local 
delivery of paclitaxel. Eur J Pharm Biopharm, 2004. 57(1): p. 53-63. 
 46
112. Dang, J.M., et al., Temperature-responsive hydroxybutyl chitosan for the culture 
of mesenchymal stem cells and intervertebral disk cells. Biomaterials, 2006. 
27(3): p. 406-18. 
113. Temenoff, J.S., et al., Thermally cross-linked oligo(poly(ethylene glycol) 
fumarate) hydrogels support osteogenic differentiation of encapsulated marrow 
stromal cells in vitro. Biomacromolecules, 2004. 5(1): p. 5-10. 
114. Robey, P.G., Bone Matrix Proteoglycans and Glycoproteins, in Principles of 
Bone Biology, J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, Editors. 1996, 
Academic Press: San Diego. p. 155-65. 
115. Dennis, J.E. and A.I. Caplan, Bone Marrow Mesenchymal Stem Cells, in Stem 





Laser-layered Micro-fabrication of Spatially Patterned Functionalized 
Tissue Engineering Scaffolds 
3.1 INTRODUCTION 
The field of tissue engineering, in recent years, has achieved significant 
milestones. One of the fundamental limitations in current efforts, however, has been our 
inability to produce multiple tissue types (e.g. bone, cartilage, ligaments, muscles etc.) in 
a pre-designed fashion inside a single scaffold structure [1, 2].  Although stem cells have 
been shown to differentiate into a variety of cell types, simultaneous construction of 
hybrid tissue structures within a single three-dimensional (3D) environment resembling 
the complex architecture of organs are yet to be reported.  The basic barrier in creating 
such structures is our lack of knowledge on how stem cells behave and differentiate under 
spatio-temporally distributed biochemical and physical microenvironments, similar to 
those encountered during organ development.   
Most patterning techniques to study cell behavior have been developed for two-
dimensional (2D) surfaces [3-5].  Although these studies have provided tremendous 
insights into a variety of cellular processes and interactions, cell behavior within 
controlled 3D microenvironments have not been studied.  Currently, most 3D scaffolding 
techniques only allow us to incorporate bio-factors “in bulk”, i.e. the factors are 
distributed randomly all throughout the matrix.  Even recent attempts in free-form 
fabricated scaffolds [6-9] or scaffolds with multiple sustained released factors [10] have 
only reported “bulk” incorporation.  Complex spatial patterning along with temporal 
distribution of signaling molecules in the immediate microenvironment of stem cells, a 
hallmark of native tissue development, has yet to be engineered and studied.  
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The two fundamental steps towards achieving patterned microenvironments inside 
scaffold structures are (a) creating localized concentrations (or gradients) of multiple 
growth factors by controlled spatial incorporation while preventing their diffusion to 
surrounding areas and (b) creating a temporal gradient of growth factors (i.e., be able to 
precisely deliver several growth factors in a physiologically relevant time sequence).  
Here we present efforts in achieving micropatterned scaffold structures using a layer-by-
layer microfabrication approach, with photo-polymerizable poly(ethylene glycol)- (PEG)-
based hydrogels and polymer microparticles.  Our goal is to create precise, pre-designed 
spatial distribution of multiple entities inside a single scaffold and mimic the 
physiological environment from which a single progenitor population can differentiate 
into multiple tissue lineages.   
We have developed a laser-based, layer-by-layer, stereolithography approach for 
photo-crosslinking bio-functionalized, acrylated PEG monomers carrying soluble and 
entrapped particles to achieve spatial patterning.  Photo-crosslinked hydrogel-based 
scaffolds, both degradable and non-degradable, have been widely investigated for 
musculoskeletal tissue engineering.  Several researchers have demonstrated that PEG-
based hydrogels can be successfully used to culture chondrocytes and osteocytes for bone 
and cartilage specific tissue regeneration [6, 11-15]. Others have developed hydrogels 
(using synthetic or natural polymers) having specific functionalities and degradation 
characteristics for similar purpose [16-18].  Chondrogenic differentiation of 
mesenchymal stem cells (MSCs) within PEG-based hydrogels has also been 
demonstrated by Elisseeff, Anseth and colleagues [19, 20]. However, most of these 
approaches use “bulk” encapsulation of cells and factors to create either bone or cartilage.  
Recent efforts to create hybrid structures have been reported using in-vitro derived 
osteocytes and chondrocytes (from MSCs) followed by incorporation of those precursor 
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cells in different layers prior to in-vivo implantation [21, 22].  Attempts to direct a single 
stem cell population into multiple lineages within a single scaffold structure by creating 
patterned growth factor distribution have not yet been reported.  In addition, PEG-based 
scaffolds with designed internal structures and porosities for cell seeding and subsequent 
study of progenitor cells in complex microenvironments are yet to be demonstrated.  
A key concept in creating localized patterning of bio-factors is the ability to 
prevent or control their diffusion into surrounding areas.  In native tissue such spatial 
patterning is created by various extracellular matrix (ECM) components that bind to and 
sequester specific growth factors.  We hypothesized that functionalizing the patterned 
scaffolds with ECM components (e.g. heparan sulfate) would allow us to sequester the 
entrapped growth factors in specific regions, thereby maintaining the spatial patterning. 
Components of the ECM not only play significant role in cell adhesion and migration but 
also supports optimal cell differentiation through molecular signaling by creating local 
concentration gradients of growth factors [reviewed by Taipale and Keski-Oja] [23].  
Hollinger et al. [2] discussed the need of tissue engineering scaffolds to incorporate 
factor-immobilization concepts since local concentrations of growth factors play key role 
in directing lineage specific differentiation of progenitor cells.  Highly charged 
glycosaminoglycans (GAG) e.g. heparan sulfates in the ECM, bind to soluble signaling 
molecules thereby preventing diffusion, creating local concentrations and optimal 
signaling, especially for basic fibroblast growth factor, FGF-2 [24-30].  Here we show 
that heparin incorporation into PEG scaffolds can create localized concentrations of 
growth factors thereby producing pre-designed spatial patterning.   
We further demonstrate that polymer microparticles can be spatially incorporated 
within the scaffolds, thereby providing evidence that eventually controlled-release 
carriers with various release kinetics can be used to create temporal patterns along with 
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spatial distributions.  Murine marrow stromal cells were successfully incorporated within 
these patterned structures by direct seeding on arginine-glycine-aspartic acid (RGD)-
functionalized  scaffolds.  Such pre-designed structures could provide us, in the short 
term, with a valuable tool to study stem cell differentiation in complex 
microenvironments and might eventually enable us to fabricate complex tissue structures 
from a single progenitor population. 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 PEGDMA Solutions and Photoinitiators 
Poly(ethylene glycol) dimethacrylate (PEGDMA, Mw 1000, Polysciences Inc.), 
was dissolved in phosphate-buffered saline (PBS) to form either 10-20% (w/v) or 100% 
(w/v) solutions.  The photoinitiator, 2-hydroxy-1-[4(hydroxyethoxy)phenyl]-2-methyl-1-
propanone (Irgacure 2959, Ciba Geigy, USA), was used to generate free radicals for the 
induction of chain polymerization, with a concentration of 0.05 wt% for the lower 
concentration PEGDMA solutions (10-20% w/v) or 0.07 wt% for the 100% (w/v) PEG 
solution.  The photoinitiator was first dissolved in PBS at a maximum concentration of 
0.7 wt% to ensure complete solubility, and subsequently added to the PEGDMA 
solutions [31].  Prepared macromer solutions were kept in a dark environment to inhibit 
the pre-crosslinking of the polymer by incidental exposure to ambient light. 
 
3.2.2 Pre-treatment of Glass Coverslips 
Surfaces of glass coverslips were modified with an organosilane to covalently 
bond the hydrogel upon polymerization, thereby promoting a strong adhesion with the 
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hydrogels when rinsed with PBS or placed in buffered solutions/cell medium [32].  
Surface-tethered methacrylate groups, which covalently attach to the acrylate groups of 
PEGDMA upon photo-polymerization, were created on the surface of glass coverslips by 
first immersing the slides in a solution of 3:1 ratio of 30% (w/v) H2O2 in distilled water 
and H2SO4.  The hydroxylated slides were then immersed in 1 mM solution of 3-
(trichlorosily)propyl methacrylate in a 4:1 solution of heptane and carbon tetrachloride.  
All chemicals were purchased from Sigma-Aldrich, unless otherwise noted. 
 
3.2.3 Microfabrication of PEG Scaffolds Using a Frequency-Tripled Nd:YAG  
Laser 
Using a 100% (w/v) PEGDMA solution with photoinitiator, 3D scaffolds were 
fabricated using an experimental set-up with the third harmonic wave of an Nd:YAG 
laser (λ = 355 nm, Surelite from Continuum, Figure 3.1), which generated nanosecond 
pulses.  The laser energy was measured to be ~10 mJ/pulse.  Macromer solutions were 
placed on a manually operated 3D micromanipulator stage.  The stage carrying the liquid 
macromer solutions was translated in the x-y direction at a scanning speed of 
approximately 50 µm/sec in order to create pre-designed patterns within a single layer of 
a tissue engineering scaffold.  The un-polymerized solution was washed off with PBS.  
This process is repeated for each different macromer solution composition to create 
single or multilayered patterned scaffolds.  
 
 
Fluorescently-labeled latex microparticles (5.47 µm Cy5, 0.93 µm FITC, and 1.0 
µm TRITC, Bangs Laboratories Inc.) were added to the macromer solutions at varying 
concentrations (ranging from 1% to 10% v/v) prior to crosslinking in order to show the 
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capabilities of this laser set-up to not only encapsulate the particles during polymer 
crosslinking, but to pattern them in a pre-designed fashion.   Vertical patterning i.e. in the 
z-direction, was achieved by creating two-layered scaffolds.  Macromer solution 
containing Cy5-labeled particles was selectively polymerized in a grid-type geometry.  
The un-polymerized solution was washed off extensively, and a second macromer 
solution containing FITC-labeled particles was polymerized over the first layer in the 
same geometry.   These constructs were analyzed using either a confocal microscope 
(Leica SP2 AOBS) or by scanning electron microscopy (Phillips 515 SEM).  Z-slices 
obtained using confocal fluorescence microscopy were reconstructed to create 3D images 
of the entire scaffolds.    
 
3.2.4 RGD and Heparin Conjugation to PEG 
Figure 3.2 shows the reaction scheme for functionalizing the scaffold material. A 
well-characterized fibronectin-derived peptide, YRGDS (tyrosine-arginine-glycine-
aspartic acid-serine, Bachem Biosciences Inc., Torrance, CA), was reacted in equimolar 
amounts with acryloyl-PEG-N-hydroxysuccinimide (acryl-PEG-NHS, Mw 3400, Nektar 
Therapeutics Inc.) [14, 18].  200 µL sodium bicarbonate buffer (pH 8.2) was added to 
acryl-PEG-NHS, which in a drop-wise fashion, was added to the YRGDS solution (1 
mg/mL in sodium bicarbonate buffer).  Conjugation was completed in a dark 
environment for 3 hours at room temperature.  Peptide-modified PEG-acryl was frozen in 
liquid nitrogen, lyophilized for 24-hours, and stored in a desiccator at -20°C until further 
use.      
To create a heparin moiety onto PEG-acrylates, ethylenediamine (EDA) was first 
reacted in excess with acryl-PEG-NHS at a 5:1 molar ratio to yield acryl-PEG-NH2, 
similar to the method for RGD conjugation.  The reaction was completed for 3 hours at 
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room temperature in a dark environment followed by extensive dialysis (Tube-o-dialyzer, 
MWCO 1000, Geno Technologies, St. Louis, MO) of unreacted EDA.  Samples were 
frozen and lyophilized for 24 hours.  Matrix-assisted laser desorption/ionization 
spectrometry (Applied Biosystems Voyager DE-PRO MALDI TOF-MS) was performed 
after this reaction to ensure that ethylenediamine did not create acryl-PEG dimers.  
Periodated heparin (Mw 10,000 Celsus Laboratories Inc., USA) was reacted in 
equimolar amounts for 3 hours in a dark environment with acryl-PEG-NH2 to yield acryl-
PEG-heparin in the presence of 50 mM NaBH3CN as the reducing agent.  Heparin, 
containing aldehyde moieties, undergoes Schiff-base reactions with organic amines, and 
if treated with NaBH3CN, the Schiff-base intermediate is reduced to its corresponding 
amine, forming an irreversible bond.  Centrifugation (Pall Macrosep®, MWCO 10,000) 
was performed to eliminate the reducing agent and unreacted components, and the 
product was lyophilized and stored in a dessicator at -20°C until further use.  Proton-
NMR was used to analyze the acryl-PEG-heparin reaction.   
 
3.2.5 Cell Culture 
Murine OP9 marrow stromal cells (a gift from T. Reid, University of Toronto) 
were cultured in Minimum Essential Medium-Alpha (Gibco Invitrogen Corp.) 
supplemented with 20% fetal bovine serum, 30 mM sodium bicarbonate (Sigma-Aldrich 
Co.), 2 mM L-glutamine (Gibco Invitrogen Corp.), 50 µg/mL penicillin-streptomycin 
(Gibco Invitrogen Corp.), and 100 mM of β-mercaptoethanol (Sigma-Aldrich Co.).  Cells 
were passaged every 2-3 days.   
An amine-reactive fluorescent dye, CellTraceTM Far Red DDAO-SE (Molecular 
Probes, Eugene OR) was used as a cell tracer to study cell attachment onto RGD-
modified scaffolds.  The succinimidyl ester reactive group of the dye forms a covalent 
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attachment to primary amines that occur in proteins and other bio-molecules on the inside 
and outside of cells.  Because the fluorescent tag is inherited by daughter cells even after 
multiple divisions, cells were labeled in culture before their use in cell attachment 
studies.  Additionally DAPI (Molecular Probes, Eugene OR) was also used to stain for 
cell nuclei.  All cell staining were performed according to manufacturer’s protocol. 
 
3.2.6 Cell Attachment to RGD-modified Hydrogels 
Acryl-PEG-RGD at a concentration of 5.0 mM was added to a 100% (w/v) 
PEGDMA solution with I2959 as the photoinitiator.  Single-layered scaffolds (2 mm x 2 
mm x 0.5 mm, L x W x H) with defined porosities were fabricated.  The scaffolds were 
UV sterilized overnight in a cell culture hood prior to cell seeding.  Parafilm was placed 
in a non-treated cell culture plate in order to form a hydrophobic surface when seeding 
the cells, and the scaffolds were placed on top of the film.    Fluorescently-labeled murine 
bone-marrow stromal cells (OP9) were seeded on both the unmodified and RGD-
modified constructs at a density of 2x104/scaffold using 200 µl of medium.   Medium was 
added to the culture plate after a 4 hr seeding period.  The scaffold-cell constructs were 
cultured for 24 hours, and then rinsed with pre-warmed PBS to remove non-immobilized 
cells.  Cells were fixed onto the scaffolds using 4% paraformaldeyde (pH 7.3) solution 
for 4 hours at 37°C.  DAPI was used to stain for cell nuclei upon fixation.  The scaffolds 
were imaged with confocal fluorescence microscopy and critical-point dried for SEM 
(Phillips 515) analysis.   
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3.2.7 FGF-2 binding to Heparin-modified PEG 
On separate methacrylate-treated coverslips, thin-layered hydrogels were 
fabricated using 10% (w/v) PEGDMA with photoinitiator and 10% acryl-PEG-heparin.  
Each thin-layered hydrogel encapsulated 2 µg of FGF-2 (R&D Systems).  Unbound FGF-
2 was allowed to diffuse out of the hydrogels overnight while incubating in PBS at 37°C.  
The PBS solution in which the substrates were submersed was replaced three times 
during a period of 24 hours incubation to remove released FGF-2.  To evaluate for FGF-2 
binding to heparin-modified hydrogels, immunostaining was performed using primary 
anti-FGF antibody, biotinylated-secondary antibody, and streptavidin-FITC. The binding 
time for the antibodies and streptavidin-FITC were one hour each.  Fluorescence 
microscopy was used to detect for FGF-2 immobilization within the hydrogels. 
To test for FGF-2 binding in the multi-layered models, a two-layered hydrogel 
construct was polymerized using a UV lamp (365 nm, intensity ~4 mW/cm2) and a 3 x 3 
x 1 mm3 plastic molding.  The first layer, with 20% (w/v) PEGDMA and 0.05 wt% I2959 
solution, was partially polymerized by exposing to the UV light for 4 minutes.  The 
second macromer solution, which had 5.0 mM acryl-PEG-heparin and 2 µg of FGF-2 in 
addition to the 20% PEGDMA solution, was polymerized over the first layer by exposing 
it to UV light for 10 minutes.  The hydrogel construct was then placed in PBS buffer (pH 
7.4) for a period of 3 days.  The construct was transversely sliced, and immunostaining 
was completed, as described previously, to evaluate for FGF-2 binding.  A control group 
to this study was formulated in a similar way, except that the layer that did not contain 





3.3.1 Microfabrication of Single and Multi-layered Scaffolds with Precise Internal 
Features 
The laser-based stereolithography method was used to create polymer scaffold 
structures with specific pore/channel dimensions.  FITC-labeled latex microparticles were 
incorporated into the macromer solution prior to laser exposure in order to demonstrate 
the ability to incorporate controlled-release carriers or biomolecules within the scaffold 
as well as for easy visualization using confocal fluorescence microscopy.  Porous 
scaffolds were fabricated with line spacings (center to center) of 300, 400 and 500 µm 
respectively. As shown in Figure 3.3(A-C) precise and highly controlled internal 
architectures can be generated during scaffold fabrication.  Pores (channels) of sizes ~175 
µm, 300 µm and 350-400 µm were achieved using the indicated line spacing within a 
single, 3D scaffold layer. As evident, highly uniform pore distribution was achieved 
using this technique. Table 3.1 shows the detailed geometrical characterization of the 
scaffolds.  The data also demonstrates that bio-factors and microparticles can be easily 
incorporated within the scaffold walls during the fabrication process.  It is to be noted 
that the horizontal walls are slightly narrower than the vertical ones.  This is due to the 
fact that the x-direction movement of the stage is computer-controlled at 50 µm/secs 
while the movement in the y direction is manually controlled to achieve an equivalent 
speed.  Minor discrepancies in laser scanning speed could create such differences in wall 
thickness (a slower speed results in a thicker polymerized area). 
Figure 3.3D shows a scanning electron micrograph of a representative, single-
layer scaffold, while Figure 3.3E demonstrates the ability to create multiple layers.  The 
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two-layer scaffold shown in Figure 3.3E also provides evidence that layers with various 
wall thickness and dimensions can be created using this approach.   
 
3.3.2 Pre-designed Spatial Patterning of Scaffold Structures can be Achieved using 
Laser Fabrication 
A key feature of this stereolithography method for scaffold fabrication is its 
ability to create pre-designed spatial patterns of single or multiple molecules and 
particles.  We have demonstrated this ability and flexibility of this technique using both 
single layer (2D) and multi-layer (3D) structures as well as in structures with precise 
internal architectures.  As shown in Figure 3.4A, TRITC-labeled latex particles can be 
spatially-patterned within a single polymer layer in a decreasing particle concentration 
(10%, 5% and 2.5% w/w).  The line-graph indicates the fluorescence intensity (and hence 
a measure of particle concentration) across the polymer layer and demonstrates the 
feasibility of creating gradients of single growth factors as well as controlled-release 
particles within the scaffold.  Figure 3.4B demonstrates patterning of multiple agents in a 
single layer. Cy5 or FITC-labeled particles were incorporated in the macromer solutions 
prior to laser exposure.  Each pattern (line) was “written” using the laser and the un-
polymerized polymer-particle solution was washed off prior to polymerizing the second 
line using a different polymer-particle solution.  This shows the ability of this fabrication 
process to create precise and pre-determined distribution of multiple factors.  
Figure 3.4C provides evidence on the feasibility of combining internal porosities 
and architectures along with spatial patterning inside a scaffold.  A scaffold was 
fabricated using FITC-labeled particle-carrying polymer as well as polymer without the 
presence of any other agents.  As shown, a pre-designed quadrant pattern was created 
using the stereolithography method in which the particles were specifically sequestered in 
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quadrants 1 and 4 while no factors were incorporated in quadrants 2 and 3.  In addition 
channels of dimension 100 µm were created during the fabrication process. 
Figures 3.4 (D-E) demonstrates the ability of this process to create multi-layered, 
3D structures with spatially distributed factors.  Either Cy5 or FITC-labeled polymer 
microparticles were incorporated within each layer during photopolymerization with the 
laser while creating uniform pores of dimension 400 µm.  Figure 3.4D shows a stacked-
confocal picture (3D reconstruction) while Figure 3.4E is a collage of confocal slices 
through vertical sections of the scaffold.   This suggests that both lateral (Figure 3.4C) 
and vertical (Figure 3.4 D-E) patterning and can be achieved using this method of 
scaffold fabrication. 
 
3.3.3 Heparin-functionalization Allows Effective Sequestration of FGF-2 
In order to maintain spatial patterning of soluble growth factors inside a scaffold 
structure, it is critical to sequester the factors in their intended regions and control the 
diffusion of the growth factors within and across the spatial region.  ECM components 
are known to participate in sequestration and localization of certain growth factors.  Here 
we demonstrate that covalent conjugation of heparin to PEGDMA prior to scaffold 
fabrication provides efficient binding of basic fibroblast growth factor (FGF-2) and 
localization in both single and multi-layered scaffold models.  MALDI-TOF ensured that 
no acryl-PEG dimers were formed with the addition of ethylenediamine during acryl-
PEG-NH2 synthesis, and only 3600 Mw peaks were found on the spectra (Figure 3.5A).  
1H-NMR confirmed the conjugation of heparin to acryl-PEG-NH2, as illustrated in 
Figure 3.5B-D.  1H-NMR showed peaks for both the presence of PEG (chemical shift 3.6 
ppm) and heparin moieties (chemical shift range 3-5.5 ppm) when analyzing acryl-PEG-
heparin.  In the single-layered model (Figure 3.6A-D), polymer-layers containing 
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heparin-modified PEGDMA showed efficient FGF-2 binding and sequestration as 
demonstrated by immuno-fluorescence assays 72 hours after the addition of FGF-2.  
Matrices without heparin did not show FGF-2 immobilization.  FGF-2 binding and 
localization was also illustrated in multi-layered hydrogels (Figure 3.6E- H).  By 
observing immuno-stained hydrogels through confocal fluorescence microscopy, FGF-2 
diffusion from the heparin-modified layer to the unmodified layer was not observed after 
a 72-hour incubation period in aqueous medium.  These findings indicate that FGF-2 
specifically binds to regions of PEG scaffolds that have been covalently modified with 
heparin.  Furthermore, FGF-2 was encapsulated in both layers of the multi-layered 
scaffolds, (Figure 3.6G-H), and green fluorescence indicates that FGF-2 is more 
concentrated in the layer that contains acryl-PEG-heparin.  Such functionalization 
concepts could provide effective means to maintain the spatial patterns created using the 
stereolithography method and allow one to control the rate of growth factor release from 
the scaffold walls. 
 
3.3.4 Laser-microfabricated Scaffolds are Conducive of Cell Attachment when 
Functionalized with RGD 
PEGDMA scaffolds containing 5 mM RGD-modified PEG resulted in efficient 
attachment and spreading of OP-9 stromal cells while scaffolds without the cell-adhesion 
peptide did not show any cell attachment.  Figure 3.7A-B shows scanning electron 
micrograph of RGD-functionalized (Figure 3.7B) and non-functionalized laser-
microfabricated scaffolds that were seeded with OP-9 cells.  After 24 hours, no cell 
attachment was seen in the PEGDMA scaffolds while the RGD-containing scaffolds were 
filled with what appears to be ECM-like substances.  Cell attachment on similar scaffolds 
was confirmed using confocal fluorescence microscopy.  Figure 3.7C shows DAPI 
 60
staining on cells seeded on RGD-functionalized microfabricated scaffolds.  It is evident 
that a large number of cells are attached to the scaffold walls.  Figure 3.7D demonstrates 
cell seeding on a porous scaffold carrying FITC-labeled polymer particles.  These cells 
were pre-labeled with CellTraceTM.  Red fluorescence specifies the attachment of cells to 
the surfaces of the scaffold, and the green fluorescence indicates that entrapped polymer. 
The data shows cells attach and spread efficiently on the scaffold wall. 
 
3.4 DISCUSSION 
One of the fundamental limitations of current efforts in the field of tissue 
engineering has been our inability to produce multiple tissue types in a pre-designed 
fashion within a single construct.  Recent and past methods in fabricating tissue 
engineering scaffolds have only incorporated a random, bulk distribution of bio-factors 
that are conducive to the differentiation of a single tissue type inside a 3D structure.  
Because complex, patterned microenvironments are necessary to develop multiple cell-
types within a single scaffold, spatial distribution of bio-factors, as well as their temporal 
release kinetics must be integrated to closely mimic the physiological environment.  
Furthermore simple, easy to fabricate 3D scaffolds that allow the study of cells within 
highly controlled geometrical features as well as within pre-designed patterns of 
biochemical and physical factors, could provide significant insights into complex cellular 
processes.  
We have developed a laser-based SL system that can build complex scaffold 
structures using a layer-by-layer photopolymerization process.   PEGDMA was used as a 
model polymer because of its easy availability as well as the ability to conjugate ECM to 
the polymer using well-defined chemistry.  However, any polymer or resins that undergo 
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photo-initiated free-radical polymerization can be used as long as they are cyto-
compatible.  In addition, degradable scaffolds can also be fabricated using this process by 
introducing hydrolytically or enzymatically degradable segments within the 
photopolymer as described by Anseth and colleagues [13, 33, 34] and Hubbell and 
colleagues [18].    
The point-by-point polymerization process is similar to a raster scanning device 
that could eventually be completely automated.  Such automated stereolithography 
systems are commercially available and can be computer-guided.  However, it must be 
noted that the resolution of most commercial stereolithography system remains 
approximately 200-250 µm.  Although some commercial systems have a theoretical 
feature size of 75 µm, they failed to create open pores and channels when provided with a 
scaffold design, similar to those presented here (data not shown).  Eventually such a 
fabrication system can be coupled to computer aided design and manufacturing 
(CAD/CAM)-driven automation and can use CT or MRI-based data as the input for 
designing complex scaffolds.  Such systems have been described by Hollister et al. [6, 
35-37] albeit at much larger feature sizes.  The attraction of a simple laser-based system 
is that it can be a benchtop, research-scale system with high resolution.  Although we 
have used an UV laser because of existing data showing cyto-compatibility of the 
photoinitiator [13], it is conceivable that other lasers can be substituted as long as a 
corresponding cell compatible photoinitiator is available.   
The cross-linking of the macromer solution induced by the focused UV pulsed 
laser (λ=355 nm), and the complexity of the scaffold’s architecture is controlled by the 
translational motion of the stage in the x-y directions, as well as feature resolution.  The 
laser beam can be modeled as a Gaussian distribution in which the beam’s diameter at the 
focal waist governs the theoretical x-y resolution of the system, which in turn dictates the 
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smallest feature sizes attainable (e.g. porosities or wall thickness of the scaffold).  The 
focal waist of a Gaussian beam with a circular cross section is given by: 
wo=(2λ / π) * f#, [Equation 1] 
where wo is the laser beam radius at the focal waist, λ is the wavelength,  f# (f number) is 
given by  
f# = f / 2w1 
 
where f is the  focal length of the lens, and w1 is the beam radius at the lens.  Using this 
equation, in our case, the theoretical resolution is calculated to be 5.8 µm (λ=355 nm, f = 
25.4 mm, and beam w1= 1 mm). Similarly, the depth of focus equation for a Gaussian 
beam with a circular cross section provides the theoretical resolution in the z-axis which 
in turn dictates the thickness of each layer.  This can be solved by: 
 
dof = (πwo2/λ)*(ζ2-1)1/2, [Equation 2] 
 
where dof is the depth of focus, and ζ is the acceptable focus within 2% or 1.02.  For the 
current setup the theoretical depth of focus calculated from Equation 2 is 15 µm.  These 
values demonstrate that the laser-based system has the potential to be a high resolution 
instrument. However, the experimental x-y resolution as well the z resolution of our 
system was measured to be ~100 µm which was governed by the amount of macromer 
solution placed on the translational stage.  These significant deviations between the 
theoretical and experimental values can be due to laser diffraction, heat conduction, 
photoinitiator diffusion, and scattering due to polymer particles.  We believe that through 
careful selection of photoinitiator, particle concentration and optimal laser-optics, this 
resolution can be significantly improved.  However, even at its current resolution, the 
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feature sizes of the setup are conducive of studying cell differentiation and tissue 
formation in a highly controlled, pre-designed manner.  An ideal wall thickness of a 
scaffold should be sufficient enough to not only encapsulate 5 to 10 µm-sized controlled-
release particles and other bio-molecules, but should provide enough surface area for 
stem cells to attach and spread for optimal cell-to-cell communication and differentiation.   
The scaffold-fabrication system developed here allows us to study the effects of channel 
wall thickness, pores size, polymer crosslink density (all leading to the issues of nutrient 
diffusivity) in a controlled and detailed manner. 
The laser-layered stereolithography process has the capability of spatially 
patterning growth factors and ECM components by their addition into the macromer 
solution prior to photo-polymerization.  Instead of bulk photo-crosslinking PEG, as 
reported by other groups [11, 13], laser SL provides a controlled point-by-point 
polymerization method of creating a pre-designed scaffold. This unique capability 
specific to SL enables multiple types of growth factors to be spatially patterned within a 
single structure, overcoming a major roadblock in current efforts with creating more 
complex tissue-like structures. Another advantage for using this method is that 
microparticles have been effectively encapsulated during the crosslinking of PEGDMA 
solution.  In our experimental applications both degradable poly(lactide-co-glycolide) 
microparticles (data not shown) and non-degradable polystyrene particles were used to 
show patterning of controlled-release carriers.  Spatial incorporation of controlled-release 
particles having pre-designed release profiles would allow effective temporal patterning 
of the growth factors necessary for the signaling of progenitor cell differentiation (e.g. 
growth factor A could be early release while growth factor B could be a late release).  
Surfaces of these micro-fabricated scaffolds must also be functionalized for cell 
recognition, providing a more biomimetic environment for stem cell proliferation and 
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behavior.  Therefore ECM components were integrated within scaffolds by covalent-
conjugation to the scaffolding biomaterial.   Fibronectin-derived RGD is a commonly 
employed amino acid sequence for functionalizing PEG. Scaffolds were functionalized 
with RGD to be more biomimetic, thereby mediating adhesion to the seeded OP-9 cells.  
Micrographs show both protein and cellular attachment to the scaffolds that were 
modified with RGD.  Cells that were seeded onto 100% PEG scaffolds without the 
presence of RGD did not remain viable.  
In addition, one of the key factors in creating hybrid tissue structures is the ability 
to effectively sequester growth factors and maintain spatial patterning by controlling their 
diffusion in the scaffold.  We hypothesized that appropriate modifications of the scaffold 
polymer with ECM components would allow for efficient binding and effective 
localization of growth factors.  To demonstrate spatial patterning as well as localization 
of specific bio-factors, FGF-2 was chosen as model growth factor.  The PEGDMA 
macromer was pre-modified with heparin prior to scaffold fabrication in order to regulate 
activity of the growth factor, FGF-2, and control its diffusion from the prescribed regions.  
By localizing growth factors into their specific compartments within a single scaffold, 
molecular signaling for hybrid stem cell differentiation can be further optimized.  
Heparin for growth factor binding was evaluated in both thin-layered and multi-layered 
systems.  The immunostaining results show that FGF-2 remained sequestered in a 
heparin-containing matrix rather than diffusing away, indicating feasibility for successful 
patterning in a scaffold structure. 
Integration of cells within PEG-based scaffolds can be mediated in two different 
ways: (a) direct cell encapsulation during the crosslinking polymerization and (b) cell 
seeding into fabricated scaffolds in which diffusion as well as surface chemistry governs 
cell distribution.  We chose the latter method for integrating cells within our micro-
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fabricated scaffolds since the pre-defined channels serve as porosities.  It should be noted 
that the structural material of the scaffold is also a hydrogel that allows for intrinsic 
diffusivity throughout the scaffold in addition to the presence of channels.  We 
hypothesize that combining the hydrogel material with a porous macrostructure will 
allow significantly improved diffusion of oxygen and nutrients to the interior of the 
scaffold, a major limitation of current scaffolding techniques.  
There are however some key limitations to this fabrication process in its current 
form.  First, the fabrication process is slow and if not automated could be tedious, 
especially for larger scaffold sizes.  Thus, cell encapsulation within the hydrogel material, 
as has been the norm by other researchers using similar materials [14, 19, 20] is not 
possible.  We have instead chosen to seed cells within the structures as an alternative. 
Direct cell encapsulation, however, in combination with laser-SL, could prove to be a 
promising method since multiple progenitor cells could ultimately be used, mimicking a 
more complex physiological tissue/organ.  It would be helpful to have both options 
(encapsulation as well as seeding) available.  We are working on increasing the speed of 
the layer-by-layer fabrication process using more advanced optical techniques that would 
allow both direct encapsulation as well as seeding of cells.  Secondly, staggered layers (to 
ensure later interconnectivity of pores and channels) have not been achieved. Since in 
traditional stereolithography such staggering and overhanging structures are quite 
common and generally achieved using a sacrificial filler material, we believe that the 
current technique can be further enhanced using such approaches.  We are continuing to 
further enhance the capabilities of this technique to incorporate such features.  Although 
it should be noted that since the walls of the scaffold are hydrogels there is actually 
lateral diffusion of oxygen and nutrients possible. Thirdly the concept of “washing off” 
one solution prior to polymerizing another (for spatial patterning) could lead to some 
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cross-contamination between patterns. Although our results indicate that we can 
successfully pattern several components, it remains to be seen how complex the 
patterning can be before mixing becomes a problem.  However, we believe that even 
simple 3D spatial patterns can provide us with unique insights on cell behavior under 
complex microenvironments.  
Another important issue that needs to be addressed in future work is to determine 
differences photo-polymerization kinetics and mechanical integrity of scaffolds upon 
functionalizing with ECM components.  Functionalization of scaffolds with RGD and 
heparin moieties decreases the rate of photo-polymerization due to their mono-functional 
acrylated macromer groups.  We also observed that scaffolds modified with either acryl-
PEG-heparin or acryl-PEG-RGD were less stiff in mechanical integrity than scaffolds 
fabricated using plain PEG macromer solution.  Insight into how varying concentrations 
of these ECM components affect overall scaffold compressive modulus or stiffness as 
well as rate of photo-polymerization will be further investigated.  These key factors could 
potentially affect stem cell behavior in such a precisely controlled microenvironment.  
In conclusion we have developed a laser-based layer-by-layer 
photopolymerization process for microfabricating porous polymer scaffolds.  This 
process allows for precise, pre-designed spatial distribution of single or multiple 
molecules within the scaffold as well as the fabrication of pre-determined internal 
architectures.  We also demonstrate that functionalizing the scaffold material with RGD 
and heparin ensures efficient cell attachment and allows for spatial sequestration of 
patterned growth factors (FGF-2).  Such microfabricated scaffold structures could 
provide tools to study progenitor cell populations under patterned, complex 
microenvironments and ultimately aid in creating pre-designed, hybrid tissue structures 
from a single stem cell population. 
Table 3.1 Geometric Characteristics of the Microfabricated Scaffolds Depicted in 
Figure 3.3(A-C) 
  






300 µm ~350 µm ~175 µm x 175 µm ~140 µm, 200 µm
400 µm ~450 µm               ~300 µm x 350 µm ~90 µm, 120 µm
500 µm ~565 µm               ~350 µm x 425 µm ~100 µm, 200 µm
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Figure 3.1 Experimental setup of the laser-based layer-by-layer stereolithography 
process for fabrication of patterned scaffolds. 
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Figure 3.2 Reaction schemes detailing the conjugation of heparin and RGD to 
acrylated polyethylene glycols. 
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Figure 3.3. Confocal fluorescence and SEM micrographs show scaffolds with precise 
internal geometries can be fabricated using the stereolithography 
method.  Fluorescence micrographs in figures (A-C) show scaffolds 
formulated with 100% (w/v) PEGDMA, 0.07 wt% Irgacure 2959, and 
1% (w/w) FITC-labeled latex particles.  Size bar shown is equal to 200 
µm.  Scaffold dimensions for each scaffold (A-C) are listed in Table 3.1, 
and the white scale bar equals 200 µm.   SEM micrographs in figures (D 
and E), formulated in the same concentrations of PEGDMA and I2959, 
represent a single layer scaffold and a multi-layered scaffold, 
respectively.  To differentiate the layers within a single scaffold when 
analyzing with SEM, the first layer of figure E was polymerized to have 




Figure 3.4  Laser-based SL can create pre-designed, spatially patterned scaffold 
structures.  Scaffolds shown here are formulated using 100% (w/v) 
PEGDMA and 0.07 wt% I2959.  Figure A illustrates decreasing 
amounts of TRITC-labeled latex particles that are linearly patterned in 
a gradient form.  The concentrations from L-R are 10%, 5%, and 2.5% 
(w/w) of particles in macromer solution.  The graph below shows the 
intensity profile indicating decreasing fluorescence (and hence particle 
concentration) from left to right. Figures B & C illustrate spatial 
patterning using either FITC- or Cy5-labeled latex particles, as well as 
the capability of the laser SL to create uniform, precise, channels 
(pores) within a scaffold (white bar = 200 µm).  Figure D illustrates a 
3D reconstruction of a multi-layered scaffold using confocal z-slices.  
The individual slices through the scaffold are shown in figure E as a 
composite picture.   The channel porosity within this particular multi-
layered scaffold was measured to be approximately 400 µm.  
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Figure 3.5  MALDI-TOF in (A) confirmed that no acryl-PEG dimers were formed 
during when EDA was reacted with acryl-PEG-NHS.  Only ~3600 Mw 
peaks were formed after this reaction (and not 7200 Mw peaks).   1H-
NMR spectra for unreacted components of acryl-PEG-NHS and 
periodated heparin in (B) and (C) respectively.  The arrow in (B) and 
(D) depict the peak for acryl-PEG-NHS that occurs at a chemical shift 
of 3.6.  The striped bar seen in (C) and (D) depict the presence of 
heparin moieties, and the chemical shift ranges from 3-5.5 ppm.  After 
conjugation of these compounds and the filtration of unreacted 
compounds, 1H-NMR shows that both heparin and PEG peaks were 
still present in (D).  Figure (D) is also a zoomed-out view, and therefore 







Figure 3.6 Incorporation of heparin mediates FGF-2 sequestration.  This was 
demonstrated using both thin-layered polymer matrices (A-D) as well 
as multi-layered scaffolds (E, F).  Localization of FGF-2 was evaluated 
via immuno-histochemistry and fluorescence microscopy (10X 
objective).  Green fluorescence is due to the presence of FGF-2.  FGF-2 
(2 µg) was encapsulated in the thin-layered hydrogels.  Brightfield 
images (A, C) and fluorescence images (B, D) were captured to 
determine FGF-2 immobilization.  Hydrogels without acryl-PEG-
heparin (A, B) do not show FGF-2 binding, whereas hydrogels  
modified with acryl-PEG-heparin (C, D) show FGF-2 sequestration.  
 Figure E is a schematic of the 
multi-layered scaffold depicted in 
F.  Both layers were constructed 
using 20% (w/v) PEGDMA, 0.05% 
Irgacure 2959, and UV light.  The 
top layer has 5.0 mM acryl-PEG-
heparin and encapsulates 2 µg of 
FGF-2.  Figure F illustrates that 
FGF-2 is effectively localized only 
within the layer that contains 
heparin.   
 Figure G is another schematic of a 
multi-layered scaffold depicted in 
H, formulated in the same way as 
explained above, except FGF-2 is 
encapsulated in both layers.  After 
72 hours in PBS, and removing 
soluble FGF-2 in the supernatant 
solution, fluorescence microscopy 
confirms that FGF-2 is more 




Figure 3.7  Incorporation of RGD in the scaffold material mediates efficient cell 
attachment and spreading. SEM micrographs show top views of a 2 mm 
x 2 mm scaffold without RGD-modification (wall thickness is ~100µm) 
(A) and of a 2 mm x 2 mm scaffold containing 5.0 mM RGD-PEG-acryl 
(wall thickness ~200 µm) (B).  Black scale bars in (A) and (B) equal 
200µm.   It appears that the attached OP-9 cells in (B) have secreted 
ECM-like materials on the scaffold.  Confocal fluorescence microscopy 
(C, D) indicated that cells only attached to RGD-functionalized 
scaffolds.  Figure C shows DAPI nuclei staining (scale bar = 200 µm), 
and figure D shows cells pre-stained with CellTracerTM.  The green 
staining seen in figure D is fluorescence from FITC-labeled particles 
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A Digital Micro-Mirror Device (DMD)-based System for the 
Microfabrication of Complex, Spatially Patterned Tissue Engineering 
Scaffolds 
4.1  INTRODUCTION 
Recent advances in fabricating scaffolds for tissue engineering applications have 
yet to report methods in creating three-dimensional (3D) constructs that incorporate 
complex spatial-patterning of extracellular matrix components (ECM) and growth 
factors, which could provide biomimetic complex microenvironments for studying cell 
behavior and differentiation [1-3].  Most 3D scaffolding systems are only capable of 
differentiating a single progenitor cell population into one particular cell lineage due to 
either (a) bulk incorporation of bio-factors within the scaffolding matrix [4] or (b) 
exogenous delivery of hormones, chemicals, or growth factors in culture medium [5-7].  
From a tissue engineering perspective, a significant advancement could be attained by 
creating precise, spatially distributed microenvironments within a single scaffold that 
would allow us to study simultaneous, patterned differentiation of stem and progenitor 
cells into multiple lineages and develop concepts to ultimately engineer complex, hybrid 
organ structures.  A key step towards achieving such patterned 3D structures is the 
development of novel scaffold-manufacturing techniques by which distributed 
environments can be incorporated in a simple yet precise, reproducible fashion.   
Laser micro-stereolithography (µSL) has become an accepted rapid prototyping 
method that allows the 3D microfabrication of solid models from images created by 
computer-aided design (CAD) programs [8-10].  We have recently reported a layer-by-
layer laser microfabrication method for creating spatially patterned scaffolds using photo-
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crosslinkable polymers.  In this method a motorized x-y-z platform immersed in a liquid 
photopolymer is selectively exposed to a focused ultra-violet (UV) laser light.  The 
polymer cures and becomes solid only at the focal point whereas non-irradiated areas 
remain liquid. After the first layer is formed the platform moves downward and a new 
layer of polymer is solidified according to the design. This layer-by-layer micro-
manufacturing method enables complex internal features such as patterning of growth 
factors and ECM proteins.  Bhatia and colleagues [11] have also provided an innovative 
soft lithography and a microsyringe method to fabricate biodegradable PLGA-based 
scaffolds with complex architectures. Multilayered structures were fabricated by 
thermally laminating each layer, and a classical salt leaching approach was used to create 
random porosities in the scaffold. 
Although fine structures can be produced by a laser-based µSL technique, the 
process is usually slow due to the nature of point-by-point laser scanning.  This prevents 
the incorporation of cells within the scaffold walls during the fabrication process and 
could also lead to denaturation and inactivation of biological molecules during the 
prolonged fabrication period.  Here we report a novel, digital micro-mirror device 
(DMD)-based scaffold fabrication technique that allows precise, pre-designed patterning 
of multiple molecules and allows generation of complex architectures in a high-
throughput, layer-by-layer fashion. 
Bertsch and colleagues reported a µSL process employing a liquid crystal display 
(LCD) as a dynamic mask to photopolymerize an entire layer simultaneously and 
demonstrated fabrication of small mechanical parts such as a turbine and spring [12, 13].  
Itoga and colleagues [14] have also explored LCD projectors to study two-dimensional 
(2D) cellular behavior through the micro-patterning of non-cytoadhesive polymers onto 
plasma-treated glass surfaces.  However, LCD as a dynamic mask has limited optical 
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efficiency [15].  A new technology, Digital Micro-mirror Device™ (DMD, Texas 
Instruments, Dallas, TX),  offers better performance in terms of optical fill factor (85% 
with DMD versus 64% with LCD) and light transmission (71% with DMD versus 21% 
with LCD).  Furthermore, computer projectors, like the ones widely used for PowerPoint 
presentations, are commercially available for utilizing DMD technology in image 
transferring. 
Rather than writing the 3D microstructure point-by-point (as previously reported 
in our laser scanning system [16]), or using a molded structure with thermal lamination 
[11], we have developed a DMD-based dynamic mask for the simultaneous photo-
polymerization of partial and/or entire layers of a scaffold via projection.  By changing 
bio-factors or controlled-released particles within the polymerizable resin, each layer or 
even partial layers were made up of a variety of controlled-release microparticles, thereby 
creating spatially distributed environments with micron-size resolution.  Heparan sulfate 
was also conjugated to poly(ethylene glycol) acryloyl, and patterned-polymerized within 
the scaffold.  This glycosaminoglycan (GAG) binds and protects growth factors, 
specifically FGF-2, an important biochemical cue for the differentiation of progenitor 
cells.  In addition, precise and complex internal architectures (e.g. pore size and shape) 
were created using DMD.  Cells were efficiently incorporated inside the scaffold walls 
during fabrication or seeded on the scaffolds following covalent modification of the 
surface with fibronectin.  Murine marrow-derived stromal cells seeded in these DMD 
µSL-fabricated patterned scaffolds efficiently differentiated into osteoblasts and 
produced scaffold mineralization thereby demonstrating the ability of such structures to 
support cell proliferation and differentiation.  
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4.2 MATERIALS AND METHODS 
 
4.2.1 PEGDA Solutions and Photoinitiator 
Macromer solutions used to fabricate hydrogel scaffolds were formulated using 
100% (w/v) poly(ethylene diacrylate) (PEGDA, Mw 3400, Nektar Therapeutics, AL)  
dissolved in phosphate buffered saline (PBS).  To induce chain polymerization through 
the generation of free radicals, an ultra-violet photoinitiator, 2-hydroxy-1-
[4(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959, Ciba Geigy, USA), 
was used at a concentration of 0.1 wt%.  The photoinitiator was first dissolved in PBS at 
a concentration of 0.7 wt% in order to ensure complete solubility before adding to the 
PEGDA solution.  Prepared macromer solutions were kept in a dark environment to 
prevent pre-crosslinking of the polymer by incidental exposure to ambient light. 
 
4.2.2 DMD Micro-stereolithography (µSL) and Scaffold Fabrication 
The micro-stereolithographic system was developed based on a commercial 
projector (PB2120, BenQ, Taiwan) coupled with a digital micro-mirror device (DMDTM, 
Texas Instruments).  Similar to a conventional stereolithography process, the DMD µSL 
created 3D microstructures in a layer-by-layer fashion. The shapes of the constructed 
layers were determined by slicing the desired 3D scaffold design into a series of evenly 
spaced planes.  Patterns of each layer were drawn in a series of PowerPoint slides, which 
were then executed on the DMD chip to generate a dynamic mask.  The illuminated light 
is modulated according to the defined mask on the DMD chip and then goes through a 
reduction-projection lens assembly to form an image on the surface of the resin or 
macromer solution. The illuminated area was solidified simultaneously under one 
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exposure, while the dark regions remained in liquid.  After one layer was patterned, the 
substrate was lowered and the as-patterned layer was then covered by fresh macromer 
solution.  Microstructures with complex geometries were created by sequentially 
polymerizing the layers.  To fabricate scaffolds with multiple material compositions, 
solidified areas were rinsed thoroughly before immersing with a different macromer 
composition.  To demonstrate the ability of this system to create spatially-patterned, 
multi-layered scaffolds, fluorescently-labeled polystyrene microparticles (1.0 µm Cy5-
labeled and 1.0 µm FITC-labeled, Molecular Probes, Eugene, OR) were added separately 
to PEGDA solutions at a final concentration of 0.03 wt% prior to irradiation.  These 
constructs were analyzed using either a confocal microscope for fluorescence patterning 
(Leica SP2 AOBS) or by scanning electron microscopy (Phillips 515 SEM) for multi-
layered scaffolds.     
The DMD µSL system is schematically shown in Figure 4.1.  The system 
consists of five major components: a DMD chip embedded in the projector as a dynamic 
mask, a light source, a projection lens assembly, a translation stage with a micrometer, 
and a container containing macromer solution.  All the components cooperate to ensure 
correct exposure, resolution, and layer thickness. To ensure cell viability through the use 
of a biocompatible UV photoinitiator, the original high intensity white light source was 
replaced with a UV light source with timer (Green Spot, UV Source Inc., CA). The light 
was guided through a ¼ inch (6.35 mm) liquid-filled fiber optics. Two bi-convex lenses 
(18 mm diameter, 40 mm focal length) with 5 mm spacing were used to converge the 
light emanating from the fiber optics.  The projection lens assembly with adjustable 
aperture and focus consisted of two equal plano-convex lenses (25 mm diameter, 25 mm 
focal length).  Each lens was oriented with the convex surface towards the longer 
conjugate distance.  The aperture was placed in-between two lenses.  All lenses were 
 85
made of UV grade fused silica (Edmund Optics, Barrington, NJ).  The average exposure 
intensity was determined to be 2 mW/cm2.  Throughout the experiments, the 
magnification (size of the scaffold/size of the pattern) was fixed at 1/90. 
The working principle of the DMD chip is also detailed in Figure 4.1. The DMD 
chip serves as an array of reflective aluminum micro-mirrors, which can be tilted with 
two bias electrodes to form angles of either +10° or -10° with respect to the surface.  
Illumination from the light source reflects into the projection lens only when the micro-
mirror is in its +10° state.  In the -10° state, the pixel appears dark because the 
illuminated light is not reflected into the projection lens. The reflected light from the -10° 
micro-mirror is collected by a light absorber.  When the micro-mirror is in +10° state, it 
is classified as “tilt on” or ON.  Conversely, when the micro-mirror is in -10° state, it is 
classified as “tilt off” or OFF.  
Though the schematic in Figure 4.1 depicts only three micro-mirrors for 
illustrative purposes, the actual DMD chip contains more than 442,000 switchable 
mirrors on a 5/8-in (15.875 mm) wide surface.  For instance, in Figure 4.1, there are 3 
pixels of white, black, white color respectively on the screen.  The DMD chip is signaled 
by the computer to tilt the first micro-mirror to +10° state, the second micro-mirror to -
10° state, and the third micro-mirror to +10° state.  The first and third micro-mirror, 
which is in ON condition, reflects the illuminated light to the projection lens.  
Subsequently, the light reflected by the DMD into the projection lens is directed into the 
resin to cure the macromer solution.  Conversely, the second mirror, which is in OFF 
condition, reflects the illuminated light to the light absorber. 
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4.2.3 Heparin Conjugation and FGF-2 Sequestration 
As previously reported [16], heparin was conjugated to acryl-PEG by first 
reacting ethylenediamine (EDA) in excess with acryloyl-PEG-N-hydroxysuccinimide 
(acryl-PEG-NHS, Nektar Therapeutics) at a 5:1 molar ratio to yield acryl-PEG-NH2.  The 
reaction was completed for 3 hours at room temperature in a dark environment followed 
by the dialysis (Tube-o-dialyzer, MWCO 1000, Geno Technologies, St. Louis, MO) of 
unreacted EDA.  Samples were frozen and lyophilized for 24 hours.  Periodated heparin 
(Mw 10,000 Celsus Laboratories Inc., USA) was reacted in equimolar amounts for 3 
hours in a dark environment with acryl-PEG-NH2 to yield acryl-PEG-heparin in the 
presence of 50 mM NaBH3CN as the reducing agent.  Filtration through centrifugation 
(Pall Macrosep®, MWCO 10,000) was performed to eliminate the reducing agent and 
unreacted components.  The product was lyophilized and stored in a dessicator at -20°C 
until further use.  
Acryl-PEG-heparin was added to the PEGDA macromer solution at a 5.0mM 
concentration, and patterned-polymerization was performed also using PEGDA 
macromer solution without acryl-PEG-heparin.  Prior to polymerization, FGF-2 (Cell 
Sciences) was added to each of the macromer solutions at a concentration of 10 µg/mL.  
Patterned-polymerization was performed similarly to how the fluorescently-labeled 
particles were patterned as described above with the DMD-µSL.  Scaffolds were rinsed 
extensively with PBS for a 48 hour period to remove unbound FGF-2, and immuno-
histochemistry was performed to evaluate for binding.  Immunostaining was performed 
using primary anti-FGF-2 antibody (Cell Sciences) and a secondary antibody bound with 
Alexa Fluor dye (Molecular Probes).  The binding time for the antibodies were one hour 
each, with PBS and 0.05% Tween-20 washings in between and an initial 1% BSA 
blocking incubation.  Fluorescence microscopy was used to detect for FGF-2 
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immobilization within the patterned hydrogels.  Furthermore heparin was stained blue 
with 1% alcian blue in 3% acetic acid to visualize the localization of the GAGs within the 
patterned scaffolds. 
 
4.2.4 DMD µSL Cell Encapsulation and Viability 
Murine OP-9 marrow stromal cells (a gift from T. Reid, University of Toronto) 
were cultured in Minimum Essential Medium-Alpha (MEM, Gibco Invitrogen Corp., 
Carlsbad, CA) supplemented with 20% fetal bovine serum, 30 mM sodium bicarbonate 
(Sigma-Aldrich Co.), and 1% (v/v) penicillin-streptomycin (Gibco Invitrogen Corp.).  
Cell passaging and medium exchange were carried out every 2-3 days. 
Before the 10th passage, OP9 cells were trypsinized and centrifuged to a pellet.  
PEGDA solution (formulated as described above) was filter sterilized and added to the 
cell pellet at concentration of 5 x 106 OP9 cells/mL macromer.  A 15 µL suspension of 
cell-macromer solution was then pattern-polymerized using DMD-µSL for ~8 minutes.  
Unpolymerized solution was rinsed away extensively with sterile PBS, and scaffolds 
were transferred into tissue culture plates with medium and placed into an incubator.  
Cell encapsulation efficiency was determined in triplicate by counting cells in the 
unpolymerized solution using a hemocytometer.  After a 24 hour incubation (5% CO2, 
37°C) period, 2 µM calcein AM (Molecular Probes, Eugene, OR) in PBS was added to 
the hydrogel-cell constructs, following the manufacturer’s protocol, which stains viable 
cells green through intracellular esterase activity.  Scaffolds were observed using 
fluorescence microscopy, and images were captured.  
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4.2.5 Surface Modification of Scaffolds for Cellular Attachment 
Surfaces of hydrogels were modified to be cyto-adhesive by covalently 
conjugating fibronectin (from Bovine serum, Sigma Aldrich, St. Louis, MO) to patterned 
scaffolds.  Prior to photo-polymerization, methacrylic acid (Sigma Aldrich, St. Louis, 
MO) was added to the macromer (PEGDA) solutions, as described above, at a molar ratio 
of 1:4 (methacrylic acid:PEGDA).  Upon vortexing to ensure thorough mixing, solutions 
were irradiated with DMD µSL for the patterned polymerization of a 3D scaffold.  The 
carboxylate groups tethering from the surfaces of the scaffolds (due to the presence of 
methacrylic acid) was activated through 1-ethyl-3-(3-dimethylaminopropyl)/N-
hydroxysulfosuccinimide chemistry (EDC/sulfo-NHS, Pierce Biotechnology Inc., 
Rockfold, IL) in order to form stable amide bonds with fibronectin [17].  Briefly, a 500 
µL solution consisting of 0.1 M MES buffer [2-(N-morpholino) ethane sulfonic acid), pH 
6.5], 30 molar excess of Sulfo-NHS and 30 molar excess of EDC were added to each 
scaffold.  The conversion of the carboxyl groups to amine-reactive sulfo-NHS esters was 
performed for 2 hours at room temperature on a plate rotator before the addition of 1.5 
mL fibronectin (10µg/mL) using low-adhesion protein binding microtubes (Fisher 
Scientific).  Fibronectin conjugation to the surfaces of the scaffolds was performed for a 
24 hour period at room temperature.  The negative control scaffolds did not contain 
methacrylic acid, but were treated in the same method as the experimental scaffolds.  X-
ray photoelectron spectroscopy (XPS, PHI 5700) was used to determine the presence of 
nitrogen (N) elements due to amide linkages of the conjugated fibronectin. Scaffolds 
were rinsed extensively with sterile PBS before cell seeding experiments. 
To detect surface-conjugated fibronectin, immunostaining was performed using 
biotinylated anti-fibronectin antibody (Abcam Inc., Cambridge, MA) and streptavidin-
FITC (Southern Biotechnology Associates, Inc., Birmingham, AL).  The incubation time 
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for the antibody was 1 hour and for the streptavidin-FITC was 30 minutes at room 
temperature using a plate rotator.  For a 24 hr period, scaffolds were incubated and rinsed 
several times with sterile PBS at room temperature.   Fluorescence microscopy was used 
to detect surface-conjugated fibronectin.  Furthermore, enzyme-linked immunosorbent 
assay (ELISA) was used to determine the amount of fibronectin conjugated to surfaces of 
the scaffolds.  Biotinylated anti-fibronectin, streptavidin horseradish peroxidase, and 
tetramethylbenzidine (R&D Systems, Minneapolis, MN) were used to detect for 
unconjugated protein in the reaction supernatant of four different scaffolds.  Absorbance 
was determined at 450 nm using a microplate reader (Opsys MR, Thermo Labsystems, 
Chantilly, VA) and plotted against a known standard curve.   
 
4.2.6 Mesenchymal Stem Cell Isolation and Osteogenic Induction 
Bone marrow was obtained from BALB/c mice (7-30 weeks old, Charles River 
Laboratories, Inc., Wilmington, MA).  Upon sacrificing mice through carbon dioxide 
asphyxiation, bone marrow was flushed out of the tibias and femurs using a 27½-gauge 
needle and barrel with basal medium.  Basal medium consisted of Dulbecco’s modified 
Eagle’s medium supplemented with 10% (v/v) fetal bovine serum and 1% (v/v) 
penicillin-streptomycin (Gibco Invitrogen Corp., Carlsbad, CA).  After washing cells via 
centrifugation (1000 rpm, 5 minutes), viable cells were counted using trypan blue and a 
hemocytometer.  To initiate murine mesenchymal stem cell culture (mMSC), cells were 
plated at a density of 2 x 106 cells/cm2.  The culture was placed in a humidified incubator 
(5% CO2, 37°C) for 72 hours when non-adherent cells were removed via medium 
exchange.  Cell passaging upon plate confluence and medium exchange were performed 
every 2-3 days [18].   
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Primary mMSCs, two weeks in culture, were trypsinized for 10 minutes at 37°C, 
centrifuged, counted, and seeded onto fibronectin-modified scaffolds at a density of 
50,000 cells per scaffold.  Sterile parafilm was placed in a non-treated cell culture plate in 
order to form a hydrophobic surface when seeding the cells, and the scaffolds were 
placed on top of the film.  Cell attachment onto scaffolds was performed by suspending 
the cells in 100 µL of medium onto the constructs, thereby forming a “ball” due to an 
increased contact angle with the parafilm surface.  Medium was added to the culture plate 
after a 4-hour incubation period.  Cell attachment was quantified in triplicate by washing 
the cell-scaffold structures with sterile PBS and counting unattached cells with a 
hemacytometer.  Osteogenic differentiation was initiated by culturing seeded mMSCs 
onto scaffolds for up to 4 weeks in basal medium supplemented with 10 mmol/L β-
glycerophosphate, 10-8 mol/L dexamethasone, and 5 µg/mL ascorbic acid 2-phosphate.   
 
4.2.7 Histology 
At two-week and four-week time points, scaffolds were removed from in vitro 
culture and fixed overnight in 4% paraformaldehyde at 4°C.  Scaffolds were dehydrated 
by adding 80% ethanol, 90% ethanol, 95% ethanol, 100% ethanol, 100% ethanol, 50% 
ethanol/50% Citrisolve (Fisher Scientific), 100% Citrisolve, 100% Citrisolve, and molten 
paraffin at 60°C in 1-hour sequential steps [6].  The scaffolds were then left overnight in 
molten paraffin at 60°C.  Paraffin embedded samples were allowed to harden for a 24-
hour period, sectioned at 10 µm using a microtome (American Optical Spencer Rotary 
Microtome Model 820), and then placed on glass slides.  The slides were warmed for 5 
minutes at 60°C and dried overnight at room temperature.  Slides were dried an 
additional 30 minutes at 60°C, rehydrated, and stained.  Nuclear fast red and von Kossa 
staining were used to visualize cell nuclei and scaffold calcification, respectively.   
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Scaffolds that did not contain cells were also von Kossa stained to determine if the PEG 
scaffolds alone stained black.  Brightfield microscopy was used to observe the samples 
(Olympus IX70, Olympus America, Melville, NY; Optronics MagnaFire digital camera, 




4.3.1 Single and Multi-layered Scaffolds with Defined Architectures Created by 
DMD µSL 
The DMD µSL method was used to create polymer scaffolds with pores and 
channels having wide variety of shapes and dimensions.  The configuration of the 
scaffold pores was dictated simply by altering the “mask” drawn on a PowerPoint slide, 
thus illustrating the powerful capability of this system to design features of any shape or 
form.  As shown in the scanning electron microscopic (SEM) micrographs of Figures 
4.2(A-D), different pore geometries (hexagons, triangles, honeycombs with triangles, and 
squares) can be included within a single scaffold (pore size dimensions range from 
~165µm to ~650µm, scale bars shown).  Precise internal features of the scaffolds were 
fabricated with one single 90 sec exposure to the UV light of the DMD µSL.   
Additionally controlled internal architectures can be generated in parallel.  Figure 4.2D 
shows scaffolds fabricated in a multi-layered fashion.  The pore dimensions used in this 
scaffold are 250µm by 250µm with a measured wall thickness of 100µm.  Construct 
edges appeared to be slightly rounded, due to swelling of the hydrogel structure.  Keeping 
the light intensity (2 mW/cm2) and exposure time constant, the smallest feature size 
attainable with DMD µSL was measured to be approximately 20 µm (data not shown). 
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This system is fundamentally limited by optical diffraction and diffusion of free radicals 
in the polymer solutions. 
  
4.3.2 Single- and Multi-layered Scaffolds can be Spatially Patterned using DMD 
µSL 
The DMD µSL system can fabricate both single layer and multi-layered scaffolds 
with pre-designed, spatially-patterned molecules and particles.   The feasibility of such 
precise spatial patterning was demonstrated using PEGDA solutions containing either 
Cy-5 or FITC-labeled polystyrene particles that were encapsulated in a pre-designed 
pattern during the polymerization process.  As shown in Figure 4.3A, solutions 
containing different particles can be patterned in a quadrant-specific geometry, in which 
the solution with Cy-5 particles were polymerized in the upper left and lower right 
regions, and the solution with FITC particles were polymerized in the upper right and 
lower left regions.  This figure demonstrates the ability of the DMD µSL system to 
pattern multiple agents within a single layer through sequential steps of polymerization 
and rinsing of unpolymerized solutions.  We also demonstrated spatial patterning in 
multi-layered scaffolds, as shown in Figures 4.3(B-C), by creating constructs that 
specifically consisted of two layers, each containing either Cy-5 or FITC-labeled 
particles.  The bottom layer was pattern-polymerized with a single 90-second exposure 
using Cy-5 particle-polymer solution, and then rinsed extensively to remove 
unpolymerized polymer and particles.  The second layer, containing FITC particle-
polymer solution, was then polymerized in the same method on top of the first layer using 
the same patterning mask.   
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4.3.3 FGF-2 Sequestration in Heparin-modified Scaffolds 
Acryl-PEG-heparin was added to PEGDA macromer solution and patterned 
polymerized on one half of an entire scaffold.  The unpolymerized heparin-modified 
solution was then rinsed away with PBS, and PEGDA solution, without acryl-PEG-
heparin was polymerized on the other half of the scaffold.  Alcian blue staining in Figure 
4.4A shows that heparin-modified PEG was effectively patterned within the pre-
determined area of the single-layered scaffolds.  FGF-2 was also sequestered in the areas 
of the patterned scaffold that only contained heparin, as illustrated with fluorescence 
microscopy in Figure 4.4B.  
 
4.3.4 Covalent Modification of Scaffold Surfaces with Fibronectin 
Since PEG polymers have hydrophilic and non-ionic properties, the scaffold 
surface must be modified to mediate efficient cell seeding.  Here we demonstrate the 
covalent conjugation of fibronectin, an extracellular matrix component that signals for 
cell anchorage and spreading, to scaffolds via EDC/sulfo-NHS chemistries.  Figure 4.5 
shows fluorescence images of immuno-stained scaffolds.  Scaffolds containing 
methacrylic acid in the macromer solution (left) fluoresce green, indicating the successful 
covalent conjugation of the fibronectin, whereas the scaffold without methacrylic acid 
(right) did not show any adsorption or conjugation of fibronectin.  ELISA studies 
indicated that fibronectin attached to scaffold surfaces at a concentration of 
approximately 9.2 µg/cm2 (± 0.3 µg/cm2) or 48.9 µmol/cm2  (± 0.03 µmol/cm2). 
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4.3.5 OP-9 Cell Encapsulation and Viability  
Patterned encapsulation of cells within the scaffold walls was achieved by the 
addition of OP-9 cells to the macromer solution prior to DMD µSL UV irradiation.  
Figure 4.6A shows a fluorescence micrograph of cells overlaid onto a transmitted 
micrograph of the scaffold, and demonstrates the viability of encapsulated cells within a 
single-layered scaffold (~150 µm thick layer).  Most of the encapsulated cells within the 
hydrogel structures remained viable after a 24 hour incubation period as indicated by 
calcein staining, indicating a cytocompatible fabrication process.  Cell encapsulation 
efficiency for this particular patterned-scaffold was determined to be approximately 73% 
(± 9.6%).  Encapsulation efficiency is, however, dependent, on scaffold channel or pore 
dimensions, the volume of cell-macromer solution used, and the presence of a container 
to hold the cell-macromer solution during the photo-polymerization process to prevent 
solution spreading.   
 
4.3.6 Osteogenic Differentiation of mMSCs in DMD µSL-fabricated Scaffolds 
Seeded mMSCs successfully attached onto patterned fibronectin-conjugated 
scaffolds created by DMD µSL, with a 70% (±3%) attachment efficiency, and were then 
exposed to osteogenic medium. Figures 4.6(B-C) show nuclear fast red and von Kossa 
staining in constructs cultured for two and four weeks.  Figure 4.6B shows von Kossa 
staining on scaffolds removed at 2-week time period (10X objective), and Figure 4.6C 
shows nuclear fast red and von Kossa staining of scaffolds removed at 4-week time 
period (40X objective).  Cell cytoplasm stains pink and the nuclei stain bright red.  
Mineralized areas of the constructs stained black.  These histological data show high 
levels of mineralization throughout the microfabricated scaffold matrix, indicating that 
seeded mMSCs transform into osteoblasts with the presence of osteogenic medium. 
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Additionally, as a negative control, PEG scaffolds alone did not stain black when von 
Kossa was applied (data not shown).  PEG-based scaffolds incorporating MSCs cultured 
only in basal medium do not show any mineralization when stained via von Kossa, as 
presented by Nuttelman et. al. [6].               
  
4.4 DISCUSSION 
A key limitation in tissue engineering is the fabrication of pre-designed, spatially-
patterned microenvironments that physiologically mimic what is observed by stem and 
progenitor cells during organ development.  Creating such complex microenvironments 
inside scaffold constructs would allow us to better study cell behavior and differentiation 
under controlled, biomimetic settings.  The ability to develop such constructs that 
combine both spatial and temporal-patterning of physical and biochemical factors could 
ultimately lead to creating multiple tissue types from a single stem cell population inside 
a 3D structure.  We have developed a versatile layer-by-layer microfabrication system 
consisting of a DMD-based dynamic masking technology to create polymer scaffolds that 
integrate complex micro-architectures and spatially patterned bio-factors for studies in 
progenitor cell differentiation.          
Similar to the laser-based stereolithography method we have previously reported 
[16], DMD µSL can also build 3D scaffold structures through a layer-by-layer photo-
polymerization technique.  In addition, the key features achieved using the laser-based 
system, for example, creation of precise gradients of bio-factors or fabrication of specific, 
pre-designed pore sizes can be easily obtained using the DMD system (data not shown). 
The main advantage of using this novel scaffold fabrication system over the laser-based 
system or other stereolithography methods is that the photo-polymerization of an entire 
single layer is achieved simultaneously, and ultimately a 3D construct is achieved by 
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“building” subsequent layers in the same fashion by exchanging polymer solution in 
between.  In addition, more complex internal architectures as well as efficient cell 
encapsulation can be achieved using DMD.  Although PEGDA was used in this present 
study, because the DMD µSL system is based on a photo-initiated, free-radical chain 
polymerization process, any polymer-photoinitiator solution undergoing such a reaction 
can be used.  To achieve degradable scaffold structures, enzymatically or hydrolytically 
degradable moieties, as reported by Anseth and colleagues and Hubbell and colleagues 
[19-22] could also be used in the DMD µSL system. 
The DMD-µSL system has the powerful capability of (a) generating complex 
internal architectures and (b) entrapping multiple biochemical factors (soluble or in 
controlled-release particles) in precise, pre-designed spatial patterns by their addition into 
the macromer solution prior to photo-polymerization.  Since the masks used for 
polymerization were designed to take on any shape or size using PowerPoint, the 
geometries of the porosities, as well as the scaffold, can virtually be of any pattern.  
Entrapped degradable particles, carrying biological or chemical factors and having 
various release kinetics, could also allow for temporal patterning necessary for the 
prolonged and sequential signaling of progenitor cell differentiation.  This 
stereolithography process could eventually lead to developing elaborate scaffolds 
conducive of creating more complex tissue-like structures, a major obstacle in current 
tissue engineering efforts. 
   The effects of exposure time, light intensity, polymer, and photoinitiator 
concentrations were investigated to optimize the resolution and patterning of the scaffold 
structures.  A crucial task in the optical set-up of DMD µSL is ensuring that the masking 
pattern irradiates uniformly by utilizing the appropriate light source.  Though optical 
fibers could potentially provide uniform light, its intensity profile could result in a quasi-
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Gaussian distribution.  Another option that would provide a uniform light source is the 
use of an optical homogenizer, which simply homogenizes the intensity profile.  Instead 
of using either of these methods, we took advantage of the versatility of DMD µSL by 
simply adjusting the gray scale of the masking patterns that were irradiated onto the 
macromer solutions.  This process was achieved by darkening the gray scale of the pixels 
that received the highest intensity from the light source to balance the non-uniformity.  
Throughout our experiments, we observed that the required exposure time to photo-
polymerize the macromer solution decreased as the light intensity increased. 
Generally, in fabricating photo-polymerized tissue engineering scaffolds, a short 
exposure time is desired for two critical reasons: (a) viability of encapsulated cells 
decreases as exposure time increases and (b) increased diffusion of free radicals from the 
photo-initiator causes distorted patterns with longer exposure times.  Exposure time could 
be reduced by increasing light intensity to avoid such issues.  Decreasing exposure time, 
however, simultaneously enhances diffraction, thereby reducing pattern resolution.  
Furthermore, both diffraction from the masking pattern and diffusion of the free radicals 
could limit scaffold resolution.  Increasing both polymer and photoinitiator 
concentrations resulted in more resolved patterning of the scaffolds, only under an 
optimum light intensity and a decreased exposure time.  Otherwise, as reported by Bhatia 
and colleagues, keeping the parameters of exposure time and light intensity constant, 
polymer and photoinitiator concentration does not affect patterning resolution [23].  We 
limited the photoinitiator concentration in the macromer solutions to no more than 
0.1wt% with our experiments based on previous photo-initiator cyto-toxicity studies done 
by Bryant et. al. [24]. 
The addition of GAGs, such as heparan sulfates, provides a more complex 
microenvironment that closely mimics the stem cell niche.  Since heparin is characterized 
 98
to not only bind, but protect certain growth factors, this biochemical factor can be 
localized within certain regions of single scaffold.  FGF-2 is an important mitogenic 
factor for the osteogenic differentiation of marrow-derived progenitor cells, and its 
localization within a structure could help mediate bone formation.  Creating a region 
within a complex architecture that is conducive of bone formation only could lead to a 
tissue-engineered structure that closely mimics physiological tissue/organ.   
Cell viability during encapsulation within 3D constructs is dependent upon the 
biocompatibility of the materials used and their by-products, scaffold fabrication process, 
and nutrient/waste diffusion throughout the porous matrix.  DMD µSL was shown to be a 
bio-compatible scaffold fabrication technique when encapsulating cells during the photo-
polymerization of the PEGDA macromer solution.  UV light intensity, exposure time for 
scaffold polymerization, and free radicals generated from the photo-initiator did not 
affect the viability of the encapsulated cells even after 24 hours in culture.  Because of its 
cross-linking nature from a liquid to a solid phase and the ability to imbibe water up to 
more than 90% [25], PEGDA is an ideal polymer to encapsulate cells and sustain their 
viability.  The cross-linking network of PEG-based hydrogels also provides efficient 
transport of nutrient and waste delivery, thus contributing to the sustainability of 
encapsulated cells.  We hypothesize that the channels serving as macro-structural pores 
of the scaffolds created by DMD-µSL further act to increase nutrient/waste diffusion of 
cells as opposed to the “bulk” polymerization of cell and PEG-based polymer solutions as 
reported by others [5, 6].  Cell viability would vary along the cross-sections (x-y-z 
directions) of thicker hydrogels that were bulk-polymerized due to inefficient 
nutrient/waste diffusion within the interior of the matrix (i.e. only surfaces of the gels 
would get optimum diffusion).  Because DMD-µSL has the capability of patterning 
channels as pores all throughout the hydrogel scaffolds, the viability of encapsulated cells 
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only depends on wall thickness (x-y directions) and not the entire thickness (height or z-
direction) of the 3D construct.  Scaffold wall thickness is easily controlled through the 
design of the masking patterns irradiated by DMD-µSL and would only have to be a 
certain thickness to encapsulate a sufficient amount of cells.  Furthermore because 
unpolymerized solutions can be washed away in between UV irradiations, multiple cell 
types could also be patterned within a single construct, leading to a more intricate tissue 
engineering construct.  
In addition to cell encapsulation, scaffold surfaces can be functionalized to 
conjugate fibronectin, thus allowing efficient cell seeding, attachment, and proliferation.  
Because fibronectin is covalently-conjugated post-fabrication, the possibility of 
denaturation due to UV exposure is eliminated.  Seeded murine MSCs attached 
efficiently to fibronectin functionalized scaffolds.  The differentiation of MSCs on 
patterned scaffolds was achieved through the addition of osteogenic culture medium and 
confirmed through standard histological staining for matrix calcification.  Mineralization 
of the scaffold over a 4-week period in culture illustrates that these DMD micro-
fabricated, patterned scaffolds are capable of allowing mMSCs to adhere, proliferate, and 
transform into osteoblasts.   
In conclusion, we have demonstrated DMD-µSL to be a powerful technology in 
creating pre-designed, spatially patterned scaffolds for applications in cell and tissue 
engineering.  This novel stereolithography system has the capability of creating precise 
distributions of chemical and biological factors within a 3D scaffolding structure.  The 
scaffolds are also suitable for the encapsulation of single or multiple cell types in a 
spatially distributed fashion.  Functionalizing the patterned scaffolds with fibronectin 
creates a microenvironment suitable for the attachment, proliferation, and differentiation 
of mMSCs.  These micro-fabricated, spatially patterned scaffolds could ultimately consist 
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of intricate architectures that combine both spatial and controlled-release kinetics of 
biochemical factors, creating a suitable environment for studying hybrid tissue formation 
from a single stem cell population.  
Figure 4.1  Schematic of the Digital Micro-mirror Device Micro-stereolithography 




Figure 4.2  Scanning electron microscopy (SEM) illustrate that DMD µSL can 
create scaffolds with intricate pore geometries.  Hexagons (honeycomb), 
triangles, triangles inside hexagons, and squares shaped pores were 
created by directly drawing in PowerPoint files and using the DMD as a 
dynamic “mask”.  Geometrical side dimensions of the pores range from 
approximately 165 µm to 650 µm (scale bars shown).  Scaffolds depicted 
in figure D specifically show a two-layered scaffold.  All scaffolds were 
irradiated for 90 seconds per layer and formulated using 100% (w/v) 
PEGDA in PBS and 0.1wt% Irgacure 2959.  
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Figure 4.3.  DMD-µSL can create pre-designed, spatially-patterning inside scaffold 
structures.  Fluorescence confocal microscopy of scaffolds formulated 
with 100% (w/v) PEGDA in PBS, 0.1 wt% Irgacure 2959, and 0.03 wt% 
carrying either FITC- or Cy5- labeled polystyrene particles (taken with 
a 10X objective).  Figure A shows spatial patterning of a single-layer in 
a “quadrant” specific pattern.  Figures B and C show spatial patterning 




Figure 4.4  Acryl-PEG-heparin was added to the PEGDA macromer solution at a 
concentration of 5.0 mM, and patterned-polymerized with the DMD 
µSL on one half of an entire scaffold, followed by extensive washing 
with PBS.  Plain PEGDA macromer solution was then patterned-
polymerized on the other half of the scaffold.  Both solutions also 
encapsulated 10 µg/mL of FGF-2.  Scaffolds were then placed in a 37°C 
incubator to allow any unbound FGF-2 to diffuse out of the scaffolds, 
while washing several times with PBS.  Heparin moieties were stained 
blue using alcian blue staining as depicted in (A) through brightfield 
microscopy (10X objective).  Immuno-histochemistry was performed to 
detect for bound FGF-2 and fluorescence microscopic images (B) shows 
that FGF-2 (red fluorescence) was only sequestered in areas that 






Figure 4.5 Immuno-histochemistry of Conjugated Fibronectin. Fibronectin was 
covalently conjugated to scaffolds surfaces.  Fluorescence micrographs 
show scaffolds immuno-stained for fibronectin.  Biotinylated anti-
fibronectin antibody and streptavidin-FITC were used to stain the 
microfabricated scaffolds following fibronectin conjugation.  Figure A 
shows the successful covalent conjugation of fibronectin through the 
methacrylic acid macromer added during the fabrication process.  The 
scaffold illustrated in figure B does not contain methacrylic acid and 





Figure 4.6.  Viable Cell Encapsulation and Differentiation of Marrow-derived Cells. 
(A) Marrow-derived stromal cells remain viable following 
encapsulation in DMD µSL fabricated scaffolds. Scaffolds depicted in 
this figure were formulated with 100% (w/v) PEGDA in PBS and 
0.1wt% Irgacure 2959.  Prior to photo-polymerization, OP-9 marrow 
stromal cells were added to the macromer solution at a concentration of 
5 x 106 cells/mL.  After a 24 hour incubation period, 2µM calcein was 
added to cell-scaffold constructs, which stains viable cells green.  
Transmitted and fluorescent images captured from confocal 
microscopy were overlaid and shown in Figure A.  Patterned scaffolds 
are capable of osteogenic differentiation of bone-marrow derived 
progenitor cells.  White scale bar represents 200 µm.  Figures (B-C) 
show fibronectin-conjugated scaffolds seeded with primary mMSCs at a 
density of 50,000 cells per scaffold.  At 2-week and 4-week time points, 
scaffolds were removed from culture, paraffin embedded, and 
sectioned.  These sections were stained with nuclear fast red and von 
Kossa.  Brightfield micrographs (figure B with a 10X objective at 2-
week time point and figure C with a 40X objective at 4-week time point) 
show extensive scaffold mineralization indicating osteogenic 
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Osteogenic Differentiation of Mesenchymal Stem Cells on DMD-
fabricated Tissue Engineering Scaffolds 
5.1 INTRODUCTION 
Pioneered from micromachining and rapid prototyping technologies [1, 2], 
stereolithography (SL) has emerged as a widespread approach for studying cellular 
function at the microscale level and for creating tissue engineering scaffolds [2-5].  
Traditional methods of studying cellular behavior involve homogenous conditions across 
planar, two-dimensional (2D) surfaces or porous polymer scaffolds that serve as three-
dimensional (3D) platforms for stem cells to attach, proliferate, and differentiate [6, 7].  
Studies in planar conditions or in bulk-fabricated scaffolds lack the complexity of cell-
cell and cell-matrix interactions found in vivo.  Pre-designed, intricate architectures, with 
micro-scale features closely mimicking the tissue defect, would better orchestrate stem 
cell differentiation within in vitro conditions.    
A tissue-engineered construct responds to local stimuli found in their 3D 
environment, and micro-SL (µSL) can create scaffolds that closely mimic structural and 
biochemical cues present in native tissue.  Micro-SL has the powerful capability of 
building 3D complex structures with specific pore sizes and shapes in a layer-by-layer 
fashion using photo-crosslinkable monomers. We have recently reported layer-by-layer 
micro-SL methods, laser- and digital micromirror-based, for creating intricate 3D 
scaffolds that spatially pattern multiple, biochemical agents within pre-determined 
regions [8, 9].  Specifically, the digital-micromirror device (DMD) based-SL system was 
shown to fabricate scaffolds in which mesenchymal stem cells (MSCs) efficiently 
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attached and differentiated into osteoblasts.  A key advantage to this system is that 
intricate architectures could combine both spatial and controlled-release kinetics of 
biochemical factors, thus producing an ideal environment in which a single stem cell 
population could simultaneously differentiate into multiple cell types.  Current stem cell 
engineering methods of creating hybrid tissues, as studied by Mao and colleagues [10, 
11], involve pre-differentiating precursor cells into multiple cells types, such as 
osteoblasts and chondrocytes, and then encapsulating these cells within a single, 
compartmentalized scaffold.  Although this method of creating composite tissues has 
proven to be successful, the homing of stem cells to a defect site in vivo and then 
simultaneously differentiating into various cell types have yet to be understood.   
DMD µSL creates scaffolds in which stem cell behavior can be analyzed in a 
more complex form.  Here we show how specific channel size and geometry of scaffolds 
can directly effect MSCs osteoblast differentiation.  During in vitro osteogenesis low 
scaffold porosity size suppresses cell proliferation and induces cell aggregation, whereas 
in vivo bone in-growth is increased with structures that have higher porosity and pore 
dimensions.   Pore size for bone formation is dependent upon the material used to 
fabricate the scaffold, and an excellent review of these materials and porosity studies is 
written by Karageorgiou and Kaplan [12].  Furthermore pore geometry has played a role 
in MSCs differentiation within in vivo cultures due to variations in vasculature and the 
delivery of oxygen [13]. 
Using poly(ethylene glycol) diacrylate (PEGDA) as the biomaterial, patterned 
scaffolds were created with various architectures, and changes in osteoblast gene 
expression levels were measured.  PEGDA is a prevalent macromer used to develop 
tissue engineering scaffolds because, when crosslinked, this hydrophilic polymer network 
can imbibe a large volume of water while efficiently transporting cell nutrient and waste 
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throughout the structure [14, 15].  Because PEG is a non-fouling material, several 
chemical modifications to PEG-based polymers have been utilized to enable cell and 
extracellular matrix component (ECM) adherence for use as a biomimetic tissue 
engineering scaffold [16, 17].  Fibronectin was conjugated to the PEGDA scaffolds upon 
fabrication to allow MSCs to attach and then undergo differentiation.  Furthermore we 
demonstrate how PEGDA mesh size alters gene expression levels of differentiated MSCs. 
 
5.2 MATERIALS AND METHODS 
 
5.2.1 Setup of the DMD-based Micro-stereolithography (DMD µSL) System 
As previously reported, the micro-stereolithographic system was constructed by 
coupling a commercial projector (PB2120, BenQ, Taiwan) to a digital micro-mirror 
device (DMDTM, Texas Instruments) with a modification to the lens component  [9]. This 
stereolithography system created 3D scaffolds in a layer-by-layer fashion, in which the 
patterns of each scaffold layer were designed using Microsoft PowerPoint slides.  These 
patterns were then translated to the DMD chip, acting as a dynamic photomask by 
illuminating the image onto the photo-curable macromer solution.  The white regions of 
the pattern polymerized the macromer solution simultaneously while the black regions 
remained liquid.  The photo-crosslinkable macromer solution was in a container placed 
on a motorized x-y-z stage.  
The light as well as intensity was adjusted by the DMD chip, as defined by the 
pattern and pixel luminance, and went through a reduction-projection lens component to 
form a mask on the resin or macromer solution.  The lens component was a fixed UV 
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focal lens (Edmunds Optics) that provided an increased focal length of the optical path, 
thereby providing a larger irradiation area as previously reported [9].     
 
5.2.2 Photocurable PEGDA Polymer and Scaffold Fabrication 
Poly(ethylene glycol) diacrylate (PEGDA Mw 3400, Nektar Therapeutics, 
Huntsville, AL) was used at a concentration of 100% (w/v) in phosphate buffered saline 
(PBS) and 0.1 wt% 2-hydroxy-1-[4(hydroxyethoxy)phenyl]-2-methyl-1-propanone 
(Irgacure 2959, Ciba Technologies) as the photo-crosslinkable macromer to fabricate the 
scaffolds.  Prior to cell encapsulation and solution formulation, PEGDA was sterilized in 
a UV hood for a 12-hour period.  Irgacure 2959 was initially made at concentration of 
0.7% (w/v) in PBS and sterilized using a 0.2µm filter syringe before adding to PEGDA 
solution.  Specific channel geometry and sizes used to create the 300 µm thick scaffolds 
are listed in Table 5.1.  Dimension of scaffold wall thickness was kept constant at 400 
µm for all scaffolds.  When creating scaffolds with varying channel geometry, the 
channel volumes were also kept constant at 0.048 mm3.  
When encapsulating cells, acryl-PEG-RGD was added to the 100% (w/v) PEGDA 
macromer solution prior to cell addition and scaffold fabrication at concentrations of 0 
mM, 0.5 mM, and 5.0 mM.  Another method of incorporating cells within the scaffolds 
was through cell seeding after scaffold fabrication. This process involved adding 
methacrylic acid (MAA, Sigma Aldrich) to the PEGDA macromer solution at a molar 
ratio of 1:4 ( MAA:PEGDA) prior to patterned UV irradiation, as illustrated in Figure 
5.1.  Scaffolds were rinsed several times with PBS to remove unreacted MAA.  The 
carboxyl functional groups from MAA were used to form a stable amide bond with 
fibronectin and activated through 1-ethyl-3-(3-dimethylaminopropyl)/N-
hydroxysulfosuccinimide chemistry (EDC/sulfo-NHS, Pierce Biotechnology Inc., 
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Rockford, IL).  Both EDC and sulfo-NHS were added to the scaffolds at 30X molar 
excess of MAA using 500 µL of 0.1 M MES buffer (pH 6.5).  Carboxyl conversion to 
amine-reactive sulfo-NHS esters was performed for 2 hour at room temperature on a 
rotator before the addition of 1.5 mL fibronectin (10µg/mL), using low-adhesion protein 
binding microcentrifuge tubes (Fisher Scientific) to complete the reactions.  Fibronectin 
conjugation was performed for a 24 hour period at room temperature.  Scaffolds were 
sterilized in 70% ethanol for 30 minutes and rinsed several times with PBS prior to cell 
seeding to remove unreacted fibronectin and ethanol.  Calcein AM staining (Molecular 
Probes, Eugene, OR), at a concentration of 2 µM was used to stain attached, viable D1 
cells to scaffolds after a 4 hour seeding period.  Digital images were captured of the 
scaffolds through fluorescence microscopy. 
 
5.2.3 Cell Culture 
D1 ORL UVA (ATCC, Manassas, VA) bone marrow progenitor cell line was 
used to study the tissue engineering properties of the scaffolds created by the DMD µSL 
system.  D1 cells are characterized to differentiate into osteocytes, chondrocytes and 
adipocytes in the presence of appropriate stimuli and environment [18, 19].  Primary 
medium was composed of 10% (w/v) fetal bovine serum (ATCC) and 1% (w/v) penicillin 
streptomyocin (Gibco) in Dulbecco’s Modified Eagle’s Medium (ATCC).  Osteogenic 
medium was formulated with the addition of 10 mM β-glycerophosphate, 10 mM 
ascorbic acid, and 10-8 M dexamethasone in primary medium (all chemicals from Sigma 
Aldrich, St. Louis, MO).  D1 cells were passaged no more than 10 times during the 
course of the differentiation studies.  
D1 cells were added to the photo-curable macromer solution at a density of 20 x 
106 cells/mL.  A total volume of 20 µL cell-macromer solution was placed on the stage of 
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the DMD µSL system and irradiated for 8 minutes (n=4).  Unpolymerized cell-macromer 
solution that remained in liquid phase was rinsed off with sterile PBS.  Scaffolds were 
placed in osteogenic medium and kept in a humidified incubator (37°C, 5% CO2) for a 2 
week culture period.  Medium exchange was performed every 2-3 days.     
In addition to using D1 mesenchymal stem cell line, the osteogenic potential of 
primary bone marrow-derived cells from mice was also analyzed.  NIH guidelines for the 
care and use of laboratory animals were observed and all animal protocols were approved 
by the Institutional Animal Care and Use Committee (IACUC) at the University of Texas 
at Austin.  BALB/c mice (7-30 wk old, Charles River Laboratories, Wilmington, MA) 
were sacrificed using carbon dioxide asphyxiation, and marrow from tibias and femurs 
were flushed out using a 27½- gauge needle and barrel with primary medium.   Cells 
were washed via centrifugation, and viable cells were counted using trypan blue and a 
hemocytometer.  MSCs culture was initiated by plating the cells at a density of 2 x 106 
cells/cm2 and cultured in a humidified incubator for 72 hour, at which point non-adherent 
cell were removed through medium exchange.  Cell passaging upon plate confluency and 
medium exchange were performed every 2-3 days. 
Primary MSCs, 2 weeks in culture, were trypsinized for 10 minutes at 37°C, 
centrifuged, counted, and seeded onto fibronectin-modified scaffolds at a density of 
200,000 cells per scaffold (n=4).  Sterile parafilm was placed in a non-treated cell culture 
plate to form a hydrophobic surface when seeding the cells, and the scaffolds were placed 
on top of the film.  Cell attachment onto scaffolds was performed by suspending the cells 
in 50µL of medium on the constructs, thereby forming a “ball” due to an increased 
contact angle with the hydrophobic parafilm surface.  Osteogenic medium was added to 
the culture plate after a 4 hour incubation period, and the parafilm was removed from 
culture.   
 
5.2.4 PEG Hydrogel Mesh Size 
Solid scaffold constructs (i.e. no channels) were photo-polymerized using the 
DMD µSL to determine polymer mesh size.  Mesh size of DMD fabricated hydrogels 
was then compared to hydrogels polymerized using a long wave UV lamp.  The Flory-
Rehner theory, modified by Peppas and Merrill, was used to determine the number 


























































in which Mn is the number average molecular weight of the uncrosslinked PEGDA, V1 is 
the molar volume of the water, v2,s is the polymer volume fraction in the equilibrium 
swollen gel, v is the specific volume of the polymer, χ is the polymer-solvent interaction 
parameter, and v2,r is the polymer volume fraction in the relaxed state.  The hydrogels 
were weighed in air and heptane immediately after crosslinking, after reaching swollen 
equilibrium, and after lyophilizing to obtain values for v2,s and v2,r.  Mesh size, ξ, was 


















where Cn is the Flory characteristic ratio (4.0 for PEGs), l is the length of the bond along 
the polymer backbone (1.47 Å for PEGs), and Mr is the monomer molecular weight.  
PEGDA hydrogels are large hydrophilic polymer networks that can imbibe a large 
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volume of water.  This inherent property of PEG provided the micro-porosity feature of 
these DMD µSL fabricated scaffolds, while the channel features created through 
patterning provided a macro-level of nutrient/waste transport, as illustrated in Figure 5.2. 
    
5.2.5  Compression Strength Analysis of PEGDA Hydrogels 
Poly(ethylene glycol) dimethacrylate (PEGDMA, Mw 1000, Polysciences Inc., 
Warrington, PA) at 10% and 100% w/v in PBS was used to determine compression 
moduli of bulk-polymerized scaffolds.  The photoinitiator, Irgacure 2959, at 0.05 wt% 
concentration was added to the macromer solution, and a long wave UV lamp was used 
to initiate crosslinking for a 10 minute irradiation period.  PEGDMA has similar 
properties to PEGDA, but was used in these preliminary experiments due to the 
inexpensive cost of the macromer.  An Instron® In-Spec 2200 benchtop instrument was 
used at a rate of 0.001mm/s up to a maximum force of 100N to determine compression 
modulus data.  Each PEGDA hydrogel was allowed to reach swollen equilibrium and 
measured for exact construct dimensions before analysis.  Compressive moduli of the 
hydrogel scaffolds without cells were determined by computing the slope of the linear 
region of a stress/strain plot. 
 
5.2.6 Cell Viability 
Viability of D1 cells encapsulated in PEGDA hydrogels was compared using both 
the DMD µSL and UV lamp.  The concentrations used when polymerizing with the UV 
lamp were 10% and 100% (w/v) PEGDA in PBS with 0.05 wt% Irgacure 2959.  The only 
concentration formulated with the DMD µSL was  100% (w/v) PEGDA and 0.1 wt% 
Irgacure 2959.  A total of 20 µL of macromer solution was used to create solid hydrogels 
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with a cell density of 20 x 106 D1/mL.  Irradiation time for both systems was 8 minutes.  
Scaffolds were rinsed extensively with sterile PBS and incubated in primary medium for 
a 24 hour period.  Methyl thiazolyl tetrazolium (MTT) assay was performed on these 
scaffolds and compared to a monolayer culture of D1 cells to calculate relative survival.    
  
5.2.7 RNA Isolation and RT-PCR 
Total RNA was isolated from the scaffolds through homogenization using TRIzol 
(Invitrogen), following the manufacturer’s protocol.  After drying the RNA pellet, it was 
re-suspended in nuclease-free water, and genomic DNA was removed using Abmion 
Turbo DNA-freeTM kit.   First strand cDNA was synthesized by reverse transcription (RT) 
using SuperscriptTM III kit (Invitrogen), following the manufacturer’s protocol.  The RT 
reaction was performed at 25°C for 10 minutes, 50°C for 50 minutes, and terminated at 
85°C for at 5 minutes.   Quantitative polymerase chain reaction (PCR) was performed 
using an ABI  Prism® 7900 Real Time thermal cycler and HotStart DNA Taq 
polymerase with SYBR green/ROX PCR master mix (Superarray, Fredrick, Maryland).  
Primers for the housekeeping gene, or β-actin, collagen I, cbfα-1, and alkaline 
phosphatase, were used (Superarray, proprietary primers, sequences not disclosed).  
Collagen I, cbfα-1, and alkaline phosphatase were all specific to the osteoblast 
phenotype.  β-actin was expressed in both differentiated and undifferentiated MSCs and 
therefore used as the housekeeping gene.  
The PCR reactions were performed at 95°C for 10 minutes to activate the 
HotStart DNA Taq polymerase and then 40 cycles of 15 seconds at 95°C for 
denaturation, 60 seconds at 60°C for elongation, and 60 seconds at 72°C for elongation.   
Threshold cycle (CT) values, as determined by the ABI PRISM® 7700 Sequence 
Detection System software, were used to analyze total product, and β-actin was used to 
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normalize relative gene expression for all the genes through the 2-∆∆CT method [20].  
Briefly, the normalized CT value for the negative control (undifferentiated D1 cells in 
monolayer) was subtracted from the normalized CT value for each of the samples, to 
obtain ∆∆CT, as illustrated in the following equation: 
∆∆CT = ∆CT (sample) - ∆CT (negative control),
where ∆CT values for the samples and negative control are determined by: 
∆CT(sample or negative control) = CT (gene of interest) – CT (β-actin). 
The latter equation normalizes the genes of interest (cbfα-1, collagen I, and alkaline 
phosphatase) using β-actin since this gene remains proportional to the amount of starting 
total RNA that was initially isolated from each sample.  Gene expression fold differences 
were then determined via 2-∆∆CT method, and the derivation of this analysis is described in 
detail by Livak and Schmittgen [20]. 
Negative controls to assess the quality of the primers and total RNA were also 
assessed, which consisted of running samples without template and synthesizing cDNA 
without reverse transcriptase, respectively.  All samples were run in triplicate within the 
assay.  End-point RT-PCR was completed by fractionating DNA amplicon on a 2% 
agarose gel containing ethidium bromide, and images were captured with a Molecular 
Imager FX (Bio-Rad Laboratories). 
 
5.2.8 Statistical Analysis 
All experiments were at least performed in triplicate. Results were reported as 
mean ± standard error.  Statistical significance was determined by analysis of variance 





5.3.1 Cell Viability 
Cell viability of encapsulated D1 cells were evaluated with bulk hydrogels 
polymerized with either the UV lamp or DMD µSL system.  These absorbance results 
show that after a 24 hour incubation period, cell viability was similar within all the 
PEGDA parameters tested (Figure 5.3).  Viability was similar between the DMD µSL 
and UV lamp fabricated scaffolds at 100% (w/v) PEGDA.  Because 10% (w/v) 
concentration of PEGDA in PBS is generally used in literature for encapsulating cells, we 
wanted to determine if cell viability is affected when using a higher PEGDA 
concentration.  These optical density (OD) results indicated that there is approximately a 
22% relative survival difference between 10% and 100% PEGDA concentrations, with 
10%  PEGDA having the higher survival rate.  Ideally, relative survival (%) would be 
determined by comparing the OD values to a monolayer culture of D1 cells; however 
MTT metabolism would not be comparable since MTT crystals require diffusion through 
PEGDA hydrogels.  In this case, absolute OD values were used to compare cell viability 
between the PEGDA concentrations.        
 
5.3.2 Differentiation of D1-encapsulated Scaffolds 
After a 2 week time point, monolayer D1 cells in osteogenic culture expressed all 
of the osteoblast genes studied as shown through end-point RT-PCR in Figure 5.4.  All 
bands were present for the bone marker genes analyzed: alkaline phosphatase, cbfα-1, 
and collagen I.  Because these osteoblast-specific genes were observed for this particular 
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immortalized cell line in monolayer culture, cell differentiation within 3D polymer 
scaffolds using the DMD µSL system were investigated.  Gene expression was analyzed 
for DMD-fabricated scaffolds encapsulating D1 cells after 2 weeks in osteogenic 
medium, and these results are depicted in Figure 5.5.  No specific gene expression trend 
was observed between the samples studied.  Gene expression analysis was also 
performed on undifferentiated D1 cells (data not shown).  Basal amounts of collagen I 
and cbfα-1 mRNA were observed, but no alkaline phosphatase activity was found; 
therefore relative gene expression of the scaffolds when compared to undifferentiated D1 
cells was observed (except for the triangle channel), as illustrated in Figure 5.5C.  
However the absolute amount of alkaline phosphatase amplicon was not abundant to 
show the presences of bands in end point RT-PCR (Figure 5.5D).         
Based on previous studies found in literature, the high PEGDA concentration used 
in these DMD µSL studies was speculated to be the underlying disadvantage to the 
design of the scaffolding system.  To investigate this hypothesis, osteoblast gene 
expression was studied for D1 cells encapsulated in hydrogels of increasing PEGDA 
concentration.  Mesh sizes of bulk-polymerized scaffolds were calculated and illustrated 
in Table 5.2.  As expected, the PEGDA concentration with the highest mesh size was 
determined to be 10% (w/v), and the one with the lowest mesh was determined to be 
100% (w/v).  Furthermore, the mesh sizes for scaffolds created with the DMD µSL were 
determined to be similar to mesh sizes of scaffolds created with the UV lamp.  Because 
PEGDA scaffolds take in a large amount of water in aqueous environments, it was 
imperative to calculate the mesh sizes of these scaffolds and to determine how much they 
varied at different polymer concentrations.  This intrinsic property of PEG-based 
scaffolds was used as the micro-level porosity of DMD µSL fabricated scaffolds.    
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Bulk-polymerized scaffolds were fabricated using a long wave UV lamp, and 
after a 2 week culture in osteogenic medium, total RNA was isolated and real time RT-
PCR was performed to determine the presence of the bone-specific markers.   Figure 5.6 
illustrates real time RT-PCR and end-point gel electrophoresis results achieved with these 
bulk-polymerized PEGDA scaffolds.  As PEGDA concentration increased from 10% to 
100% (w/v), collagen I and cbfα-1 fold changes also increased, when compared to 
undifferentiated D1 cells (Figures 5.6A and 5.6B).  On the contrary, alkaline 
phosphatase expression fold change decreased with increasing PEGDA concentration 
(Figure 5.6C).  Gel electrophoresis of the generated amplicons for each gene was 
performed (Figure 5.6D) and compared to 100bp DNA ladder.  All of the genes analyzed 
were present for all PEGDA concentrations, except for alkaline phosphatase in the 50, 80, 
and 100% (w/v) PEGDA concentrations.  Based on these end point gel electrophoresis 
results, it was concluded that encapsulating D1 cells at a high PEGDA concentration 
greater than 30% (w/v) could inhibit the osteogenic differentiation capacity of D1 cells, 
and therefore a different method of cell integration within the micro-fabricated scaffolds 
had to be used.     
 
5.3.3 Compression Moduli for PEGDA Hydrogels    
Young’s moduli were determined to be 33 kPa and 655 kPa for 10% and 100% 
w/v PEGDMA in PBS hydrogels, respectively, as depicted in Figure 5.7.  The 100% w/v 
PEGDMA hydrogels were observed to be significantly higher than 10% w/v PEGDMA 
hydrogels.  The higher PEGDMA concentration was determined to be 20 times more than 
the lowest PEGDMA bulk-polymerized scaffolds evaluated in our studies, which could 
contribute to the variations in differentiation potential of encapsulated MSCs.   
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5.3.4 Differentiation of D1-seeded Cells onto DMD-fabricated Scaffolds 
D1 cells successfully attached to PEGDA:MAA scaffolds modified with 
fibronectin, as depicted in Figure 5.8.  Green fluorescence due to calcein AM staining 
showed that cells adhered to scaffold surfaces and remain viable upon seeding.  To 
ensure that the immortalized D1 cell line still maintained stem cell functionality in 3D 
cultures, this cell line was compared to marrow-derived progenitor cells, a more 
commonly used source of MSCs found in literature.  D1 cells and marrow-derived cells 
were seeded at the same density to separate, fibronectin-modified, DMD-fabricated 
scaffolds and cultured in osteogenic medium for 2 weeks.  Figure 5.9A shows end point 
RT-PCR results obtained from the D1 and marrow-derived seeded scaffolds; bands for all 
osteoblasts genes were present.   Real time RT-PCR was performed, and the ∆CT value 
for each MSCs population was used to determine that D1 cells had a higher osteoblast 
gene expression than primary marrow-derived MSCs.  D1 ∆CT values were then 
compared to the ∆CT values of marrow-derived MSCs, as illustrated in Figure 5.9B.  
Gene expression fold changes for D1 showed that collagen I, cbfα-1, and alkaline 
phosphatase were expressed 2, 8, and 10 times more than marrow-derived MSCs, 
respectively.   
Because D1 cells demonstrated increased osteoblast expression over marrow-
derived MSCs, this cell population was therefore selected to study osteogenic 
differentiation of seeded cells onto DMD-fabricated scaffolds.  Both real time (Figures 
5.10A-C) and end-point (Figure 5.10D) RT-PCR results depict positive osteoblast gene 
expression results when D1 cells were seeded onto DMD-fabricated scaffolds and 
cultured in osteogenic medium for 2 weeks.  From the channel parameters studied and 
listed in Table 5.1, the optimum channel size was determined to be 0.4 mm by 0.4 mm 
and with a square geometry.  These particular channel parameters had the highest gene 
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expression fold changes for all of the genes analyzed than the other groups studied, when 
compared to undifferentiated D1 cells.  Furthermore D1 cells seeded onto DMD µSL 
patterned scaffolds showed higher gene expression levels than D1-encapsulated scaffolds.  
 
5.4 DISCUSSION 
Photolithographic patterning of hydrogel scaffolds is a popular fabrication method 
since cell placement can be done in a controlled manner when using photo-crosslinkable 
monomers and light to initiate the gelation reaction.  These photolithographic patterning 
methods can be used to effectively create multi-layered cell-hydrogel structures, but 
require the use of spacers and physical photomasks, that take time and plotters to 
fabricate [21, 22].  As previously reported, DMD µSL can create scaffolds with precisely 
controlled channel size and geometry using a simple computer-aided process that can 
create dynamic photomasks through Microsoft PowerPoint.  Multi-layered scaffolds with 
spatially distributed factors in the same layer and across different layers can be readily 
fabricated using this stereolithography technique [9].  Here we present a more intensive 
study of specific scaffold properties, easily fabricated using DMD µSL, that optimize the 
osteogenic differentiation of MSCs.   
Osteoprogenitor cells have predominantly been isolated from the bone marrow.  
Immortalized D1 cell line, cloned from a multipotent mouse bone marrow stromal 
precursor, was used to study channel parameters of DMD-fabricated scaffolds.  These D1 
cells, like marrow-derived precursor cells, have osteogenic, chondrogenic, and 
adipogenic differentiation potential.  RT-PCR results illustrated osteogenic gene 
expression in 2D culture and proved this particular cell type can commit exclusively into 
the bone pathway.   
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Previous studies found in literature have successfully encapsulated MSCs within 
photo-polymerizable PEGDA at low concentrations (i.e., 10 to 30% w/v) and confirmed 
either osteogenic or chondrogenic differentiation [17, 23, 24].  We show that increased 
PEGDA concentrations, specifically macromer concentrations over 30%, show decreased 
alkaline phosphatase expression, an enzymatic activity responsible for bone matrix 
calcification by osteoblasts.  Because alkaline phosphatases are concentrated within the 
cell surfaces, high binding affinities to positively charged calcium molecules occur, 
causing matrix calcification.  Since lower PEGDA concentrations have larger mesh sizes 
due to decreased polymer crosslinking, nutrient and waste diffusion can occur more 
easily.  Transport of β-glycerophosphate, ascorbic acid, and other proteins necessary for 
bone matrix deposition is more readily available with 10% and 30% (w/v) PEGDA 
hydrogels, thus increasing alkaline phosphatase activity.  β-glycerophosphate acts as an 
organic phosphate around cells, thus triggering increased alkaline phosphatase activity 
and matrix calcification within in vitro cultures.  Additionally ascorbic acid also acts to 
increase collagen secretion within the bone matrix.   
Contrary to what is seen with alkaline phosphatase, both collagen I and cbfα-1 
gene expression, also specific to osteoblasts, decrease with decreasing PEGDA 
concentration.  Collagen I is the major extracellular matrix protein of bone, making up 
~90% of the total organic bone matrix; therefore this protein is the most common marker 
for the osteoblast phenotype [25].  Cbfα-1 is a transcription factor that regulates 
osteocalcin production and marks the early development of osteoblasts precursors [26, 
27].  Interestingly, scaffolds with the higher PEGDA concentrations also appear to have 
increased expressions of collagen I and cbfα-1, another inconsistent result from what was 
expected.  We speculate that this conflicting trend with collagen I and cbfα-1 gene 
expression could be due to that D1 cells in the lower concentrated PEGDA scaffolds are 
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at a more advanced stage of osteoblast differentiation; therefore mRNA production for 
collagen I and cbfα-1 decreased as these cells became more committed in phenotype.  
Future experiments involve looking at longer culture periods in osteogenic medium to 
determine if any of these osteoblast-specific genes would undergo a different trend.   
In addition to mesh size differences, we also speculate that changes in hydrogel 
mechanical stiffness may also contribute to variations in the differentiation potential of 
encapsulated MSCs.  Increasing PEG macromer concentrations from 10% to 100% (w/v) 
in PBS also increases Young’s moduli within the hydrogels (from ~33 kPa to ~655 kPa), 
thus changing the local mechanical environment to which the encapsulated cells respond.  
Osteocytes in vivo are known to respond to local mechanical stimuli within the bone 
matrix, and signal to osteoblasts, based on these specific mechanical forces, for bone 
remodeling via gap junctions and mitogen-activated protein kinase pathway (MAPK) 
signaling pathway [28].  Increased mechanical stiffness of 50-100% (w/v) PEGDA 
hydrogels could have reduced the rate of osteoblast maturation, and future work would 
involve evaluating effects of local mechanical changes on the differentiation pathways of 
MSCs.     
These initial studies with bulk-polymerized scaffolds and their effects on the 
osteogenesis of MSCs allowed us to recognize a drawback of the DMD µSL system.  
Differentiation capacity of MSCs into osteoblasts decreased when encapsulating D1 cells 
at high PEGDA concentrations.  The current DMD µSL set-up can only encapsulate cells 
and photo-polymerize 100% (w/v) PEGDA scaffolds at this specific concentration 
without losing feature resolution.  Longer curing times could allow photo-polymerization 
of PEGDA at lower concentrations without losing feature resolution; however, cell 
viability would decrease due to the amount of time exposed to a harsh, non-culture 
environment.   
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  Although this drawback does exist with the DMD µSL system, another option 
for cell incorporation within the scaffolds is available and was demonstrated to be 
successful.  Cell seeding after scaffold fabrication was used to integrate cells within the 
spatially patterned 3D scaffolds.  After 2 weeks in osteogenic medium, D1 cells seeded 
within the 3D scaffolds successfully expressed all the osteoblast-specific genes analyzed.  
Keeping scaffold wall dimensions and thickness constant, the optimum channel 
parameters found to have the highest gene expression fold change, when compared to 
undifferentiated D1 cells, are with a square geometry and channel dimension of 0.4 mm 
by 0.4 mm.  Optimum pore dimensions of scaffolds for the formation of bone have also 
been characterized in literature to range from 300-400 µm (or 0.3-0.4 mm) [29], and this 
is consistent with what we find within our micro-fabricated scaffolds.  Pore dimension 
within tissue engineered constructs is a critical aspect to the types of tissues being 
generated as this important feature is also incorporated in physiological environments.  
Cancellous or trabecular bone, specifically, is known to have such similar pore 
geometries within their sponge-like matrix.  Mimicking this micro-scale feature is 
essential to in vitro 3D cultures that aim to differentiate MSCs into osteoblasts.    
Furthermore, effects of geometrical shape variations in scaffold porosities within 
in vitro systems have to be reported, but seem to alter MSCs differentiation behavior, as 
observed in our studies.  Perhaps curved surfaces as seen with the circle channel 
geometry, when compared to flat surfaces (square and triangle channels), may cause 
differences in intracellular signaling due to changes in cell shape and attachment.  
Intracellular signaling can be influenced by the surfaces to which they are attached due to 
variations in fibronectin orientation.  Curved surfaces could present fibronectin in a more 
clustered form, thus changing anchorage through the amount of cell focal adhesions 
created.  Additional studies with scaffold pore geometry within in vivo systems found in 
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literature, demonstrate that pore shape, specifically honeycomb architectures, do affect 
bone formation due to vascularization of the tissue [13].  These studies, however, only 
discuss a single, scaffold geometry and shows that increased tissue formation was 
exclusively due to the length and continuity of the pores.  Future work will focus on how 
channel and scaffold shape directly affects stem cell behavior within multi-layered 
constructs.    
Though we did observe decreased osteoblast gene expression levels with D1-
encapsulated scaffolds, we have demonstrated another promising method for integrating 
and differentiating stem cells into the patterned scaffolds by method of seeding.  Other 
limitations to the DMD µSL are light scattering and increased curing depth during the 
photo-curing process of several layers.  Problems with light scattering affects previous 
layers of multi-layered scaffolds, causing macromer crosslinking to decrease feature 
resolution within these existing layers; therefore intricate structures requiring many layers 
causes the initial layers to lose interconnective porosity.  This drawback, however, can be 
resolved using a UV quencher dye that absorbs scattered light within the bottom regions 
of the polymer solution.  Additionally a dye quencher can act to decrease the curing depth 
of the projected light at the focal plane, thereby providing thinner, or more resolved, 
layers.  These multi-layered scaffolds are currently underway using MSCs to study 
differences in total porosity and interconnective pathways within the structures.   
Furthermore, because RNA isolation and RT-PCR was performed on whole, 
homogenized scaffolds, undifferentiated MSCs could also be present within the 
constructs along with differentiated osteoblasts.  Future experiments consist of in situ 
hybridization with these multi-layered, spatially patterned scaffolds to determine which 
regions had optimal differentiation or if a differentiation gradient can be observed 
throughout a multi-layered scaffold.   
Table 5.1. DMD µSL Microfabricated Scaffold Channel Parameters 
 
       Total Channel Volume 
Geometry    square     0.048 mm3
   circle     0.048 mm3
   triangle    0.048 mm3 
 
Size    200µm x 200µm    0.012 mm3
(surface area)  400µm x 400µm    0.048 mm3









Mesh Size ± Error (Å) 
10%; long wave lamp 46.7 ± 4.05 * 
30%; long wave lamp 25.3 ± 1.1 
50%; long wave lamp 26.4 ± 4.8 
80%; long wave lamp 25.4 ± 2.1 
100%; long wave lamp 22.0 ± 1.8 
100%; DMD 28.4 ± 2.7 
 
(n=4, *: P < 0.02) 









Figure 5.3 Cell Viability: UV Lamp versus DMD µSL Fabrication. Cell viability of 
D1-encapsulated scaffolds created by UV lamp or DMD µSL was 
determined through MTT assay.  Scaffolds encapsulating D1 cells at a 
density of 20 x 106 cells/mL were bulk-polymerized using both methods, 
and optical density (OD) values were determined.   The scaffolds were 
incubated in primary medium for a 24 hour period before the addition 
of MTT.  At 100% (w/v) PEGDA concentration, cell viability was 
similar using both polymerization methods.  The 10% (w/v) PEGDA 
scaffold photo-polymerized with the UV lamp had the highest cell 
viability.  Bars represent standard error of n=4 samples, and significant 




















Figure 5.4.  Gene expression analysis of differentiated D1 cells.  End-point RT-PCR 
of D1 cells cultured in osteogenic medium for 2 weeks.  Bands for 
osteogenic-specific genes (alkaline phosphatase, collagen I, and cbfα-1) 
as well as the β-actin housekeeping gene were present, indicating that 
D1 immortalized cell line effectively differentiated into osteoblasts.  “No 
RT” lane showed that DNA contamination was not present during RT-
PCR.  Amplicon product sizes for β-actin, alkaline phosphatase, cbfα-1, 
and collagen I are 154, 150, 101, and 122, respectively. 
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Figure 5.5 Gene expression analysis of D1 cells encapsulated in patterned PEGDA 
scaffolds fabricated by DMD µSL.  The channel parameters studied for 
these scaffolds are listed in Table 5.1.  All osteoblast specific genes were 
expressed with no specific trend observed for each pattern.  Collagen I 
is depicted in (A), cbfα-1 is depicted in (B) and alkaline phosphatase is 
depicted in (C).  End point RT-PCR is depicted in (D).  The end point 
RT-PCR results do not show alkaline phosphatase expression.  Because 
there was no basal level of alkaline phosphatase activity in 
undifferentiated D1 cells, relative gene expression fold changes of 
scaffolds were still observed with real time PCR analysis.  Alkaline 
phosphatase amplicon generation is not abundant to show the presence 
of bands when performing end point RT-PCR.  Bars represent 
standard error of n=3 samples.  Collagen I expression for channel 
dimension of 0.2 mm by 0.2 mm was found to be significantly lower 
than 0.6 mm by 0.6 mm channels dimensions (*: P < 0.01).  Alkaline 
phosphatase expression for circle channel geometry was observed to be 
significantly higher than both the square and triangle channel 





Figure 5.6  Gene expression analysis for D1 cells encapsulated in bulk-polymerized 
PEGDA scaffolds using a long UV lamp.  Concentrations studied were 
10, 30, 50, 80 and 100% PEGDA (w/v) in PBS with 0.05 wt% Irgarcure 
2959 photoinitiator and 20 x 106 D1 cells/mL.  Collagen I (figure A) and 
cbfα-1 (figure B) gene expressions increase with increasing PEGDA 
concentration, whereas alkaline phosphatase (figure C) is only seen in 
10 and 30% PEGDA concentrations.  Figure (D) depicts an image of 
end-point agarose gel illustrating the genes present for each PEGDA 
concentration.  Bars represent standard error of n=3 samples.  Collagen 
I expression for 100% w/v PEGDA hydrogels was significantly higher 
than all of the other concentrations (*: P < 0.05).  The 10 and 30% 
PEGDA hydrogels were significantly lower than the 50 and 100% w/v 
PEGDA (#: P < 0.05) when comparing collagen I expression.  Cbfα-1 
expression from 10 and 30% w/v PEGDA concentrations was 
significantly lower than the 100% (&: P < 0.03).  Alkaline phosphatase 
expression was significantly highest for 10% w/v PEGDA when 
compared to all of the other PEGDA concentrations (@: P < 0.05).  
Lastly 50% was significantly higher than 80% (! : P < 0.03), and 80% 
was significantly lower than 100% w/v PEGDA (^ : P < 0.02) when 






Figure 5.7 Compression strengths of 10% and 100% w/v PEGDMA bulk-
polymerized hydrogel scaffolds.  Young’s moduli were determined for 
the lowest and highest PEG macromer solutions used in these 
experiments.  The 10% and 100% (w/v) PEGDMA solutions were 
determined to be approximately 33 kPa and 655 kPa, respectively and 
found to be significantly different (* : P < 0.01).  Bars indicate standard 
error of n=3 samples.  This significant difference in compression 





























Figure 5.8  Fluorescence micrograph of D1 seeded cells onto fibronectin-modified 
scaffolds. Phase contrast (A) and fluorescence microscopic (B) digital 
images captured after 24 hour D1 cell seeding onto fibronectin-modified 
PEGDA scaffolds (taken with a 10X objective).   Calcein AM stained 
viable cells green as seen in (B).  Scaffolds were fabricated using 1:10 
molar ratio of PEGDA:MAA using DMD µSL.  EDC/sulfo-NHS 
chemistry was used to activate the carboxyl group of MAA, and thus 
fibronectin was successfully conjugated to the amine reactive functional 
group; D1 cells efficiently attached to DMD-fabricated scaffolds.  White 




Figure 5.9 Gene expression analysis: D1 versus primary MSCs. D1 and primary 
MSCs were seeded onto separate fibronectin-modified DMD µSL 
fabricated scaffolds.  After 2 weeks in osteogenic culture, total RNA was 
removed, and gene analysis was investigated through real time RT-PCR 
and gel electrophoresis.   Comparing the ∆CT gene values of each cell 
type showed that the immortalized D1 cell line expressed higher levels 
of each gene during PCR than the primary bone-marrow derived cells.  
Figure (A) illustrates an end-point agarose gel for both cell types, 
indicating that all osteogenic genes studied were expressed.  Figure (B) 
depicts a quantitative measure of the gene expression fold change for 
D1 cells when compared to primary bone marrow-derived cells.   Bars 





Figure 5.10  Effects of channel size and geometry on the osteogenesis of D1 Cells 
seeded onto DMD µSL fabricated scaffolds.  Scaffold channel size and 
geometry were varied, and D1 cells were seeded onto DMD µSL 
fabricated scaffolds.  After 2 weeks in culture, end-point and real time 
RT-PCR were performed to determine gene presence and gene 
expression fold changes compared to undifferentiated D1 cells.  Based 
on real time PCR results (A-C), 0.4 mm by 0.4 mm channel size and 
square channel geometry had the highest gene expression fold change 
for all the bone-specific genes analyzed.  All four genes were present for 
all channel parameters studied (D).  Bars represent standard error of 
n=4 samples.  Collagen I and cbfα-1 expressions were significantly 
highest for 0.4 mm by 0.4 mm within the varying channel dimension 
group (* : P < 0.03).  Cbfα-1 expression was significantly highest the for 
square channel geometry within the varying channel shape group (* : P 
< 0.03).  Collagen I and cbfα-1 expressions for 0.2 mm by 0.2 mm 
channel dimension was significantly lower than 0.4 mm by 0.4 mm (#: P 
< 0.03).  Collagen I and cbfα-1 expressions for the circle channel 
geometry was significantly lower than the square channel geometry (% 
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Preliminary Studies: Simultaneous Differentiation of Mesenchymal 
Stem Cells within a Multi-Layered Scaffold 
 
6.1 INTRODUCTION 
The ultimate goal for creating complex, spatially-patterned scaffolds with 
temporal release-kinetics of biomolecules is to mimic the physiological 
microenvironment of differentiating stem cells.  Though differentiation is complex and 
requires a specific cascade of intracellular signaling to occur, numerous studies in cellular 
biology and tissue engineering have enabled us to better understand stem cell behavior.  
Creating hybrid structures composed of multiple cell types has gained much interest in 
the past decade due to a myriad of milestones in single phenotype differentiation of stem 
cells [1-3].  Composite tissue engineering has successfully created hybrid tissue types by 
combining multiple, committed cell types within a single construct or scaffold; however, 
a large gap exists in understanding how stem cells in the physiological environment 
undergo simultaneous differentiation into various cell types.   
Here we present preliminary results for the simultaneous differentiation of 
mesenchymal stem cells using the D1 ORL UVA immortalized cell line.  D1 cells were 
encapsulated in photo-polymerizable poly(ethylene glycol) (PEGDA) in bulk form (i.e., 
irradiated with a long wave ultra-violet lamp) and differentiated into both bone- and 
cartilage-like cells within specific regions of a single scaffold.   We discuss the 
biochemical factors used within each region to cue for either osteogenesis or 
chondrogenesis.  Results gained from these studies can be used to create complex, 
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spatially patterned scaffolds using DMD µSL, as presented in Chapter Four and Chapter 
Five. 
 
6.2 MATERIALS AND METHODS 
 
6.2.1 RGD and Heparin Conjugation to PEG 
YRGDS (tyrosine-arginine-glycine-aspartic acid-serine, Bachem Biosciences Inc., 
Torrance, CA) was reacted in equimolar amounts with acryloyl-PEG-N-
hydroxysuccinimide (acryl-PEG-NHS, Mw 3400 Nektar Therapeutics Inc.) using 50 mM 
sodium bicarbonate buffer (pH 8.2).  Briefly, acryl-PEG-NHS in 200µL of sodium 
bicarbonate buffer was added in drop-wise fashion to the YRGDS in sodium bicarbonate 
buffer (1mg/mL).  The reaction was completed in a dark environment for 3 hours at room 
temperature.  Unreacted YRGDS was removed with a MicrosepTM Centrifugal Device 
(1K membrane, Pall Corporation, East Hills, NY), lyophilized, and stored at -20°C until 
further use.  
To create a heparin moiety onto PEG-acrylates, ethylenediamine (EDA) was first 
reacted in excess with acryl-PEG-NHS at a 5:1 molar ratio to yield acryl-PEG-NH2, 
similar to the method for RGD conjugation.  The reaction was completed for 3 hours at 
room temperature in a dark environment followed by extensive dialysis (Tube-o-dialyzer, 
MWCO 1000, Geno Technologies, St. Louis, MO) of unreacted EDA.  Samples were 
frozen and lyophilized for 24 hours.  Periodated heparin (Mw 10,000 Celsus Laboratories 
Inc., USA) was reacted in equimolar amounts for 3 hours in a dark environment with 
acryl-PEG-NH2 to yield acryl-PEG-heparin in the presence of 50 mM NaBH3CN as the 
reducing agent.  Heparin, containing aldehyde moieties, undergoes Schiff-base reactions 
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with organic amines, and if treated with NaBH3CN, the Schiff-base intermediate is 
reduced to its corresponding amine, forming an irreversible bond.  Centrifugation (Pall 
Macrosep®, MWCO 10,000) was performed to eliminate the reducing agent and 
unreacted components.  The product was lyophilized and stored in a dessicator at -20°C 
until further use.  
 
6.2.2 D1 Cell Culture 
D1 ORL UVA (ATCC, Manassas, VA) bone marrow progenitor cell line was 
used to study the tissue engineering properties of the multi-layered scaffolds photo-
polymerized by a long wave ultra-violet (UV) lamp (Blak Ray®, Ted Pella Inc., Redding, 
CA).  Primary medium was composed of 10% (w/v) fetal bovine serum (ATCC) and 1% 
(w/v) penicillin streptomyocin (Gibco) in Dulbecco’s Modified Eagle’s Medium 
(ATCC).  D1 cells were passaged no more than 10 times during the course of the 
differentiation studies.  
 
6.2.3 Fabrication of Multi-layered Scaffolds 
Formulations of the macromer solutions were varied for the osteogenic and 
chondrogenic layers, as this contributes to the hybrid differentiation of D1 within a single 
scaffold.  All chemicals and reagents were either filter sterilized (0.2µm filter) or placed 
under UV light in a tissue culture hood 24 hours prior to cell encapsulation experiments.  
The macromer solution use to create the osteogenic layer was composed of 10% 
(w/v) PEGDA (Mw 3400, Nektar Therapeutics) in PBS with 0.05 wt% Irgacure 2959 
(Ciba Technologies Inc.).  D1 cells were added to the macromer solution at a 
concentration of 20 x 106 cells/mL.  The following were also added to the solution prior 
to polymerization: 2 ng/mL FGF-2, 1 mM acryl-PEG-heparin, 2 mM acryl-PEG-RGD, 
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and soluble 10 mM β-glycerophosphate.  A total volume of 125 µL was used to create the 
first layer of the scaffold by placing the macromer solution in a cuvette cap as the mold.  
The homogenous solution was then polymerized in a sterile tissue culture hood for 5 
minutes using a long wave UV lamp. 
 The chondrogenic layer was composed of 20% w/v PEGDA in PBS and 0.05 
wt% Irgacure 2959.  D1 cell density utilized was 40 x 106 cells/mL, which was twice the 
amount used for the osteogenic solution.  Furthermore, 10 ng/mL of TGF-β1 and 1.0 mM 
acryl-PEG-heparin were also added to the chondrogenic macromer solution.  A total 
volume of 125 µL of solution was then pipetted onto the top of the initial polymerized 
osteogenic layer.  It was irradiated under a UV lamp for another 5 minute period. These 
double-layered hydrogels were each placed in a well of a 6-well plate and cultured with 
D1 primary medium supplemented with 10-8 M of dexamethasone and 5 µg/mL of 
ascorbic acid-2-phosphate for a period of 4 weeks (n=4).  A schematic is illustrated of 
how each layer of the scaffold was formulated in Figure 6.1.  Control scaffolds, cultured 
in primary medium only, were composed of the same cell encapsulation densities and 
PEGDA concentrations for each layer.  β-glycerophosphate, acryl-PEG-RGD, acryl-
PEG-heparin, and growth factors were not encapsulated within these layers. 
 
6.2.4 Viability of Encapsulated D1 Cells 
Multi-layered scaffolds cultured in primary medium (control scaffolds) were 
removed from culture and stained with 2 µM calcein AM for 30 minutes at room 
temperature, which stained viable cells green.  A thin-slice was obtained from the middle 
of cell-hydrogel systems since this part of the scaffold had the least amount of 
nutrient/waste transport.  Samples were analyzed through fluorescence microscopy, and 




At a 4 week time point, double-layered scaffolds were removed from culture and 
fixed in 10% formalin at 4°C for an overnight period.  Fixed scaffolds were then 
dehydrated for paraffin embedding using 1-hr sequential steps in the following order: 
80%, 95%, 95% ethanol in dH2O, 100% ethanol, 50/50 ethanol/Citrisolv, 100% Citrisolv, 
100% Citrisolv, 60°C molten paraffin, and 60°C molten paraffin for an overnight period.  
Paraffin-embedded scaffolds were sliced in transverse sections at 10 µm using a rotary 
microtome.  Sections were stained for differentiation at the interface of the osteogenic 
and chondrogenic layers.  Von Kossa was used to stain matrix mineralization black (bone 
formation), and safranin O was used to stain excessive proteoglycan secretion red 
(cartilage formation).   
 
6.3 RESULTS 
Cells encapsulated in bulk-form using a UV lamp remained viable after 2 weeks 
in culture as illustrated in Figure 6.2 with calcein AM staining.  The dimensions of the 
entire double-layered scaffold was measured to be approximately 4mm x 4mm x 3mm 
(length x width x height).  Preliminary studies using safranin O and von Kossa staining of 
paraffin-embedded samples after 4 weeks in culture demonstrated the simultaneous 
differentiation of D1 progenitor cells.  Sections stained with safranin O showed that cells 
in the cartilage layer stained redder in color than cells in the osteogenic layer, thus 
indicating a higher proteoglycan secretion from these cells (Figure 6.3).  Since 
proteoglycans and glycosaminoglycans make up approximately 70% of the cartilage 
matrix, safranin O staining is a common histological method for marking cartilage 
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formation.  Matrix calcification as determined through von Kossa staining (black color) 
showed that increased mineralization occurred in the bone-specific layer and not so much 
in the cartilage layer (Figure 6.4).  There was some mineralization seen in the 
chondrogenic layer, and this was possibly due to the diffusion of β-glycerophosphate out 
of the osteogenic layer.  These histological methods were just initial analyses for matrix 
secretion by the encapsulated D1 cells, and a more thorough evaluation of gene 
expression, such as in situ hybridization, could be performed to ultimately determine 
mRNA synthesis from differentiating cell types.  
 
6.4 DISCUSSION 
Preliminary studies with bulk-polymerized scaffolds indicate that D1 cells have 
the potential to simultaneously differentiate into both bone and cartilage, if given the 
proper conditions.  The osteogenic region of the scaffold contained acryl-PEG-RGD 
because osteoblasts require a signaling sequence that is triggered by cell anchorage to a 
substrate.  Cell anchorage through αVβ3 integrins activates the Rho signaling pathway for 
dense cytoskeleton organization, thus changing cell shape and mechanics [4].  
Additionally FGF-2, also known as basic fibroblast growth factor, was encapsulated 
within this layer as it has been long noted in literature to be an important, early mitogen 
that allows marrow-derived stromal cells to undergo the osteogenic differentiation.  FGF-
2 is known to cause the auto-phosphorylation of tyrosine receptor kinases due to receptor 
clustering, thus activating the mitogen-activated protein kinase (MAPK) pathway.  
Transcription factor, AP-1, thus gets activated, which signals for the onset of cell 
proliferation .  Cbfα-1 is also activated, which is another commonly studied transcription 
factor that marks pre-osteoblast type cells [5]. 
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Adding heparin to the osteogenic macromer solution, in the form of acryl-PEG-
heparin, also aids in sequestering FGF-2 within this particular layer and helps prevent 
diffusion into the chondrogenic layer and medium.  Soluble β-glycerophosphate was also 
added to induce mineralization by increasing alkaline phosphatase activity, a highly 
exhibited enzymatic activity in pre-mature osteocytes.  A future consideration in 
incorporating β-glycerophosphate within  scaffolds could be to directly conjugate this 
inorganic molecule to PEG polymer, thereby preventing its diffusion to neighboring 
regions [6].   
The chondrogenic layer encapsulated the growth factor, TGF-β1, known to 
differentiate marrow-derived progenitor cells into chondrocytes.   This growth factor is 
also localized in this layer by binding to acryl-PEG-heparin.  Additionally the amount of 
D1 cells encapsulated in the chondrogenic layer was increased from 20x106 D1/mL to 
40x106 D1/mL since chondrocytes are physiologically found more condensed.  Acryl-
PEG-RGD was not included in the macromer solution because chondrocytes tend to 
adopt a more rounded shape and do not require cell anchorage.  PEGDA concentration 
was increased from 10% to 20% w/v in order to increase crosslinking density and 
compressive stress, thereby mimicking physiological cartilage.  These preliminary results 
could be used to further determine optimal conditions for the osteogenesic and 
chondrogenesic properties of marrow-derived progenitor cells, such as the following, but 
not limited to: (1) in vitro culture time period, (2) variations in cell density, (3) variations 
in PEGDA macromer concentration, (4) RGD, or heparin concentrations, and (5) 
differences in degradation rates of degradable polymers.  Once these basal parameters 
have been determined through bulk-polymerized scaffolds, more complex architectures 
could be created through DMD µSL, as discussed in Chapter Four and Chapter Five. 
  
Figure 6.1 Schematic of Multi-Layered Scaffold for the Simultaneous 
Differentiation of D1 Cells. These schematic lists the components of a 
multi-layered scaffold conducive of D1 hybrid differentiation into Bone- 
and cartilage-like cells. 
 
CARTILAGE LAYER: 
 125 µL of 20% w/v PEGDA 
 0.05 wt% Irgacure 2959 
 40 x 106 D1/mL  
 10 ng/mL TGF-β1 
 1.0 mM acryl-PEG-hepain 
BONE LAYER: 
 125 µL of 10% w/v PEGDA Chondrogenic 
 0.05 wt% Irgacure 2959 
 20 x 106 D1/mL 
 2 ng/mL FGF-2 Osteogenic 
 1 mM acryl-PEG-heparin 
 2 mM acryl-PEG-RGD 
 10 mM β-glycerophosphate   
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Figure 6.2 At a two-week time point, double-layered scaffolds cultured in basal 
medium were removed from culture and stained with 2 µM calcein AM 
for 30 minutes at room temperature.  A thin-slice was obtained from 
the middle of the cell-hydrogel construct using a surgical scalpel to 
determine if encapsulated D1 cells remained viable after a 2 week 
culture period.  Calcein AM stains viable cells green. Digital images 
were captured and fluorescence micrographs (B) revealed that 
encapsulated D1 cells remained viable.  Image depicted in (C) is an 
overlay of the brightfield micrograph in (A) and fluorescence 




Figure 6.3 Safranin O stains proteoglycans red, which comprises 70% of cartilage 
matrix.  The chondrogenic layer (A) showed cells to be redder in color 
than cells in the osteogenic layer (B), possibly indicating that each layer 
was differentiating into different lineages.   Presence of GAGs and 
proteoglycans secreted by cells were observed to be more abundant in 
the cartilage layer that the osteogenic layer.  (Brightfield microscopy 




Figure 6.4 Von Kossa stains extracellular matrix mineralization black.  (A) The 
osteogenic layer (below the white dotted line) mineralized to a greater 
extent than the chondrogenic layer (above the white dotted line).  Von 
Kossa staining was performed on paraffin-embedded samples that were 
in culture for 4 weeks.  Increased mineralization (black color) is 
abundantly seen in the bone layer, with some mineralization in the 
chondrogenic layer.  Pink color is cell nuclei staining due to nuclear fast 
red.  (B) von Kossa staining was also performed on negative control 
scaffolds that were cultured in primary medium.   No mineralization 
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Conclusions and Future Directions 
7.1 SUMMARY 
We have demonstrated novel, yet feasible, approaches in microfabricating 
complex, spatially patterned three-dimensional (3D) scaffolds for use in tissue 
engineering and stem cell behavior studies.  Ultra-violet (UV)-based layer-by-layer 
stereolithography methods were used to create intricate, polymer architectures with 
varying pore geometry and dimensions in the micro-scale.  We show that temporally-
released polymer microparticles can also be encapsulated in spatially-patterned regions of 
a single scaffold in a pre-designed fashion.  These degradable, controlled-release 
microparticles could entrap biochemical cues that are specific to the differentiation of a 
cell lineage, thereby creating a construct that can differentiate a single stem cell 
population into hybrid tissue structures.  Furthermore extracellular matrix components 
(ECM), such as small amino acid sequences, fibronectin and heparan sulfates, were 
covalently conjugated to the polymer to create a more biomimetic niche in which 
mesenchymal stem cells (MSCs) can attach, proliferate, and differentiate into multiple 
cell types, as illustrated in Figure 7.1.  This figure illustrates the overall goal discussed in 
this dissertation and how compartmentalized stem cell differentiation could be mediated.  
ECM-functionalized, microfabricated scaffolds could provide the means to study 
progenitor cell populations under patterned, complex microenvironments and ultimately 
aid in creating pre-designed, hybrid tissue/organ structures. 
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7.2 CONCLUSIONS WITH LASER-BASED STEREOLITHOGRAPHY AND FUTURE 
DIRECTIONS 
Chapter Three discussed a laser-based, layer-by-layer, photo-polymerization 
process for developing porous, polymer scaffolds in the micrometer scale.  This 
technique allowed for precise, pre-designed, spatial distribution of single or multiple 
molecules within the scaffold as well as the fabrication of intricate architectures.  This 
laser-based, stereolithographic system provided a raster-scanning style of polymerization 
using photo-crosslinkable poly(ethylene glycol) diacrylates (PEGDA).  The patterning of 
complex architectures was achieved by manually moving a translational stage in the x-y 
direction.   
We also illustrated that functionalizing PEGDA scaffolds with RGD and heparin 
ensures sufficient cell attachment and allows for spatial sequestration of patterned growth 
factors, specifically basic fibroblast growth factor (FGF-2).  FGF-2 was demonstrated to 
be localized in certain regions of a scaffold due to the presence of heparin, which is 
known to bind and protect growth factors from heat degradation.  Heparin also enhanced 
growth factor chemical signaling by clustering FGF-2 to cell tyrosine kinase receptors, 
thus enabling their phosphorylation.  FGF-2 is a crucial signaling molecule for the 
osteogenic differentiation of MSCs; therefore concentrations of this protein in specific 
regions of a scaffold can facilitate localized bone formation.  Furthermore, RGD, a small 
amino acid sequence derived from fibronectin, enabled protein and cellular attachment to 
the non-fouling PEGDA polymer. 
Two future directions specific to the laser-based manufacturing of the scaffold 
could be taken.  First, the viability rate of encapsulated cells could be increased by 
increasing the speed of the layer-by-layer fabrication process. Secondly, staggered layers 
or overhanging structures, to ensure pore interconnectivity, have yet to be achieved with 
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this system due to an increased laser depth of focus and monomer cross-linking in pre-
existing layers.  In traditional stereolithography, such overhanging structures are quite 
prevalent and are generally accomplished using a sacrificial filler material.  Using 
advanced SL techniques such as this could allow for more complex structures.   
Another recommendation for enhancing this system to is determine the effects of 
biochemical cross-contamination between the uses of various types of solutions. 
Although our results indicated that we can successfully pattern several components, it 
remained to be seen how complex the patterning can be before mixing becomes a 
problem.  However, we believe that even simple 3D spatial patterns can provide us with 
unique insights on cell behavior under complex microenvironments.   
 
7.3 CONCLUSIONS AND FUTURE DIRECTIONS WITH DIGITAL MICROMIRROR 
DEVICE (DMD)-BASED STEREOLITHOGRAPHY 
We demonstrated in Chapter Four that DMD-µSL was another powerful 
stereolithographic technology that can create pre-designed, spatially patterned scaffolds 
for applications in stem cell and tissue engineering.  We have developed a simple and 
feasible, layer-by-layer micro-stereolithography system consisting of an UV light source, 
a digital micro-mirror masking device, and a conventional computer projector, that 
allows fabrication of complex internal features along with precise spatial distribution of 
biological factors inside a single scaffold.  These scaffolds were suitable for the 
encapsulation of single or multiple cell types in a spatially distributed fashion.  The main 
advantage of using this scaffold fabrication system over the laser-based system presented 
in Chapter Three or other stereolithography methods was that the photo-polymerization 
of an entire single layer is achieved simultaneously, and ultimately a 3D construct was 
achieved by “building” subsequent layers by exchanging polymer solution in between.  
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Functionalizing the patterned scaffolds with fibronectin after fabrication created a 
microenvironment suitable for the attachment, proliferation, and differentiation of MSCs.  
By the addition of methacrylic acid to the PEGDA macromer solution, carboxyl 
activation (from methacrylic acid) could bind with free amine groups from fibronectin.  
Post-processing these scaffolds using standard EDC/sulfo-NHS bio-conjugation methods 
allowed fibronectin to be successfully conjugated to the surfaces of the scaffolds.  MSCs 
were seeded onto the spatially patterned scaffolds and efficiently attach.  Similarly to the 
scaffolds created with the laser-based SL system, these spatially patterned, DMD-
fabricated scaffolds could ultimately consist of intricate architectures that combine both 
spatial and controlled-release kinetics of biochemical factors, creating a suitable 
environment for studying hybrid tissue formation from a single stem cell population. 
In this research project, MSCs were successfully encapsulated with DMD-µSL.  
A promising next step would be to use multiple progenitor or committed cell types, 
mimicking a more complex physiological tissue/organ.  The ability to do both cell 
encapsulation and seeding would be the most optimum for incorporating cells within the 
structures.   
 
7.4 CONCLUSIONS AND FUTURE DIRECTIONS WITH THE OSTEOGENIC 
DIFFERENTIATION MSCS ON DMD-FABRICATED TISSUE ENGINEERING SCAFFOLDS 
In Chapter Five, the osteogenic properties of murine MSCs are further analyzed 
using patterned PEGDA scaffolds fabricated by the DMD-µSL system.  MSC 
differentiation in bulk-polymerized PEGDA scaffolds, created using a long wave UV 
lamp, is also investigated in this chapter.  This particular study involve encapsulating 
MSCs in bulk-form within increasingly concentrated PEGDA solutions to determine 
changes in osteogenic gene expression levels when compared to undifferentiated MSCs.  
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Results obtained from this investigation allowed us to realize a limitation with the DMD-
SL system: when MSCs were encapsulated in a scaffold with a high PEGDA 
concentration (100% w/v in PBS), maturation of osteoblasts was inhibited due to 
decreased cell nutrient and waste transport and changes in compression moduli.  
Currently the DMD-µSL system can encapsulate cells without losing feature resolution 
only when using a high macromer concentration (100% w/v PEGDA in PBS).  Lower 
PEGDA concentrations could be used to create the scaffolds, but increased exposure time 
to polymerize the macromer solution could ultimately decrease cell viability.   
Instead of encapsulation, MSCs were then seeded onto fibronectin-modified 
patterned scaffolds after fabrication, and osteogenic medium was used to culture the cell-
scaffold systems.  Scaffold channel size and geometry were varied, while keeping wall 
dimension and overall scaffold thickness constant.  Additionally channel volumes of 
scaffolds with varying pore geometry were also kept constant. After 2 week in culture, 
osteoblast gene expression levels (collagen I, cbfα-1, and alkaline phosphatase) were 
analyzed, and the highest MSCs differentiation gene expressions were determined to be 
on scaffolds with a channel dimension of 0.4 mm by 0.4 mm and with a square channel 
geometry.  It was also determined in these studies that an immortalized MSCs cell line, 
D1 ORL UVA, expressed higher osteoblast gene expression than primary bone-marrow 
derived cells when cultured in osteogenic medium for 2 weeks; therefore all osteoblast 
differentiation studies were used with the D1 immortalized cell line to remove cell source 
as a originator of variance. 
Other limitations to the DMD-µSL system that could be further investigated are 
light scattering and increased curing depth during the photo-curing process of several 
layers.  Challenges with light scattering affected previously fabricated layers of multi-
layered scaffolds, causing macromer crosslinking to decrease feature resolution within 
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these existing layers.  More intricate structures requiring several layers cause the bottom 
layers to lose interconnective porosity.  However, this drawback can be resolved using a 
UV quencher dye that absorbs scattered light within the bottom regions of the polymer 
solution.  Additionally a dye quencher can act to decrease the curing depth of the 
projected light at the focal plane, thereby providing thinner, or more resolved, layers.  We 
conclude that complex, polymer scaffolds fabricated with UV stereolithography can 
mimic the niche in which MSCs can differentiate into multiple cell types.  By combining 
knowledge gained from stem cell biology and spatio-temporally patterned scaffolds, 
hybrid tissue structures from a single stem cell population can ultimately be achieved.  
Chapter Six discusses preliminary studies with hybrid tissue formation by encapsulating 
MSCs in a multi-layered scaffold.  Specific biochemical parameters were added within 
separate layers of a multi-layered scaffold to induce the simultaneous differentiation of 
bone- and cartilage-like cells.  Histology on these composite scaffolds was performed 
after a 4 week culture period in vitro.  Future work involves determining optimum 
parameters for these biochemical factors, and then utilizing these results within DMD 
µSL fabricated scaffolds.      










Visible Light-based Digital Micromirror Device (DMD) Micro-
Stereolithography 
A.1 INTRODUCTION 
Photo-polymerization is considered to be an attractive process in the biomedical 
sciences due to a myriad of applications [1, 2] in solidifying a liquid macromer solution 
to match a defect site.  We have studied two forms of stereolithography processes that 
involve the use of photo-polymerizing acrylated monomers, as discussed in Chapters 
There and Four.  During the initial stages of creating a digital micro-mirror device-based 
micro-stereolithography system (DMD µSL), both visible and ultra-violet (UV) light 
sources were considered in fabricating complex tissue engineering scaffolds.  This 
appendix discusses polymerization and cell viability results with two types of visible 
photoinitiating systems studied with the encapsulation of murine OP9 stromal cells: 
2,4,5,7-tetraiodo-6-hydroxy-3-fluorone (H-Nu 535) and camphorquinone (CQ).  
Additionally a profile of light intensity versus photomask pixel luminance used with the 
visible-DMD µSL was also determined.   Based on this analysis, we utilized the UV-
based DMD µSL system to ultimately create scaffolds for stem cell differentiation 
studies.  
 
A.2 MATERIALS AND METHODS 
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A.2.1 Visible DMD-µSL 
The visible-based stereolithography system used in this study was fabricated the 
same way the UV-based DMD-µSL was created in Chapter Four.  The high intensity 
white light originally built into the commercial projector (PB2120, BenQ, Taiwan) was 
used for this system.  This was the only modification to the system, as described in 
Chapter Four.  The commercial projector was coupled to a digital micro-mirror device 
(DMDTM, Texas Instruments) and the patterns of each layer were drawn in a series of 
Microsoft PowerPoint slides.  These patterns were then executed onto the DMD chip to 
generate a dynamic mask.   
Visible light was modulated according to the defined mask on the DMD chip and 
went through a reduction-projection lens assembly to form an image on the surface of the 
photo-crosslinkable macromer solution. The illuminated area was solidified 
simultaneously under one exposure, while the dark regions remained liquid.  This system 
consisted of five major components: a DMD chip embedded within the projector as a 
dynamic mask, a visible light source, a projection lens assembly, a translation stage with 
capable of micrometer movements, and a container to hold the macromer solution. 
 
A.2.2 H-Nu 535 Visible Photoinitiating System 
Concentrations of 10% and 30% w/v poly(ethylene glycol) diacrylate (PEGDA) 
in PBS were utilized when evaluating a visible photoinitiator (H-Nu 535, Spectra Group 
Limited, Inc.) and the DMD µSL system.  The visible photoinitiator comes with three 
components: H-Nu 535, Uvacure 1600 OPPI (a coinitiator), and a liquid amine group, 
which provides hydrogens for a more efficient rate of initiation. These components were 
not soluble in the macromer solution alone and were therefore added to N-vinyl 
pyrrolidone (n-PVP) at a concentration of 10% (w/v).  Furthermore these components 
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were heated at 50°C for approximately 2 hours, as recommended by the manufacturer.  
Upon solubilizing, the photoinitiator was added to the PEGDA solutions, at 
concentrations ranging from 0.05-0.10% (w/v) in macromer solution.  Minimum 
exposure time to pattern-polymerize PEGDA macromer solution was determined.   
 
A.2.3 Cell Viability  
Each component of the visible-based DMD µSL system was evaluated separately 
to determine if any of the components were toxic to cells.  While creating a white 
photomask on MS PowerPoint (255 pixel luminance value), OP9 cells seeded in a 96-
well plate (~50,000 cells/cm2) were irradiated for 1, 2.5, 5,10, and 15 minutes  (n=5).  A 
maximum irradiation time of 15 minutes was chosen because this was the maximum time 
the cells would have to endure for the polymerization of a single hydrogel layer while 
using a low photoinitiator concentration.  Methyl thiazolyl tetrazolium (MTT) assay was 
completed after a 24 hour incubation period to determine relative survival when 
compared to non-irradiated cells. 
Cyto-toxicity of H-Nu 535, OPPI coinitiator, and the liquid amine group without 
visible light irradiation was determined individually. To evaluate for photoinitiator cell 
toxicity, each photoinitiating component was directly placed in a monolayer culture of 
OP9 cells (density of 50,000 cells/cm2) at two different concentrations: 0.05 and 0.1% 
(w/v).  MTT assay was performed after a 24-hour incubation period with the initiators.   
n-PVP alone was also filter sterilized and directly added to separate OP9 cell culture 
wells.  After a 24 hour incubation time, cultures were observed through microscopy. 
 167
 
A.2.4 Camphorquinone Visible Photoinitiating System 
Camphorquinone (CQ) was another visible photoinitiator used to study patterned-
polymerization of visible DMD µSL.  Cell viability using this photoinitiating system was 
previously studied by Bryant et. al. [3].  Macromer solutions of 30% and 100% (w/v) 
PEGDA with 0.05 wt% CQ system were used to encapsulate OP9 cells (density 3x106 
cells/mL) for approximately 7 and 18 minutes respectively, using DMD µSL.  A 10 µL 
PEG-cell solution was placed onto a coverslip and irradiated using a high intensity solid 
photomask (255 pixel luminance).  Cell-gel systems were washed extensively with sterile 
PBS and were incubated for a 24 hour period before performing MTT assay (n=3).  
To determine if cells could be effectively encapsulated using visible DMD µSL, 
OP9 cells were added to 30% (w/v) PEGDA in PBS and 0.05 wt% CQ photoinitiator.  
Cell densities tested were  1 x 106 and 5 x 106  OP9 cells/mL of macromer solution.  
Scaffolds were observed using phase contrast microscopy, and digital images were 
captured. 
 
A.3 RESULTS AND DISCUSSION 
Microsoft PowerPoint was used to create slides containing different pixel 
luminance (ranging from 0 to 255) as a solid photomask.  Using a power meter, the 
intensity was calculated by dividing the measured power by the area of irradiation.  The 
area of irradiation from the visible DMD µSL was measured to be 3 mm x 4 mm (or 0.12 
cm2).  Figure A.1 illustrates intensity versus pixel luminance graph.  Increasing pixel 
luminance from 0 to 255 resulted in increased intensity.  The minimum amount of time 
required to polymerize either 10% or 30% (w/w) of PEGDA in PBS using H-Nu 535 
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photointiator without losing feature resolution was determined, and these results are 
summarized in Table A.1. 
Visible light from the DMD µSL system did not exclusively effect cell viability as 
determined through MTT and depicted in Figure A.2 (n=2).  Relative cell survival was 
above 80% for all exposure times studied without the use of photoinitiating systems.  
Because it was determined that visible light was not toxic to cells, components of the H-
Nu 535 photoinitiating system was studied.  H-Nu 535, OPPI coinitiator, and liquid 
amine group were individually added to OP9 cells and resulted in 41% cell viability or 
higher, as illustrated in Figure A.3.  It was found that these components had varying 
levels of toxicity on an individual basis.  OPPI had the greatest affect on cell apoptosis 
with a 41% mean relative survival rate for both concentrations studied.  The amine liquid 
group varied for the 0.05 and 0.10%, with a mean relative survival rate of 87% and 41%, 
respectively.  H-Nu 535 had a mean survival rate of at least 66%.  Because these 
chemicals are not soluble in aqueous solutions, it was necessary to add them into n-PVP 
before solubilizing in macromer solutions.  Cell cultures treated with the photoinitiator in 
n-PVP detached from the plate, showing that this specific photoinitiating system is cyto-
toxic.  Furthermore, it was also determined that direct addition of sterile n-PVP to OP9 
cells resulted in complete cell death after a 24 hour incubation time.  All cells were 
observed floating in the medium when compared to the control group. 
Using CQ photoinitiating system to encapsulate D1 cells with visible DMD µSL 
resulted in the relative mean survival rates for 30% and 100% to be less than 65% and 
56%, respectively, when compared to OP9 cells cultured in monolayer.  Literature 
discusses that CQ photoinitiator is not cyto-toxic at levels below 0.01 wt%; however the 
PEGDA concentrations used in this study did not polymerize at such a low photoinitiator 
concentration, and 0.05 wt% was the lowest concentration necessary to obtain PEGDA 
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crosslinking using DMD µSL.  Furthermore when cells were encapsulated using 
patterned photomasks, feature resolution was lost during photo-polymerization (Figure 
A.5).  Increased concentrations of cells within the macromer solution  (from 1 x 106 to 5 x 
106  OP9 cells/mL) caused increased light diffraction, thus polymerizing other areas of 
the scaffolds.  Figure A.5B shows that an entire layer was polymerized when using a cell 
density of 5 x 106 OP9 cells/mL, and no scaffold porosity could be observed.       
Based on these photo-polymerization studies, it was determined that the H-Nu 
535 photoinitiating system was not cyto-compatible due to the necessity of n-PVP 
solution.  However, n-PVP itself was also found to be detrimental to cells.  Furthermore, 
CQ photoinitiator polymerizes PEGDA solution with OP9 cells using DMD µSL and is a 
more common compound used in dental applications.  Although CQ proves to be a 
promising chemical compound to initiate chain polymerization, feature resolution of 
scaffolds was still not attainable when encapsulating cells.  These studies confirmed that 
ultra-violet based DMD µSL (as discussed in Chapter Four) was a better method of 
fabricating pre-designed, spatially patterned scaffolds, since shorter wavelengths are 
higher in energy. 
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Table A.1 Minimum Polymerization Time Using Visible Photoinitiator 
 
Solution 
Minimum Time for 
Polymerization 
(minutes) 
10% (w/w) PEG in PBS; 0.05 wt% H-Nu 535 14 
10% (w/w) PEG in PBS; 0.07 wt% H-Nu 535 10 
10% (w/w) PEG in PBS; 0.10 wt% H-Nu 535 8-10 
30% (w/w) PEG in PBS; 0.05 wt% H-Nu 535 6 
30% (w/w) PEG in PBS; 0.07 wt% H-Nu 535 6-8 
30% (w/w) PEG in PBS; 0.10 wt% H-Nu 535 6 





















Figure A.2 Cell Viability of Irradiated Cells using Visible DMD µSL.  MTT assay 
shows that visible light irradiation using DMD µSL does not effect OP9 
cell viability after 24 hours in culture.  Exposure times varied from 0 to 
15 minutes, and relative survival did not go below 80% when compared 























Figure A.3 Cell Viability of H-Nu 535 Photoinitiating System.  MTT assay shows 
that individual components of the H-Nu 535 photoinitiating system 
were toxic to OP9 cells, even without visible light exposure. OPPI 
component seemed to be the most toxic with approximately 41% 
relative survival mean for both concentrations evaluated. H-Nu 535 had 
over 65% relative survival mean for both concentrations.  The amine 
component greatly reduced cell viability at a higher concentration.  
Relative survival was determined by comparing to scaffolds that did not 






























Figure A.4 Cell viability of encapsulated OP9 cells using visible DMD µSL and 
camphorquinone photoinitiating system at a concentration of 0.05% 
(w/v) was evaluated using MTT assay.  After a 24 hour incubation 
period, relative mean survival rates of encapsulated D1 cells were 
determined to be less that 65% for the 30% (w/v) PEGDA solution and 
56% for the 100% (w/v) PEGDA solution.  Bars represent standard 



























Figure A.5 Scaffolds Encapsulating Cells using Visible DMD µSL.  Patterned 
scaffolds were formulated with 30% PEGDA and polymerized for 10 
minutes using visible DMD µSL.  (A) OP9 cells were encapsulated in 
scaffolds at a density of 1x106 OP9/mL with a wall thickness dimension 
of 200µm.  Cells were encapsulated but feature resolution was 
sacrificed.  (B) This scaffold encapsulated a higher OP9 density (5x106 
OP9/mL) and the entire scaffold layer was polymerized while using a 
patterned photomask.  Scaffold wall dimension was kept constant.  
These results indicate that visible DMD-mSL does not encapsulate OP9 
within spatially-patterned scaffolds.  Diffraction due to the presence of 
cells causes polymerization all throughout the layer, even with a 
patterned photomask.  Feature resolution is lost when cells are added 
into the macromer solution; therefore UV DMD µSL was ultimately 
chosen to create these patterned scaffolds.   Black scale bar is equal to 
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Basic Fibroblast Growth Factor (FGF-2) Release from Heparin-
modified Poly(ethylene glycol) Hydrogels 
B.1 INTRODUCTION 
FGF-2 is a well-characterized protein that binds to heparan sulfates 
glycosaminoglycans (GAGs) while promoting cell proliferation and playing a critical role 
in osteoblast formation from mesenchymal progenitor cells.  Because proteins and other 
growth factors are unstable under physiological conditions due to heat and pH changes, 
heparin acts to stabilize FGF-2 both in vivo and in vitro.  In our studies, heparin is used to 
not only protect the signaling provided by FGF-2, but to localize this particular growth 
factor within a specific region of a patterned scaffold.  As initially stated in specific aim 
2, sequestration studies of basic fibroblast growth factor (FGF-2) to heparin modified 
scaffolds were to be studied.  This section summarizes experimental attempts in 
quantifying FGF-2 release studies from heparin-modified scaffolds and future 
recommendations to further analyze conflicting results obtained from this study.   
 
B.2 MATERIALS AND METHODS 
 
B.2.1 Heparin Conjugation to PEG Monomer 
As previously reported, heparin was conjugated to acryl-PEG by first reacting 
ethylenediamine (EDA) in excess with acryloyl-PEG-N-hydroxysuccinimide (acryl-PEG-
NHS, Nektar Therapeutics) at a 5:1 molar ratio to yield acryl-PEG-NH2.  The reaction 
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was completed for 3 hours at room temperature in a dark environment followed by 
dialysis (Tube-o-dialyzer, MWCO 1000, Geno Technologies, St. Louis, MO) to remove 
unreacted EDA.  Samples were frozen and lyophilized for 24 hours.   
Periodated heparin (Mw 10,000 Celsus Laboratories Inc., USA) was then reacted 
in equimolar amounts for 3 hours in a dark environment with acryl-PEG-NH2 to yield 
acryl-PEG-heparin in the presence of 50 mM NaBH3CN as the reducing agent.  Filtration 
through centrifugation (Pall Macrosep®, MWCO 10,000) was performed to eliminate the 
reducing agent and unreacted components.  The product was lyophilized and stored in a 
dessicator at -20°C until further use.  
 
B.2.2 Native PAGE  
To ensure FGF-2 binds to synthesized acryl-PEG-heparin, native polyacrylamide 
gel electrophoresis (PAGE) was performed on FGF-2 and acryl-PEG-heparin samples.  A 
total amount of 200 ng FGF-2 (Cell Sciences) was added to 4 mg acryl-PEG-heparin 
(1:20,000 molar ratio FGF-2:acryl-PEG-hep) using 100µL of PBS as the buffer solution.  
The samples were placed on a rotator at 37°C for a 2 hour binding period.  A pre-cast 
polyacrylamide gel (4-20% Ready Gel, Tris-HCL, Bio-Rad) was used to load acryl-PEG-
heparin with and without FGF-2.  Silver staining method was used to stain for bound 
FGF-2.       
 
B.2.3 Cumulative Release of FGF-2 from Heparin-modified PEGDA Hydrogels 
FGF-2 (4 ng) was encapsulated in a 200µL solution of 20% w/v poly(ethylene 
glycol) diacrylate (PEGDA) in PBS and 0.1 wt% Irgacure 2959 using a long wave ultra-
violet (UV) lamp and an irradiation time of 10 minutes (n=3).  A 1.0 mM concentration 
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of  acryl-PEG-heparin was then added to another 200µl 20% PEGDA, as well as 4 ng of 
FGF-2 (n=3); these hydrogels were also created by polymerizing with a UV lamp for 10 
minutes (n=3).  Each hydrogel was placed in 4 mL of PBS and rotated at 37°C.  150µL 
was extracted from each sample at (1, 6hr, 12hr, 24hr, 48hr, 7d, 14d, and 21d time points) 
and replaced with fresh 150µL PBS each time.  Sandwich ELISA (R&D Systems) was 
performed on these extracted solutions to determine the cumulative release of FGF-2 
from the heparin-modified and unmodified PEGDA hydrogels.   
 
B.3 RESULTS AND DISCUSSION 
FGF-2 binding affinity to acryl-PEG-heparin was not affected after periodated-
heparin conjugation to acryl-PEG-NH2, as illustrated with native PAGE in Figure B.1.  
Silver staining marks nanogram amounts of protein dark brown/black, and lane 2 in this 
figure shows that FGF-2 is present and bound to heparin-modified PEG.  The negative 
control, acryl-PEG-heparin without any FGF-2, does not stain brown/black, thus 
indicating that the presence of a band is exclusively due to FGF-2.  Heparin is a type of 
GAGs composed of repeating disaccharide units made up of alternating uronic acid and 
glucosamine residues.  GAGs usually have extended conformations that occupy a huge 
volume relative to their mass and are highly negatively charged.  Heparin plays an 
important role chemical signaling between cells by binding to certain molecules, such as 
FGF-2, and causing their aggregation.  This clustering causes FGF-2 to crosslink, thus 
activating their transmembrane tyrosine kinase receptors.  FGF-2 affinity to heparin is 
mainly due to ionic interactions with some hydrogen bonding, van der Waals, and 
hydrophobic interactions. 
It was initially speculated that encapsulated FGF-2 would be sequestered more in 
PEGDA scaffolds containing heparin; however FGF-2 release studies from heparin-
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modified and unmodified bulk-polymerized gels do not confirm this hypothesis.  The first 
study was performed over a 48 hour period, as illustrated in Figure B.2(A), and scaffolds 
with 1.0 mM acryl-PEG-heparin actually released 3% more FGF-2 than scaffolds 
without.  This study was then repeated for a longer incubation time period of 21 days 
total since the initial study was only completed for a 48 hour period.    Results from this 
study confirmed the same release data from the initial studies: increased FGF-2 release 
was observed from heparin-modified scaffolds, as depicted in Figure B.2B.  
Future studies recommended to further analyze these conflicting results involve 
studying the mesh sizes between the modified and unmodified scaffolds.  There could 
also be the possibility of unpolymerized acryl-PEG-heparin that has not diffused out of 
the polymerized hydrogels.  The supernatant solution should also be analyzed of 
unconjugated acryl-PEG-heparin, thus also increasing the amount of FGF-2 in the 
solution.  Instead of encapsulating FGF-2, the protein could also be added to the 
supernatant solution of the hydrogels after washing the scaffold extensively to remove 
unreacted acryl-PEG-heparin.  Since heparin has a high density of negative charges, 
cations (such as Na+) are attracted, causing hydrogels to be more osmotically active with 
large volumes of water diffusing into the polymer mesh.  The mesh sizes of both polymer 
meshes should also be evaluated to compare FGF-2 diffusion throughout the scaffold.          
 
Figure B.1 Native PAGE and silver staining indicate that FGF-2 still binds to 
heparin even after conjugation to acryl-PEG-NH2.  Lane 1 shows acryl-
PEG-heparin without FGF-2 (as the negative control) and lane 2 shows 
acryl-PEG-heparin with FGF-2.   Silver staining stains proteins a dark 
brown color, and this staining is only observed in lane 2 due to the 
presence of FGF-2.   The negative control (lane 1) does not stain for 
protein, indicating that acryl-PEG-heparin exclusively does not stain 
during the addition of silver staining components. 
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Figure B.2 FGF-2 release from unmodified PEGDA and PEGDA with 1.0 mM 
acryl-PEG-heparin was determined through sandwich ELISA.   Graph 
(A) depicts a time period of 48 hr and graph (B) depicts a time period of 
21 days.  Results were contrary to what was hypothesized: hydrogels 
modified with heparin released more FGF-2 than hydrogels that did not 
contain any heparin, even for a 3 week incubation period.  Bars indicate 
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